#chr	start	end	ref	obs	genotype	quality	gene	variant_type	coding_and_splicing	1000g	ExAC	gnomAD	dbSNP	ljb2_phylop	ljb2_mt	ljb2_sift	ljb2_pp2hvar	esp6500si_ea	cosmic64	RepeatMasker	OMIM	ClinVar	ihdb_hom_80	ihdb_het_80	ihdb_wt_80	ihdb_allsys	classification	validated
chrX	2724760	2724760	T	C	hom	222	XG	nonsynonymous SNV	XG:NM_001141919:exon8:c.T392C:p.L131P,	0.97	0.9	0.3	rs111382948 [];	0.1390		0.3400	0.0000	0.9975					0.95	0	0.05	141		
chrX	2726396	2726396	A	G	hom	194	XG			0.96	0.96	0.96	rs6567645 [];										0.4375	0	0.5625	46		
chrX	2729552	2729552	-	A	hom	214	XG			0	0	0											0.3375	0.0125	0.65	41		
chrX	2732367	2732367	-	T	hom	101	XG			0	0	0											0.2125	0	0.7875	40		
chrX	2733109	2733109	T	G	hom	222	XG			0.72	0.72	0.72	rs5939124 [];										0.775	0.0375	0.1875	76		
chrX	2733210	2733210	G	A	hom	222	XG			0.71	0.71	0.71	rs5939125 [];										0.7875	0.0375	0.175	78		
chrX	2733276	2733276	G	A	hom	222	XG			0.91	0.91	0.91	rs5939339 [];										0.975	0	0.025	94		
chrX	2733641	2733641	A	G	hom	222	XG			0.75	0.75	0.75	rs3672 [];										0.8625	0.025	0.1125	89		
chrX	2733668	2733668	G	A	hom	222	XG			0.74	0.74	0.74	rs3671 [];										0.7625	0.0375	0.2	78		
chrX	2733845	2733845	-	TACACACACACACA	hom	135	XG			0	0	0								198			0.025	0.0125	0.9625	5		
chrX	2733863	2733863	-	CACACACACACACACC	hom	214	XG			0	0	0								198			0.4625	0	0.5375	46		
chrX	2748051	2748051	T	C	hom	79.3	GYG2			0.75	0.75	0.75	rs57068689 [];										0.35	0	0.65	35		
chrX	2748253	2748253	G	C	hom	222	GYG2			0.93	0.93	0.93	rs55640257 [];					0.9941					0.4375	0	0.5625	95		
chrX	2748292	2748292	C	G	hom	222	GYG2			0.67	0.67	0.67	rs6641656 [];										0.35	0.0125	0.6375	83		
chrX	2774478	2774478	A	G	hom	222	GYG2			0.98	0.98	0.98	rs5939132 [];										0.4375	0	0.5625	46		
chrX	2774700	2774700	T	G	hom	222	GYG2			0.34	0.34	0.34	rs5939133 [];					0.2765					0.0125	0.0625	0.925	18		
chrX	2774761	2774764	TCTA	-	hom	214	GYG2			0	0	0	rs142907396 [];							702			0.075	0.025	0.9	14		
chrX	2800295	2800295	G	C	hom	222	GYG2			0.81	0.81	0.81	rs211660 [];										0.9125	0.0375	0.05	88		
chrX	2800624	2800624	G	T	hom	222	GYG2			0.54	0.54	0.54	rs1269 [];										0.6125	0.0875	0.3	64		
chrX	2800677	2800677	A	G	hom	222	GYG2			0.68	0.68	0.68	rs1268 [];										0.6	0.1	0.3	65		
chrX	2821978	2821978	A	C	hom	222	ARSD			0.22	0.22	0.22	rs61619902 [];										0.075	0.05	0.875	11		
chrX	2821979	2821979	G	T	hom	222	ARSD			0.18	0.18	0.18	rs4141211 [];										0.075	0.05	0.875	11		
chrX	2832618	2832618	G	T	het	42	ARSD			0	0	0	rs73632952 [];										0	0.2125	0.7875	24		
chrX	2832661	2832661	A	T	het	94	ARSD			0	0	0	rs111318153 [];										0	0.4625	0.5375	61		
chrX	2832668	2832668	A	G	het	35	ARSD			0.0024	0.0024	0.0024	rs139484145 [];	-0.7670	0.0000								0	0.25	0.75	39		
chrX	2832742	2832742	G	C	hom	222	ARSD			0.76	0.76	0.76	rs211648 [];	-1.5460	0.0000	0.0300	0.0000	0.6253					0.5125	0.3625	0.125	122		
chrX	2832771	2832771	C	T	het	225	ARSD			0.0012	0.0012	0.0012	rs78142040 [];										0	0.8	0.2	110		
chrX	2832787	2832787	A	G	het	225	ARSD			0	0	0	rs73632954 [];	-0.1320	0.0002	0.5200	0.0030						0	0.8	0.2	110		
chrX	2832860	2832860	G	A	het	225	ARSD			0	0	0	rs73632955 [];										0	0.3375	0.6625	54		
chrX	2832871	2832871	A	G	het	225	ARSD			0	0	0	rs115343387 [];										0	0.3375	0.6625	37		
chrX	2832881	2832881	-	AT	het	211	ARSD			0	0	0	rs72264262 [];										0	0.3375	0.6625	37		
chrX	2832937	2832937	A	G	het	79	ARSD			0	0	0								1640			0	0.3375	0.6625	37		
chrX	2833506	2833506	G	C	het	170	ARSD			0.76	0.76	0.76	rs211649 [];										0.125	0.1125	0.7625	25		
chrX	2833507	2833507	T	C	het	22	ARSD			0	0	0	rs73632956 [];										0	0.025	0.975	5		
chrX	2833551	2833551	A	T	het	40	ARSD			0	0	0	rs114724695 [];										0	0.1125	0.8875	17		
chrX	2833552	2833552	C	G	het	64	ARSD			0.01	0.01	0.01	rs115030126 [];										0	0.1125	0.8875	17		
chrX	2833580	2833580	A	G	het	90	ARSD			0.0036	0.0036	0.0036	rs112594989 [];										0	0.275	0.725	46		
chrX	2833749	2833749	T	C	het	94	ARSD			0	0	0	rs112924969 [];										0	0.15	0.85	22		
chrX	2833752	2833752	C	T	het	102	ARSD			0	0	0	rs115063380 [];										0	0.125	0.875	18		
chrX	2835831	2835831	C	T	het	180	ARSD			0.07	0.07	0.07	rs75490251 [];										0	0.3375	0.6625	55		
chrX	2835863	2835863	G	T	het	225	ARSD	nonsynonymous SNV	ARSD:NM_001669:exon5:c.C845A:p.A282D,	0.08	0.08	0.08	rs78034736 [];	1.3380	0.9429	0.0000	0.9930						0	0.8125	0.1875	112		
chrX	2835964	2835964	G	A	het	225	ARSD	synonymous SNV	ARSD:NM_001669:exon5:c.C744T:p.F248F,	0	0	0	rs73632972 [];										0	0.825	0.175	112		
chrX	2836037	2836037	G	C	het	225	ARSD	nonsynonymous SNV	ARSD:NM_001669:exon5:c.C671G:p.S224C,	0.41	0.41	0.41	rs211653 [];	0.3420	0.0967	0.2300	0.1790	0.4505					0.0125	0.4125	0.575	56		
chrX	2836041	2836041	A	T	het	171	ARSD	nonsynonymous SNV	ARSD:NM_001669:exon5:c.T667A:p.F223I,	0	0	0	rs67272620 [];	-1.3810	0.0000	0.6900	0.0060						0	0.8	0.2	99		
chrX	2836047	2836047	C	T	het	176	ARSD	nonsynonymous SNV	ARSD:NM_001669:exon5:c.G661A:p.G221S,	0.06	0.06	0.06	rs67359049 [];	0.3830	0.1782	0.1400	0.9430						0	0.8	0.2	99		
chrX	2836060	2836060	G	A	het	150	ARSD	synonymous SNV	ARSD:NM_001669:exon5:c.C648T:p.A216A,	0.07	0.07	0.07	rs113318393 [];										0	0.8125	0.1875	103		
chrX	2836084	2836084	C	G	het	188	ARSD	synonymous SNV	ARSD:NM_001669:exon5:c.G624C:p.A208A,	0.07	0.07	0.07	rs73632973 [];										0	0.8125	0.1875	106		
chrX	2836138	2836138	G	A	het	225	ARSD	synonymous SNV	ARSD:NM_001669:exon5:c.C570T:p.P190P,	0.07	0.07	0.07	rs73632974 [];										0	0.8125	0.1875	105		
chrX	2836181	2836181	A	T	het	127	ARSD	nonsynonymous SNV	ARSD:NM_001669:exon5:c.T527A:p.M176K,	0.09	0.09	0.09	rs73632975 [];	1.1320	0.1479	0.0300	0.2480						0	0.8125	0.1875	117		
chrX	2836184	2836184	C	T	het	109	ARSD	nonsynonymous SNV	ARSD:NM_001669:exon5:c.G524A:p.G175D,	0.08	0.08	0.08	rs73632976 [];	1.3940	0.9369	0.0100	0.8830						0	0.8125	0.1875	113		
chrX	2836211	2836211	A	T	het	219	ARSD	nonsynonymous SNV	ARSD:NM_001669:exon5:c.T497A:p.L166Q [1(large_intestine)]; 	0.09	0.09	0.09	rs73632977 [];	1.1320	0.5142	0.0300	0.9300		298990 [1(large_intestine)]; 				0.0125	0.8125	0.175	110		
chrX	2836238	2836238	G	A	het	207	ARSD	nonsynonymous SNV	ARSD:NM_001669:exon5:c.C470T:p.S157F,	0.08	0.08	0.08	rs73632978 [];	0.3710	0.4682	0.0400	0.1040						0.0125	0.8125	0.175	97		
chrX	2836349	2836349	G	C	het	44	ARSD			0.03	0.03	0.03	rs111614007 [];										0	0.2625	0.7375	29		
chrX	2836373	2836373	A	G	het	30	ARSD			0.02	0.02	0.02	rs113026716 [];										0	0.3375	0.6625	37		
chrX	2856155	2856155	C	T	hom	222	ARSE	nonsynonymous SNV	ARSE:NM_000047:exon9:c.G1270A:p.G424S,	0.57	0.57	0.57	rs35143646 [];	1.3550	0.0272	0.4300	0.5110	0.6707			300180 [Arylsulfatase E - Chondrodysplasia punctata, X-linked recessive, 302950 (3)];		0.725	0.025	0.25	154		
chrX	2856441	2856441	-	CT	het	184	ARSE			0	0	0									300180 [Arylsulfatase E - Chondrodysplasia punctata, X-linked recessive, 302950 (3)];		0	0	1	0		
chrX	2871474	2871474	G	A	hom	179	ARSE			0.29	0.29	0.29	rs211639 [];								300180 [Arylsulfatase E - Chondrodysplasia punctata, X-linked recessive, 302950 (3)];		0.2375	0.025	0.7375	26		
chrX	2928329	2928329	C	T	hom	222	ARSH			0.06	0.06	0.06	rs62584840 [];										0.025	0.0375	0.9375	8		
chrX	2942109	2942109	T	C	hom	222	ARSH	synonymous SNV	ARSH:NM_001011719:exon6:c.T949C:p.L317L,	0.73	0.73	0.73	rs5939407 [];					0.6458					0.575	0.0625	0.3625	96		
chrX	2950961	2950961	A	G	hom	222	ARSH			0.74	0.74	0.74	rs5982634 [];										0.25	0.0375	0.7125	28		
chrX	2950998	2950998	C	T	hom	222	ARSH			0.73	0.73	0.73	rs5939411 [];										0.25	0.0375	0.7125	28		
chrX	2951434	2951434	C	G	hom	222	ARSH			0.75	0.75	0.75	rs5939155 [];					0.6730					0.575	0.0625	0.3625	96		
chrX	2984968	2984969	TT	-	hom	29.9	ARSF			0	0	0											0.0625	0.1125	0.825	18		
chrX	2999141	2999141	G	A	hom	205	ARSF			0.77	0.77	0.77	rs5983001 [];										0.25	0.0375	0.7125	29		
chrX	3002219	3002219	T	C	hom	195	ARSF			0.77	0.77	0.77	rs5983002 [];										0.2375	0.0375	0.725	28		
chrX	3002687	3002687	A	G	hom	222	ARSF	synonymous SNV	ARSF:NM_001201539:exon6:c.A810G:p.E270E,ARSF:NM_004042:exon6:c.A810G:p.E270E,ARSF:NM_001201538:exon6:c.A810G:p.E270E,	0.77	0.77	0.77	rs5983003 [];					0.6639					0.5375	0.0625	0.4	87		
chrX	3007480	3007480	G	T	hom	222	ARSF			0.75	0.75	0.75	rs2290453 [];										0.2125	0.0375	0.75	26		
chrX	3523094	3523101	ACACACAC	-	het	42.5	PRKX			0	0	0								432			0.1125	0.025	0.8625	12		
chrX	3523831	3523831	A	G	hom	222	PRKX			0.23	0.23	0.23	rs1056373 [];										0.1625	0.0375	0.8	19		
chrX	3524309	3524309	T	C	hom	222	PRKX			0.8	0.8	0.8	rs6567569 [];										0.65	0.0625	0.2875	70		
chrX	3524493	3524493	T	C	hom	164	PRKX			0.98	0.98	0.98	rs6420576 [];							2386			0.9125	0	0.0875	89		
chrX	3524603	3524603	T	C	hom	199	PRKX			0.8	0.8	0.8	rs6567570 [];							2386			0.625	0.075	0.3	65		
chrX	3526369	3526369	A	C	hom	222	PRKX			0.12	0.12	0.12	rs1056369 [];										0.025	0.025	0.95	5		
chrX	3526619	3526626	TACACACA	-	het	217	PRKX			0	0	0								438			0	0	1	0		
chrX	3526658	3526665	ACACACAA	-	het	217	PRKX			0	0	0								438			0	0.0125	0.9875	1		
chrX	3530512	3530512	A	C	hom	204	PRKX			0.65	0.65	0.65	rs7066317 [];										0.2125	0.075	0.7125	31		
chrX	3735732	3735732	G	A	hom	222	LOC389906			0.6	0.6	0.6	rs1054501 [];										0.6	0.0625	0.3375	61		
chrX	3746558	3746558	C	T	hom	222	LOC389906			0.99	0.99	0.99	rs4826742 [];										0.9125	0.0125	0.075	85		
chrX	3747085	3747085	A	G	hom	222	LOC389906			0	0	0	rs2258084 [];										0.55	0.0625	0.3875	57		
chrX	3747240	3747240	G	A	hom	200	LOC389906			0	0	0	rs36020849 [];										0.35	0.0125	0.6375	35		
chrX	3747372	3747372	C	T	hom	222	LOC389906			0.34	0.34	0.34	rs141334099 [];										0.3625	0.025	0.6125	37		
chrX	3747555	3747555	G	T	hom	210	LOC389906			0.16	0.16	0.16	rs35728676 [];										0.1125	0.025	0.8625	16		
chrX	6145942	6145942	C	T	hom	222	NLGN4X			0.15	0.15	0.15	rs2290487 [];								300427 [Neuroligin 4 - {Autism susceptibility, X-linked 2}, 300495 (3); {Aspergersyndrome susceptibility, X-linked 2}, 300497 (3); Mental retardation, X-linked, 300495 (3)];		0.0625	0.0625	0.875	11		
chrX	6146000	6146001	GG	-	hom	89.5	NLGN4X			0	0	0	rs72413786 [];								300427 [Neuroligin 4 - {Autism susceptibility, X-linked 2}, 300495 (3); {Aspergersyndrome susceptibility, X-linked 2}, 300497 (3); Mental retardation, X-linked, 300495 (3)];		0.3125	0.0125	0.675	29		
chrX	6452604	6452604	C	A	hom	45.1	VCX3A			0	0	0	rs201994163 [];										0.4	0.025	0.575	41		
chrX	6967175	6967175	G	A	hom	222	HDHD1			0.33	0.33	0.33	rs6982 [];										0.1875	0.0875	0.725	27		
chrX	6967806	6967806	T	C	hom	222	HDHD1			0.34	0.34	0.34	rs3761597 [];							230			0.175	0.0875	0.7375	27		
chrX	6968011	6968011	A	G	hom	222	HDHD1			0.6	0.6	0.6	rs10458 [];							225			0.4625	0.05	0.4875	51		
chrX	6995315	6995315	C	T	hom	222	HDHD1	synonymous SNV	HDHD1:NM_001178136:exon3:c.G327A:p.P109P,HDHD1:NM_001135565:exon4:c.G525A:p.P175P,HDHD1:NM_012080:exon3:c.G456A:p.P152P,HDHD1:NM_001178135:exon3:c.G456A:p.P152P,	0.64	0.64	0.64	rs2379206 [];					0.5927					0.4625	0.05	0.4875	84		
chrX	6995537	6995537	C	A	hom	222	HDHD1			0.33	0.33	0.33	rs3747390 [];					0.3239					0.075	0.0625	0.8625	25		
chrX	7066051	7066051	A	C	hom	170	HDHD1			0.67	0.67	0.67	rs1473666 [];	-0.6680				0.6212					0.4125	0.025	0.5625	62		
chrX	7108850	7108850	A	T	hom	222	HDHD1;STS		HDHD1:dist=42619;STS:dist=28622	0.63	0.63	0.63	rs802913 [];										0.2	0.05	0.75	27		
chrX	7109083	7109083	G	A	hom	222	HDHD1;STS		HDHD1:dist=42852;STS:dist=28389	0.63	0.63	0.63	rs809104 [];										0.2	0.05	0.75	27		
chrX	7270996	7270996	A	G	hom	222	STS			0.63	0.63	0.63	rs1131289 [];										0.625	0.0875	0.2875	68		
chrX	7811747	7811747	T	C	hom	222	VCX	nonsynonymous SNV	VCX:NM_013452:exon3:c.T311C:p.L104P,	0.55	0.55	0.55	rs71247277 [];	0.1380	0.0078	0.2500	0.0030						0.375	0.2375	0.3875	86		
chrX	7812017	7812017	C	T	hom	190	VCX	nonsynonymous SNV	VCX:NM_013452:exon3:c.C581T:p.P194L,	0	0	0	rs78342118 [];	-1.8340	0.0040	0.3300	0.0040	0.4206					0.6625	0.1	0.2375	107		
chrX	7812197	7812197	T	C	het	56	VCX			0	0	0											0.0125	0.05	0.9375	7		
chrX	7867378	7867378	T	C	hom	222	PNPLA4			0.67	0.67	0.67	rs34709717 [];										0.55	0.0625	0.3875	58		
chrX	7867435	7867435	G	A	hom	222	PNPLA4			0.72	0.72	0.72	rs12009989 [];										0.5625	0.0625	0.375	59		
chrX	7867668	7867668	G	C	hom	66	PNPLA4			0	0	0	rs77398473 [];							486			0.1125	0.025	0.8625	17		
chrX	7867732	7867732	A	G	hom	222	PNPLA4			0.62	0.62	0.62	rs6639976 [];										0.55	0.05	0.4	56		
chrX	7890215	7890215	C	T	hom	222	PNPLA4			0.63	0.63	0.63	rs1183732 [];										0.275	0.0375	0.6875	33		
chrX	8138080	8138080	G	C	hom	222	VCX2	nonsynonymous SNV	VCX2:NM_016378:exon3:c.C413G:p.T138S,	0.91	0.91	0.91	rs1058239 [];	-0.7590	0.0001	1.0000	0.0000	0.8064					0.725	0.0125	0.2625	141		
chrX	8138170	8138170	-	G	het	22.5	VCX2	frameshift insertion	VCX2:NM_016378:exon3:c.322_323insC:p.S108fs,	0	0	0											0	0	1	10		
chrX	8138182	8138182	A	G	het	47	VCX2	nonsynonymous SNV	VCX2:NM_016378:exon3:c.T311C:p.L104P,	0.48	0.48	0.48	rs41305169 [];	0.1050	0.0248	0.0800	0.8830						0.2	0.175	0.625	71		
chrX	8138284	8138284	G	C	het	81	VCX2	nonsynonymous SNV	VCX2:NM_016378:exon3:c.C209G:p.A70G,	0.68	0.68	0.68	rs41309545 [];	-0.7920	0.0001	1.0000	0.0000						0.45	0	0.55	59		
chrX	8139196	8139196	C	T	hom	222	VCX2			0	0	0	rs56101217 [];										0.4625	0.1125	0.425	59		
chrX	8433285	8433285	G	T	het	146	VCX3B			0	0	0											0.0375	0.25	0.7125	27		
chrX	8434448	8434448	C	T	het	38	VCX3B			0	0	0	rs112103242 [];										0.0375	0.025	0.9375	9		
chrX	8498979	8498979	G	A	hom	222	KAL1			0.28	0.28	0.28	rs808127 [];										0.375	0.0875	0.5375	44		
chrX	8503641	8503641	G	A	hom	222	KAL1	synonymous SNV	KAL1:NM_000216:exon12:c.C1833T:p.I611I,	0.54	0.54	0.54	rs809446 [];					0.6663					0.6125	0.0625	0.325	107		
chrX	8504773	8504773	G	T	hom	222	KAL1			0.56	0.56	0.56	rs56520561 [];					0.6717					0.25	0.05	0.7	53		
chrX	8504833	8504833	C	T	hom	222	KAL1	nonsynonymous SNV	KAL1:NM_000216:exon11:c.G1600A:p.V534I,	0.55	0.55	0.55	rs808119 [];	-1.0550	0.0033	1.0000	0.0010	0.6706					0.6	0.0625	0.3375	104		
chrX	8553547	8553547	T	C	hom	222	KAL1			0.07	0.07	0.07	rs56186619 [];										0.05	0.025	0.925	8		
chrX	8766291	8766291	T	C	hom	222	FAM9A			0.43	0.43	0.43	rs2018496 [];					0.3576					0.175	0.075	0.75	36		
chrX	9379472	9379472	C	G	hom	148	FAM9B;TBL1X		FAM9B:dist=378356;TBL1X:dist=51863	0	0	0	rs6638939 [];										0.0375	0.1625	0.8	20		
chrX	9379578	9379578	C	T	het	36	FAM9B;TBL1X		FAM9B:dist=378462;TBL1X:dist=51757	0	0	0	rs28502220 [];										0	0.1375	0.8625	15		
chrX	9379675	9379675	G	A	hom	121	FAM9B;TBL1X		FAM9B:dist=378559;TBL1X:dist=51660	0	0	0	rs6640411 [];										0.0875	0.6125	0.3	65		
chrX	9379773	9379773	T	A	hom	107	FAM9B;TBL1X		FAM9B:dist=378657;TBL1X:dist=51562	0	0	0	rs6640412 [];										0.025	0.1125	0.8625	14		
chrX	9379828	9379828	A	G	het	101	FAM9B;TBL1X		FAM9B:dist=378712;TBL1X:dist=51507	0	0	0	rs4083207 [];										0.025	0.15	0.825	15		
chrX	9622451	9622451	-	AGA	hom	214	TBL1X			0	0	0	rs71801536 [];										0.275	0.025	0.7	30		
chrX	9651839	9651839	T	A	hom	222	TBL1X			0.92	0.92	0.92	rs2732883 [];										0.85	0.0375	0.1125	82		
chrX	9685901	9685901	T	C	hom	222	TBL1X			0.06	0.06	0.06	rs17321120 [];										0.1125	0.025	0.8625	11		
chrX	9686187	9686187	T	C	hom	222	TBL1X			0.42	0.42	0.42	rs2106705 [];										0.5375	0.05	0.4125	55		
chrX	9859098	9859098	A	G	hom	222	SHROOM2	synonymous SNV	SHROOM2:NM_001649:exon3:c.A399G:p.P133P,	0.89	0.89	0.89	rs6640543 [];					0.9395					0.8875	0.025	0.0875	142		
chrX	9859197	9859197	A	G	hom	222	SHROOM2			0.84	0.84	0.84	rs6640544 [];					0.9386					0.3875	0.025	0.5875	72		
chrX	9880691	9880691	C	T	hom	222	SHROOM2			0.43	0.43	0.43	rs2238882 [];										0.0625	0.025	0.9125	10		
chrX	10085674	10085674	T	C	hom	222	WWC3	synonymous SNV	WWC3:NM_015691:exon11:c.T1575C:p.D525D,	0.94	0.94	0.94	rs6530368 [];					0.8671					0.825	0.0125	0.1625	93		
chrX	10107056	10107056	A	G	hom	110	WWC3			0.56	0.56	0.56	rs5934764 [];										0.075	0.0375	0.8875	9		
chrX	10112338	10112338	C	A	hom	222	WWC3			0.19	0.19	0.19	rs7995 [];										0.1875	0.0125	0.8	19		
chrX	10201780	10201780	A	G	hom	222	CLCN4			0.56	0.56	0.56	rs5933825 [];										0.4	0.05	0.55	68		
chrX	10202343	10202343	C	T	hom	222	CLCN4			0.55	0.55	0.55	rs2269815 [];										0.3875	0.05	0.5625	69		
chrX	10203395	10203395	A	C	hom	222	CLCN4			0.43	0.43	0.43	rs2269814 [];							306			0.3	0.0375	0.6625	59		
chrX	11129746	11129746	C	A	hom	128	HCCS			0	0	0									300056 [Holocytochrome c synthase (cytochrome c heme-lyase) - Microphthalmia, syndromic 7, 309801 (3)];		0	0	1	0		
chrX	11786839	11786839	T	C	hom	222	MSL3			0.91	0.91	0.91	rs2525868 [];					0.7852					0.3875	0.0125	0.6	59		
chrX	12628049	12628049	T	C	hom	222	FRMPD4			0.59	0.59	0.59	rs2304604 [];					0.5734					0.15	0.0375	0.8125	52		
chrX	12633034	12633034	T	C	hom	222	FRMPD4			0.6	0.6	0.6	rs6654760 [];					0.5719	COSN168717 [1(large_intestine)]; 				0.15	0.0375	0.8125	55		
chrX	12722616	12722616	C	G	hom	222	FRMPD4			0.99	0.99	0.99	rs4469660 [];					0.9921					0.4375	0	0.5625	100		
chrX	12725061	12725061	-	TT	het	59.5	FRMPD4			0	0	0											0	0.025	0.975	2		
chrX	12837558	12837558	C	T	hom	191	PRPS2			0.83	0.83	0.83	rs5935399 [];										0.35	0.0375	0.6125	41		
chrX	12838934	12838934	A	G	hom	222	PRPS2			0.52	0.52	0.52	rs917580 [];					0.6350					0.25	0.0375	0.7125	50		
chrX	12841452	12841452	-	TTT	het	217	PRPS2			0	0	0											0.0125	0.0875	0.9	13		
chrX	12903659	12903659	A	T	hom	222	TLR7	nonsynonymous SNV	TLR7:NM_016562:exon3:c.A32T:p.Q11L,	0.15	0.15	0.15	rs179008 [];	-0.6370	0.0372	0.1900	0.0000	0.2124					0.2	0.0375	0.7625	38		
chrX	12939928	12939928	T	C	hom	222	TLR8	synonymous SNV	TLR8:NM_138636:exon2:c.T2769C:p.D923D,	1	1	1	rs2109135 [];					0.9967					0.9875	0	0.0125	146		
chrX	12994883	12994885	TTT	-	het	3.25	TMSB4X			0	0	0											0	0	1	1		
chrX	13681115	13681115	C	T	hom	222	TCEANC	nonsynonymous SNV	TCEANC:NM_152634:exon4:c.C578T:p.S193L,	0.53	0.53	0.53	rs2361159 [];	-0.4150	0.0142	0.4200	0.1310	0.5368					0.475	0.075	0.45	81		
chrX	13681638	13681638	C	T	hom	222	TCEANC	synonymous SNV	TCEANC:NM_152634:exon4:c.C1101T:p.N367N,	0.53	0.53	0.53	rs5935649 [];					0.5273					0.4875	0.075	0.4375	81		
chrX	13681679	13681679	G	T	hom	222	TCEANC	nonsynonymous SNV	TCEANC:NM_152634:exon4:c.G1142T:p.W381L,	0.57	0.57	0.57	rs5935650 [];	0.6850	0.2772	0.1900	0.0000	0.5447					0.4875	0.0875	0.425	83		
chrX	13682577	13682577	G	A	hom	222	TCEANC			0.53	0.53	0.53	rs3761625 [];										0.475	0.075	0.45	50		
chrX	13682715	13682715	G	A	hom	222	TCEANC			0.53	0.53	0.53	rs3761626 [];										0.45	0.075	0.475	48		
chrX	13683170	13683170	G	A	hom	222	TCEANC			0.53	0.53	0.53	rs4830885 [];										0.45	0.075	0.475	48		
chrX	13686246	13686246	-	TTTA	hom	214	TCEANC;RAB9A		TCEANC:dist=3999;RAB9A:dist=20994	0	0	0	rs67025710 [];										0.45	0.0875	0.4625	49		
chrX	13730787	13730787	G	C	hom	222	TRAPPC2			0.74	0.74	0.74	rs7716 [];										0.65	0	0.35	59		
chrX	13734539	13734539	T	C	hom	222	TRAPPC2			0.59	0.59	0.59	rs2285633 [];										0.225	0.0125	0.7625	25		
chrX	13734920	13734920	-	TTTG	hom	214	TRAPPC2			0	0	0											0.225	0.0125	0.7625	24		
chrX	13767718	13767718	A	G	hom	186	OFD1			0.75	0.75	0.75	rs7878592 [];								300170 [OFD1 protein - Oral-facial-digital syndrome 1, 311200 (3); Simpson-Golabi-Behmelsyndrome, type 2, 300209 (3); Joubert syndrome 10, 300804 (3)];		0.2375	0	0.7625	24		
chrX	13779422	13779422	-	T	hom	214	OFD1			0	0	0									300170 [OFD1 protein - Oral-facial-digital syndrome 1, 311200 (3); Simpson-Golabi-Behmelsyndrome, type 2, 300209 (3); Joubert syndrome 10, 300804 (3)];		0.225	0	0.775	23		
chrX	13803960	13803960	C	T	hom	222	GPM6B			0.59	0.59	0.59	rs5978663 [];					0.5681					0.1875	0.0125	0.8	34		
chrX	13835096	13835096	T	C	hom	222	GPM6B			0.21	0.21	0.21	rs3747420 [];										0.2125	0.1	0.6875	28		
chrX	14599572	14599572	A	G	hom	222	GLRA2			0.54	0.54	0.54	rs2074211 [];					0.5854					0.175	0.05	0.775	45		
chrX	14625415	14625415	-	T	het	211	GLRA2			0	0	0											0.0375	0.175	0.7875	21		
chrX	14627144	14627144	T	C	hom	222	GLRA2	synonymous SNV	GLRA2:NM_001171942:exon9:c.T480C:p.H160H,GLRA2:NM_002063:exon7:c.T747C:p.H249H,GLRA2:NM_001118886:exon7:c.T747C:p.H249H,GLRA2:NM_001118885:exon8:c.T747C:p.H249H,	0.22	0.22	0.22	rs2229963 [];					0.3047					0.225	0.0625	0.7125	47		
chrX	14749341	14749341	T	C	hom	222	GLRA2			0.37	0.37	0.37	rs11795712 [];										0.425	0.0875	0.4875	55		
chrX	14749604	14749604	T	C	hom	222	GLRA2			0.21	0.21	0.21	rs11796093 [];										0.2	0.05	0.75	27		
chrX	14868806	14868806	A	G	hom	222	FANCB			0.45	0.45	0.45	rs2905223 [];					0.5893			300515 [Fanconi anemia-associated polypeptide, 95kD - Fanconi anemia, complementation group B, 300514 (3)];		0.4375	0.075	0.4875	95		
chrX	14887147	14887147	C	G	hom	222	FANCB			0.53	0.53	0.53	rs2188383 [];								300515 [Fanconi anemia-associated polypeptide, 95kD - Fanconi anemia, complementation group B, 300514 (3)];		0.4625	0.075	0.4625	98		
chrX	14891258	14891258	G	T	hom	106	FANCB;MOSPD2			0.54	0.54	0.54	rs2285490 [];										0.2	0.0625	0.7375	29		
chrX	14929375	14929375	G	A	hom	222	MOSPD2	nonsynonymous SNV	MOSPD2:NM_152581:exon9:c.G719A:p.S240N,MOSPD2:NM_001177475:exon8:c.G530A:p.S177N,	0.02	0.02	0.02	rs35164803 [];	0.9140	0.9995	0.2200	0.5430	0.0357					0.0125	0	0.9875	3		
chrX	15262814	15262814	T	A	hom	222	ASB9			0	0	0	rs28628283 [];										0.0125	0	0.9875	1		
chrX	15333842	15333842	T	A	hom	189	ASB11			1	1	1	rs4830529 [];										0.4375	0	0.5625	46		
chrX	15511412	15511412	A	C	hom	222	PIR			0.83	0.83	0.83	rs2271550 [];										0.65	0.075	0.275	69		
chrX	15552564	15552564	T	C	hom	222	BMX			0.71	0.71	0.71	rs1877752 [];										0.275	0.075	0.65	36		
chrX	15552574	15552574	-	A	hom	25.5	BMX			0	0	0	rs5901566 [];										0.2875	0.0625	0.65	36		
chrX	15554602	15554602	T	G	hom	222	BMX			0.71	0.71	0.71	rs28505625 [];					0.6258					0.2875	0.0625	0.65	47		
chrX	15554625	15554626	CA	-	het	9.04	BMX			0	0	0											0	0.025	0.975	2		
chrX	15607650	15607650	T	C	hom	222	ACE2			0.79	0.79	0.79	rs971249 [];										0.25	0.075	0.675	34		
chrX	15610348	15610348	C	T	hom	222	ACE2		ACE2:NM_021804:exon5:c.439+4G>A	0.32	0.32	0.32	rs2285666 [];					0.2106					0.2	0.0375	0.7625	29		
chrX	15720113	15720113	C	-	hom	83.5	CA5BP1			0	0	0	rs35670763 [];										0.225	0	0.775	21		
chrX	15720325	15720325	A	G	hom	222	CA5BP1			0.71	0.71	0.71	rs1877923 [];										0.5	0.075	0.425	54		
chrX	15720681	15720682	TG	-	hom	214	CA5BP1			0.7	0.7	0.7	rs35373086 [];										0.4875	0.075	0.4375	53		
chrX	15720723	15720723	C	T	hom	222	CA5BP1			0.71	0.71	0.71	rs5934267 [];										0.4875	0.075	0.4375	53		
chrX	15720745	15720745	G	A	hom	222	CA5BP1			0.07	0.07	0.07	rs56002876 [];										0.15	0.0125	0.8375	14		
chrX	15792527	15792527	T	A	hom	208	CA5B			0.64	0.64	0.64	rs4364812 [];						150768 [1(stomach)]; 				0.6875	0.025	0.2875	79		
chrX	15794764	15794764	G	A	hom	172	CA5B			0.62	0.62	0.62	rs5980183 [];										0.275	0.075	0.65	34		
chrX	15794815	15794815	G	A	hom	222	CA5B			1	1	1	rs5936050 [];					0.9906					0.4375	0	0.5625	74		
chrX	15801330	15801330	A	C	hom	222	CA5B			0.23	0.23	0.23	rs12841514 [];							346			0.3375	0.0625	0.6	40		
chrX	15801643	15801643	A	G	hom	183	CA5B			0.66	0.66	0.66	rs28707735 [];							2264			0.7	0.025	0.275	73		
chrX	15804387	15804387	-	A	hom	214	INE2			0	0	0	rs67895333 [];										0.3375	0.0625	0.6	37		
chrX	15804984	15804984	G	A	hom	222	INE2			0.23	0.23	0.23	rs10521650 [];										0.325	0.0625	0.6125	36		
chrX	15805571	15805571	G	A	hom	222	INE2			1	1	1	rs5936053 [];										0.9375	0	0.0625	87		
chrX	15805791	15805791	A	G	hom	183	INE2;CA5B			0.23	0.23	0.23	rs5021752 [];										0.125	0.0625	0.8125	20		
chrX	15808795	15808795	T	C	hom	157	ZRSR2			1	1	1	rs4830994 [];										0.4375	0	0.5625	46		
chrX	15817963	15817963	A	G	hom	222	ZRSR2			0.88	0.88	0.88	rs5980192 [];					0.7116					0.325	0.025	0.65	62		
chrX	15818115	15818115	T	-	hom	214	ZRSR2			0.56	0.56	0.56	rs62985661 [];					0.4751					0.2	0.0875	0.7125	51		
chrX	15822013	15822013	C	T	hom	187	ZRSR2			0.3	0.3	0.3	rs5936060 [];							690			0.1875	0.075	0.7375	29		
chrX	15822022	15822022	C	T	hom	164	ZRSR2			0.56	0.56	0.56	rs5934280 [];							690			0.2	0.0875	0.7125	34		
chrX	15827524	15827524	T	G	hom	190	ZRSR2			0.88	0.88	0.88	rs5980193 [];										0.325	0.025	0.65	39		
chrX	15836648	15836648	T	G	hom	190	ZRSR2			0.56	0.56	0.56	rs5936062 [];					0.4889					0.2	0.0875	0.7125	53		
chrX	15838366	15838366	C	T	hom	222	ZRSR2	synonymous SNV	ZRSR2:NM_005089:exon10:c.C864T:p.N288N,	0.55	0.55	0.55	rs2301724 [];					0.4872					0.4625	0.1	0.4375	91		
chrX	15844915	15844915	-	AAA	het	87.5	AP1S2			0	0	0									300629 [Adaptor-related protein complex 1, sigma-2 subunit - Mental retardation, X-linked 59, 300630 (3)];		0	0.05	0.95	6		
chrX	15863953	15863953	A	T	hom	211	AP1S2			1	1	1	rs798169 [];								300629 [Adaptor-related protein complex 1, sigma-2 subunit - Mental retardation, X-linked 59, 300630 (3)];		0.4375	0	0.5625	46		
chrX	16171381	16171381	T	A	hom	222	GRPR			0.59	0.59	0.59	rs6632770 [];										0.5125	0.05	0.4375	53		
chrX	16171382	16171382	T	A	hom	222	GRPR			0.66	0.66	0.66	rs6632771 [];										0.4875	0.05	0.4625	51		
chrX	16171595	16171595	A	-	hom	74.5	GRPR			0.63	0.63	0.63	rs11340309 [];										0.5	0.0375	0.4625	50		
chrX	16709626	16709626	G	A	hom	222	CTPS2			0.56	0.56	0.56	rs5980322 [];					0.4270					0.2	0.075	0.725	37		
chrX	16717353	16717353	G	A	hom	181	CTPS2			0.55	0.55	0.55	rs5980324 [];										0.175	0.0875	0.7375	26		
chrX	16721129	16721129	T	C	hom	222	CTPS2			0.56	0.56	0.56	rs4831053 [];										0.175	0.0875	0.7375	26		
chrX	16762002	16762002	A	G	hom	222	SYAP1			0.86	0.86	0.86	rs4830562 [];					0.8423					0.2875	0.05	0.6625	60		
chrX	16854118	16854118	C	T	hom	182	TXLNG			0.61	0.61	0.61	rs4828560 [];							1855			0.2875	0.0625	0.65	33		
chrX	16859628	16859628	G	A	hom	222	TXLNG	synonymous SNV	TXLNG:NM_018360:exon10:c.G1326A:p.Q442Q,TXLNG:NM_001168683:exon8:c.G930A:p.Q310Q,	0.66	0.66	0.66	rs5924530 [];					0.3900					0.2625	0.075	0.6625	56		
chrX	16860134	16860134	T	C	hom	222	TXLNG			0.43	0.43	0.43	rs3747366 [];										0.2	0.05	0.75	28		
chrX	16876980	16876980	G	A	hom	222	RBBP7			0.6	0.6	0.6	rs4828536 [];					0.4092					0.2875	0.0625	0.65	59		
chrX	16887997	16887997	G	C	hom	63	RBBP7			0.3	0.3	0.3	rs113369180 [];										0.025	0	0.975	2		
chrX	17070688	17070688	G	A	hom	202	REPS2			0.87	0.87	0.87	rs933946 [];										0.3125	0.0625	0.625	40		
chrX	17073092	17073092	C	T	hom	222	REPS2			0.22	0.22	0.22	rs73189116 [];					0.2548					0.1	0.0375	0.8625	23		
chrX	17092152	17092152	G	T	hom	196	REPS2			0.88	0.88	0.88	rs1346246 [];										0.3125	0.0625	0.625	40		
chrX	17166219	17166219	C	T	hom	222	REPS2			1	1	1	rs1426797 [];										0.925	0	0.075	91		
chrX	17166795	17166795	A	G	hom	222	REPS2			0.89	0.89	0.89	rs5924606 [];										0.6875	0.1	0.2125	77		
chrX	17705853	17705853	-	T	hom	214	NHS			0	0	0									300457 [NHS gene - Nance-Horan syndrome, 302350 (3); Cataract, congenital, X-linked,302200 (3)];		1	0	0	156		
chrX	17743822	17743822	G	A	hom	222	NHS	synonymous SNV	NHS:NM_001136024:exon7:c.G1065A:p.E355E,NHS:NM_198270:exon6:c.G1533A:p.E511E,	0	0	0	rs146437542 [];					0.0007			300457 [NHS gene - Nance-Horan syndrome, 302350 (3); Cataract, congenital, X-linked,302200 (3)];		0	0	1	0		
chrX	17753436	17753436	A	T	hom	222	NHS			1	1	1	rs5909331 [];								300457 [NHS gene - Nance-Horan syndrome, 302350 (3); Cataract, congenital, X-linked,302200 (3)];		0.9625	0	0.0375	155		
chrX	17819377	17819377	T	C	hom	222	RAI2	nonsynonymous SNV	RAI2:NM_021785:exon2:c.A754G:p.M252V,RAI2:NM_001172732:exon3:c.A604G:p.M202V,RAI2:NM_001172743:exon3:c.A754G:p.M252V,RAI2:NM_001172739:exon3:c.A754G:p.M252V,	1	1	1	rs6527818 [];	1.2330	0.0000	1.0000	0.0000	0.9993					0.95	0	0.05	141		
chrX	18372664	18372664	C	G	hom	203	SCML2			1	1	1	rs12689111 [];										0.4375	0	0.5625	45		
chrX	18372668	18372668	C	G	hom	194	SCML2			1	1	1	rs12689113 [];										0.4375	0	0.5625	45		
chrX	18597869	18597869	C	A	hom	196	CDKL5			0.34	0.34	0.34	rs4825261 [];								300203 [Cyclin-dependent kinase-like 5 - Epileptic encephalopathy, early infantile, 2, 300672 (3);Angelman syndrome-like, 105830 (3)];		0.1125	0.05	0.8375	15		
chrX	18631235	18631235	G	A	het	12.3	CDKL5			0	0	0								1158	300203 [Cyclin-dependent kinase-like 5 - Epileptic encephalopathy, early infantile, 2, 300672 (3);Angelman syndrome-like, 105830 (3)];		0	0.225	0.775	26		
chrX	18638204	18638204	T	A	hom	183	CDKL5			0.56	0.56	0.56	rs3752484 [];								300203 [Cyclin-dependent kinase-like 5 - Epileptic encephalopathy, early infantile, 2, 300672 (3);Angelman syndrome-like, 105830 (3)];		0.125	0.05	0.825	16		
chrX	18824794	18824794	T	G	hom	222	PPEF1			0.59	0.59	0.59	rs2239437 [];										0.2875	0.05	0.6625	32		
chrX	18844012	18844012	G	A	hom	222	PPEF1			0.59	0.59	0.59	rs2273247 [];					0.7659					0.325	0.0375	0.6375	37		
chrX	18846164	18846164	G	T	hom	198	PPEF1			0.45	0.45	0.45	rs239739 [];										0.2875	0.05	0.6625	33		
chrX	18910879	18910879	-	T	het	64.5	PHKA2			0	0	0											0	0.3125	0.6875	26		
chrX	19041592	19041592	C	T	hom	222	GPR64			0.66	0.66	0.66	rs5909263 [];					0.6976					0.2375	0.075	0.6875	56		
chrX	19478294	19478294	T	A	hom	222	MAP3K15			0.91	0.91	0.91	rs5909118 [];					0.9036					0.4	0.025	0.575	62		
chrX	19478341	19478341	-	A	hom	214	MAP3K15			0	0	0											0.4	0.025	0.575	44		
chrX	19482476	19482476	C	T	hom	222	MAP3K15	nonsynonymous SNV	MAP3K15:NM_001001671:exon4:c.G574A:p.A192T,	0.72	0.72	0.72	rs5909299 [];	0.5730		0.1000		0.8867					0.875	0.0375	0.0875	133		
chrX	19564284	19564284	C	T	hom	222	SH3KBP1			0.0048	0.0048	0.0048	rs145571575 [];										0	0.0125	0.9875	1		
chrX	20144116	20144116	C	T	het	3.54	EIF1AX			0	0	0	rs199880393 [];										0	0.4625	0.5375	49		
chrX	21861434	21861434	A	G	hom	222	MBTPS2	synonymous SNV	MBTPS2:NM_015884:exon2:c.A222G:p.Q74Q,	0.47	0.47	0.47	rs3213451 [];					0.3896			300294 [Membrane-bound transcription factor protease, site 2 - Ichthyosis follicularis, atrichia, and photophobia syndrome, 308205(3); Keratosis follicularis spinulosa decalvans, X-linked, 308800 (3)];		0.2875	0.0875	0.625	98		
chrX	21875822	21875822	A	-	hom	97.5	YY2			0	0	0	rs11339991 [];								300294 [Membrane-bound transcription factor protease, site 2 - Ichthyosis follicularis, atrichia, and photophobia syndrome, 308205(3); Keratosis follicularis spinulosa decalvans, X-linked, 308800 (3)];		0.125	0.025	0.85	16		
chrX	22051034	22051034	A	G	hom	222	PHEX			0.49	0.49	0.49	rs178710 [];										0.3375	0.0125	0.65	33		
chrX	22115197	22115197	A	G	hom	222	PHEX			0.08	0.08	0.08	rs58524357 [];					0.0300					0.025	0.025	0.95	4		
chrX	22230975	22230975	T	C	hom	222	PHEX			0.3	0.3	0.3	rs3213493 [];					0.3427					0.0625	0.0375	0.9	22		
chrX	22239720	22239720	C	T	hom	222	PHEX			0.29	0.29	0.29	rs3752433 [];					0.3074					0.0625	0.05	0.8875	31		
chrX	22244529	22244530	TT	-	hom	82.5	PHEX			0	0	0	rs60807057 [];					0.3148					0.0875	0	0.9125	20		
chrX	23689636	23689636	A	T	hom	222	PRDX4			0.53	0.53	0.53	rs513572 [];					0.3460					0.1875	0.0375	0.775	54		
chrX	23689637	23689637	T	C	hom	222	PRDX4			0.53	0.53	0.53	rs513573 [];					0.3518					0.45	0.05	0.5	76		
chrX	23697485	23697485	G	A	hom	222	PRDX4			0.66	0.66	0.66	rs795493 [];										0.1625	0.0625	0.775	26		
chrX	23700473	23700473	G	A	hom	222	PRDX4			0.66	0.66	0.66	rs552105 [];					0.5748					0.1625	0.0625	0.775	37		
chrX	23700693	23700693	A	G	hom	222	PRDX4			0.45	0.45	0.45	rs795489 [];					0.4104					0.0875	0.0625	0.85	28		
chrX	23722835	23722835	A	G	hom	222	ACOT9	synonymous SNV	ACOT9:NM_001033583:exon14:c.T1207C:p.L403L,ACOT9:NM_001037171:exon15:c.T1234C:p.L412L,	0.13	0.13	0.13	rs11175 [];					0.1880					0.1	0.0375	0.8625	25		
chrX	23723261	23723261	T	C	hom	222	ACOT9			0.52	0.52	0.52	rs2270142 [];										0.275	0.0625	0.6625	34		
chrX	23723384	23723384	A	G	hom	222	ACOT9			0.33	0.33	0.33	rs5970777 [];										0.1875	0.0875	0.725	29		
chrX	23761537	23761537	G	T	hom	75.5	ACOT9			0.4	0.4	0.4	rs3764881 [];										0.075	0.0375	0.8875	10		
chrX	23801593	23801593	A	G	hom	168	SAT1			0.66	0.66	0.66	rs3764885 [];					0.7859					0.3375	0.0125	0.65	62		
chrX	23801702	23801702	G	C	hom	141	SAT1			0.61	0.61	0.61	rs3764884 [];					0.7839					0.3125	0.025	0.6625	58		
chrX	23928489	23928489	C	T	hom	222	CXorf58	nonsynonymous SNV	CXorf58:NM_152761:exon2:c.C70T:p.R24C [1(prostate)]; CXorf58:NM_001169574:exon2:c.C70T:p.R24C [1(prostate)]; 	0.47	0.47	0.47	rs2707164 [];	-0.2740	0.0113	0.1900	0.5500	0.7053	1179846 [1(prostate)]; 				0.55	0.075	0.375	87		
chrX	23934052	23934052	G	A	hom	150	CXorf58			0.51	0.51	0.51	rs2520231 [];										0.2375	0.0875	0.675	33		
chrX	23934202	23934202	A	G	hom	141	CXorf58			0.42	0.42	0.42	rs2520230 [];										0.2625	0.0625	0.675	33		
chrX	24073761	24073761	C	T	hom	222	EIF2S3	synonymous SNV	EIF2S3:NM_001415:exon2:c.C99T:p.H33H,	0.48	0.48	0.48	rs36018672 [];	-0.7490				0.6748					0.625	0.0375	0.3375	145		
chrX	24084254	24084254	-	T	hom	192	EIF2S3			0	0	0											0.2625	0.0625	0.675	44		
chrX	24231817	24231817	-	A	hom	214	ZFX			0	0	0											0.15	0.1375	0.7125	28		
chrX	24545949	24545949	C	G	hom	222	PDK3			0.15	0.15	0.15	rs16983110 [];							206			0.0375	0.0625	0.9	8		
chrX	24577591	24577591	T	A	hom	209	PCYT1B			0.77	0.77	0.77	rs2178608 [];							654			0.6375	0.0375	0.325	63		
chrX	24578270	24578270	C	T	hom	222	PCYT1B			0.14	0.14	0.14	rs3761612 [];										0.075	0.0375	0.8875	9		
chrX	24578306	24578306	G	A	hom	222	PCYT1B			0.66	0.66	0.66	rs3761611 [];										0.7	0.0375	0.2625	73		
chrX	24578551	24578551	T	A	hom	222	PCYT1B			0.71	0.71	0.71	rs3761610 [];										0.75	0.025	0.225	80		
chrX	24578803	24578803	C	T	hom	222	PCYT1B			0.69	0.69	0.69	rs10156959 [];										0.7	0.0375	0.2625	75		
chrX	24579663	24579663	T	A	hom	222	PCYT1B			0.0036	0.0036	0.0036	rs41303157 [];										0.0125	0	0.9875	1		
chrX	24579779	24579779	A	C	hom	222	PCYT1B			0.0036	0.0036	0.0036	rs41303159 [];										0.0125	0	0.9875	1		
chrX	24593513	24593513	T	G	hom	222	PCYT1B			0.6	0.6	0.6	rs3747401 [];										0.3	0.0375	0.6625	38		
chrX	24605407	24605407	C	A	hom	222	PCYT1B	synonymous SNV	PCYT1B:NM_004845:exon5:c.G516T:p.P172P,PCYT1B:NM_001163265:exon5:c.G516T:p.P172P,PCYT1B:NM_001163264:exon5:c.G462T:p.P154P,	0.0006	0.0006	0.0006	rs34701484 [];					0.0022					0	0	1	0		
chrX	24608365	24608365	G	C	hom	222	PCYT1B			0.01	0.01	0.01	rs7066434 [];										0	0	1	0		
chrX	24637193	24637193	A	C	hom	222	PCYT1B	synonymous SNV	PCYT1B:NM_004845:exon2:c.T126G:p.T42T,PCYT1B:NM_001163265:exon2:c.T126G:p.T42T,PCYT1B:NM_001163264:exon2:c.T72G:p.T24T,	0.09	0.09	0.09	rs7060616 [];					0.0174					0.025	0	0.975	2		
chrX	24745887	24745887	A	G	hom	222	POLA1			0.0048	0.0048	0.0048	rs41305181 [];					0.0135					0	0	1	0		
chrX	24751958	24751958	T	C	hom	222	POLA1			1	1	1	rs75310488 [];										0.9875	0	0.0125	140		
chrX	24753460	24753460	-	A	hom	205	POLA1			0	0	0											0	0	1	0		
chrX	24760288	24760288	C	T	hom	214	POLA1			0	0	0	rs201164972 [];										0	0	1	0		
chrX	24767166	24767166	T	C	hom	222	POLA1			0.0048	0.0048	0.0048	rs147463158 [];										0	0	1	0		
chrX	24833092	24833092	-	T	het	110	POLA1		POLA1:NM_016937:exon30:c.3279-4->T	0	0	0											0	0.2875	0.7125	25		
chrX	24844517	24844517	G	A	hom	222	POLA1			0.0048	0.0048	0.0048	rs146221613 [];					0.0135					0	0	1	0		
chrX	26156448	26156448	A	T	hom	222	MAGEB18			0.69	0.69	0.69	rs6526549 [];										0.1875	0.0375	0.775	22		
chrX	26157220	26157220	C	T	hom	222	MAGEB18	nonsynonymous SNV	MAGEB18:NM_173699:exon2:c.C118T:p.P40S,	0.68	0.68	0.68	rs5944317 [];	-2.3050	0.0012	1.0000	0.0000	0.4215					0.4	0.0625	0.5375	67		
chrX	26157792	26157792	C	T	hom	222	MAGEB18	synonymous SNV	MAGEB18:NM_173699:exon2:c.C690T:p.A230A,	0.69	0.69	0.69	rs5944318 [];					0.4217					0.4125	0.05	0.5375	67		
chrX	26158809	26158809	C	T	hom	222	MAGEB18			0.27	0.27	0.27	rs4898259 [];										0.2875	0.05	0.6625	31		
chrX	26210586	26210586	C	T	hom	222	MAGEB6			0.4	0.4	0.4	rs11795624 [];										0.3375	0.05	0.6125	38		
chrX	26213219	26213219	T	C	hom	222	MAGEB6			0.4	0.4	0.4	rs5986312 [];					0.3325	COSN414054 [1(urinary_tract)]; 				0.325	0.0625	0.6125	49		
chrX	26213365	26213365	-	TTGTC	hom	214	MAGEB6			0	0	0	rs67830399 [];										0.3625	0.05	0.5875	40		
chrX	27194484	27194484	T	A	hom	222	VENTXP1;SMEK3P		VENTXP1:dist=615315;SMEK3P:dist=283844	0.77	0.77	0.77	rs4829038 [];										0.6375	0.0625	0.3	68		
chrX	27608645	27608645	T	C	hom	222	SMEK3P;DCAF8L2		SMEK3P:dist=127187;DCAF8L2:dist=156281	0.2	0.2	0.2	rs7054841 [];										0.075	0	0.925	8		
chrX	27839572	27839572	T	C	hom	222	MAGEB10	nonsynonymous SNV	MAGEB10:NM_182506:exon3:c.T149C:p.F50S,	0.36	0.36	0.36	rs1368769 [];	0.0020	0.0000	1.0000	0.0000	0.5321					0.425	0.1125	0.4625	82		
chrX	27839617	27839617	G	A	hom	222	MAGEB10	nonsynonymous SNV	MAGEB10:NM_182506:exon3:c.G194A:p.R65Q [1(prostate)]; 	0.25	0.25	0.25	rs12557898 [];	-1.5850	0.0000	1.0000	0.0040	0.5019	1179847 [1(prostate)]; 				0.4	0.0875	0.5125	77		
chrX	28605887	28605887	T	-	hom	3.8	IL1RAPL1			0	0	0								233	300206 [Il-1 receptor accessory protein-like 1 - Mental retardation, X-linked, 21/34, 300143 (3)];		0.275	0	0.725	57		
chrX	28606322	28606332	TATGTGTGTGT	-	hom	203	IL1RAPL1			0	0	0								579	300206 [Il-1 receptor accessory protein-like 1 - Mental retardation, X-linked, 21/34, 300143 (3)];		0	0	1	0		
chrX	29417510	29417510	C	A	hom	222	IL1RAPL1			1	1	1	rs4829347 [];								300206 [Il-1 receptor accessory protein-like 1 - Mental retardation, X-linked, 21/34, 300143 (3)];		0.4375	0	0.5625	46		
chrX	29974468	29974468	G	-	het	5.08	IL1RAPL1			0	0	0											0	0.0375	0.9625	3		
chrX	30236878	30236878	G	A	hom	222	MAGEB2	nonsynonymous SNV	MAGEB2:NM_002364:exon2:c.G181A:p.E61K [1(stomach)]; 	0.84	0.84	0.84	rs2529541 [];	-0.8280	0.0000	0.8900	0.0040	0.9485	150775 [1(stomach)]; 				0.8875	0	0.1125	135		
chrX	30269887	30269887	T	A	hom	222	MAGEB1			1	1	1	rs2529569 [];										0.925	0	0.075	90		
chrX	30326983	30326983	C	T	hom	222	NR0B1	synonymous SNV	NR0B1:NM_000475:exon1:c.G498A:p.R166R,	0.41	0.41	0.41	rs2269345 [];					0.1968			300473 [DSS-AHC critical region on the X chromosome, gene 1 - Adrenal hypoplasia, congenital, with hypogonadotropic hypogonadism,300200 (3); Dosage-sensitive sex reversal, 300018 (3)];		0.1875	0.075	0.7375	54		
chrX	30577185	30577185	G	C	hom	168	CXorf21			0.89	0.89	0.89	rs2532873 [];							2268			0.75	0.0375	0.2125	77		
chrX	30577224	30577224	C	T	hom	184	CXorf21			0.89	0.89	0.89	rs2710402 [];							2268			0.775	0.0375	0.1875	79		
chrX	30577846	30577846	A	C	hom	222	CXorf21	synonymous SNV	CXorf21:NM_025159:exon3:c.T627G:p.V209V,	0.88	0.88	0.88	rs887369 [];					0.7496					0.775	0.0375	0.1875	124		
chrX	30709444	30709444	G	A	hom	179	GK			0.31	0.31	0.31	rs55895067 [];								300474 [Glycerol kinase - Glycerol kinase deficiency, 307030 (3)];		0.1	0.05	0.85	15		
chrX	30712796	30712796	G	C	hom	200	GK			0.81	0.81	0.81	rs5927587 [];								300474 [Glycerol kinase - Glycerol kinase deficiency, 307030 (3)];		0.3	0.0125	0.6875	34		
chrX	30715827	30715827	C	T	hom	222	GK			0.77	0.77	0.77	rs2035432 [];					0.7519			300474 [Glycerol kinase - Glycerol kinase deficiency, 307030 (3)];		0.2875	0.0125	0.7	108		
chrX	30718877	30718877	-	AAAT	hom	214	GK			0	0	0	rs143145925 [];								300474 [Glycerol kinase - Glycerol kinase deficiency, 307030 (3)];		0.3	0.0125	0.6875	33		
chrX	30747058	30747058	G	-	het	22.5	GK			0	0	0									300474 [Glycerol kinase - Glycerol kinase deficiency, 307030 (3)];		0	0.0625	0.9375	5		
chrX	30747888	30747888	G	T	het	158	GK			0	0	0	rs201500166 [];								300474 [Glycerol kinase - Glycerol kinase deficiency, 307030 (3)];		0	0.275	0.725	35		
chrX	30748284	30748284	T	C	hom	222	GK			0.7	0.7	0.7	rs5926945 [];								300474 [Glycerol kinase - Glycerol kinase deficiency, 307030 (3)];		0.6	0.025	0.375	111		
chrX	30849030	30849030	-	CC	hom	61.5	TAB3			0	0	0											0.275	0.0875	0.6375	35		
chrX	30849176	30849176	G	A	hom	222	TAB3			0.58	0.58	0.58	rs5972240 [];										0.5375	0.0375	0.425	58		
chrX	30872602	30872602	A	G	hom	222	TAB3	nonsynonymous SNV	TAB3:NM_152787:exon6:c.T1180C:p.W394R,	1	1	1	rs5927629 [];	0.4700	0.0000	1.0000	0.0000	0.9997					0.9875	0	0.0125	147		
chrX	30889857	30889857	A	G	hom	222	TAB3			0.87	0.87	0.87	rs5927633 [];										0.825	0.0125	0.1625	81		
chrX	31144921	31144923	AAA	-	hom	3.39	DMD			0	0	0								219	300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.0625	0	0.9375	6		
chrX	31165675	31165678	GAAA	-	hom	214	DMD			0	0	0								279	300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.0125	0.0125	0.975	2		
chrX	31191589	31191589	C	T	hom	222	DMD			0.87	0.87	0.87	rs2404496 [];					0.8476			300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.325	0.0625	0.6125	64		
chrX	31200843	31200843	-	T	hom	214	DMD			0	0	0									300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.2	0	0.8	23		
chrX	31224684	31224684	A	G	hom	222	DMD			0.82	0.82	0.82	rs2293668 [];					0.8793			300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.35	0.0125	0.6375	116		
chrX	31224881	31224881	G	A	hom	183	DMD			0.82	0.82	0.82	rs2293667 [];								300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.35	0	0.65	39		
chrX	31496350	31496350	C	T	hom	222	DMD	nonsynonymous SNV	DMD:NM_004009:exon59:c.G8798A:p.R2933Q,DMD:NM_004014:exon5:c.G623A:p.R208Q,DMD:NM_004011:exon31:c.G4787A:p.R1596Q,DMD:NM_004010:exon59:c.G8441A:p.R2814Q,DMD:NM_004022:exon16:c.G1430A:p.R477Q,DMD:NM_004006:exon59:c.G8810A:p.R2937Q,DMD:NM_004013:exon16:c.G1430A:p.R477Q,DMD:NM_004007:exon58:c.G8441A:p.R2814Q,DMD:NM_004020:exon16:c.G1430A:p.R477Q,DMD:NM_004023:exon16:c.G1430A:p.R477Q,DMD:NM_004012:exon31:c.G4778A:p.R1593Q,DMD:NM_004021:exon16:c.G1430A:p.R477Q,DMD:NM_000109:exon59:c.G8786A:p.R2929Q,	0.94	0.94	0.94	rs1800280 [];	0.7890	0.0000	0.8200	0.0010	0.9392			300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.8875	0	0.1125	199		
chrX	31676096	31676096	G	A	hom	206	DMD			0.32	0.32	0.32	rs2270672 [];					0.3511			300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.15	0.0375	0.8125	41		
chrX	31986607	31986607	G	A	hom	222	DMD	nonsynonymous SNV	DMD:NM_004009:exon45:c.C6451T:p.R2151W,DMD:NM_004011:exon17:c.C2440T:p.R814W,DMD:NM_004010:exon45:c.C6094T:p.R2032W,DMD:NM_004006:exon45:c.C6463T:p.R2155W,DMD:NM_004007:exon44:c.C6094T:p.R2032W,DMD:NM_004012:exon17:c.C2431T:p.R811W,DMD:NM_000109:exon45:c.C6439T:p.R2147W,	0.01	0.01	0.01	rs1800273 [];	0.0880	0.0000	0.0400	0.8250	0.0378			300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.025	0	0.975	9		
chrX	32173667	32173667	T	C	hom	172	DMD			0.05	0.05	0.05	rs55672607 [];								300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.0375	0	0.9625	4		
chrX	32360466	32360466	C	A	hom	222	DMD			0.14	0.14	0.14	rs6527184 [];								300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.0125	0.025	0.9625	5		
chrX	32363965	32363965	-	AG	hom	214	DMD			0	0	0	rs34160829 [];								300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.2875	0.05	0.6625	36		
chrX	32481863	32481863	T	C	hom	201	DMD			0.68	0.68	0.68	rs170608 [];								300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.3125	0.025	0.6625	37		
chrX	32503194	32503194	T	C	hom	222	DMD	nonsynonymous SNV	DMD:NM_004009:exon21:c.A2633G:p.D878G,DMD:NM_004010:exon21:c.A2276G:p.D759G,DMD:NM_004006:exon21:c.A2645G:p.D882G,DMD:NM_004007:exon20:c.A2276G:p.D759G,DMD:NM_000109:exon21:c.A2621G:p.D874G,	0.73	0.73	0.73	rs228406 [];	0.0880	0.0000	0.5900	0.0130	0.6629			300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.6	0.025	0.375	154		
chrX	32614060	32614060	T	A	hom	222	DMD			0.05	0.05	0.05	rs1435727 [];								300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.0125	0.0125	0.975	2		
chrX	32614103	32614103	C	T	hom	148	DMD			0.57	0.57	0.57	rs808543 [];								300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.1375	0.025	0.8375	17		
chrX	32662194	32662194	T	C	hom	199	DMD			0.04	0.04	0.04	rs6628728 [];								300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0	0	1	0		
chrX	34150506	34150506	C	T	hom	222	FAM47A			0.56	0.56	0.56	rs2939997 [];										0.2875	0.0125	0.7	30		
chrX	34645144	34645144	G	A	hom	222	TMEM47			0.33	0.33	0.33	rs5928614 [];										0.1	0.025	0.875	13		
chrX	34648280	34648280	G	A	hom	222	TMEM47			0.22	0.22	0.22	rs10522027 [];						COSN414060 [1(urinary_tract)]; 				0.0625	0.0125	0.925	8		
chrX	34674970	34674970	C	G	hom	222	TMEM47	synonymous SNV	TMEM47:NM_031442:exon1:c.G177C:p.R59R,	0.39	0.39	0.39	rs5928617 [];					0.2418					0.25	0.0125	0.7375	43		
chrX	34962909	34962909	A	C	hom	222	FAM47B			0.45	0.45	0.45	rs6632131 [];					0.2781					0.2375	0.05	0.7125	30		
chrX	37301351	37301351	G	A	hom	222	PRRG1			0.02	0.02	0.02	rs41309725 [];										0.0375	0	0.9625	3		
chrX	37536392	37536393	TG	-	hom	214	LANCL3			0	0	0								281			0.025	0.15	0.825	14		
chrX	37700014	37700014	C	A	hom	78.1	DYNLT3			0	0	0	rs112187044 [];							585			0.175	0.0625	0.7625	26		
chrX	37932886	37932886	A	G	hom	222	SYTL5	synonymous SNV	SYTL5:NM_001163335:exon6:c.A489G:p.A163A,SYTL5:NM_001163334:exon4:c.A489G:p.A163A,SYTL5:NM_138780:exon5:c.A489G:p.A163A,	0.28	0.28	0.28	rs4827330 [];					0.2469					0.1625	0.05	0.7875	38		
chrX	37935994	37935994	T	A	hom	222	SYTL5			0.27	0.27	0.27	rs5918468 [];					0.2482					0.0375	0.0375	0.925	17		
chrX	37948832	37948832	A	G	hom	222	SYTL5	nonsynonymous SNV	SYTL5:NM_001163335:exon8:c.A823G:p.I275V,SYTL5:NM_001163334:exon6:c.A823G:p.I275V,SYTL5:NM_138780:exon7:c.A823G:p.I275V,	0.1	0.1	0.1	rs4827331 [];	0.5970	0.0001	0.3300	0.0120	0.1558					0.0875	0.025	0.8875	18		
chrX	37967868	37967868	T	C	hom	222	SYTL5	synonymous SNV	SYTL5:NM_001163335:exon13:c.T1350C:p.Y450Y,SYTL5:NM_001163334:exon12:c.T1416C:p.Y472Y,SYTL5:NM_138780:exon12:c.T1350C:p.Y450Y,	0.35	0.35	0.35	rs5918476 [];					0.2487					0.15	0.05	0.8	37		
chrX	37979767	37979767	A	C	hom	222	SYTL5			0.22	0.22	0.22	rs4827334 [];					0.1761					0.0375	0.025	0.9375	11		
chrX	37981474	37981474	T	A	hom	222	SYTL5			0.3	0.3	0.3	rs56406900 [];					0.1908					0.125	0.025	0.85	28		
chrX	38008727	38008727	G	C	hom	222	SRPX			0.91	0.91	0.91	rs9934 [];										0.8375	0.0375	0.125	83		
chrX	38132628	38132628	A	G	hom	182	RPGR			0.14	0.14	0.14	rs4084271 [];					0.2884					0.1125	0.025	0.8625	42		
chrX	38144065	38144065	A	G	hom	222	RPGR			0.1	0.1	0.1	rs55711031 [];							354			0.1	0.075	0.825	17		
chrX	38144340	38144340	C	-	hom	214	RPGR			0	0	0											0	0	1	0		
chrX	38160695	38160695	C	T	hom	222	RPGR			0.08	0.08	0.08	rs41311843 [];										0.0375	0.0125	0.95	6		
chrX	38211289	38211289	C	T	hom	161	OTC			0.68	0.68	0.68	rs5963412 [];							2473			0.275	0.05	0.675	34		
chrX	38211304	38211304	G	A	hom	222	OTC			0.68	0.68	0.68	rs5963413 [];							2473			0.275	0.05	0.675	34		
chrX	38211431	38211434	TTCT	-	hom	214	OTC			0	0	0	rs57752938 [];										0.675	0.0625	0.2625	68		
chrX	38211509	38211509	A	G	hom	222	OTC			0.69	0.69	0.69	rs5917572 [];										0.6875	0.05	0.2625	68		
chrX	38211591	38211591	G	A	hom	222	OTC			0.69	0.69	0.69	rs5917573 [];										0.65	0.05	0.3	65		
chrX	38535174	38535174	A	G	hom	222	TSPAN7			0.73	0.73	0.73	rs4826996 [];								300096 [Transmembrane 4 superfamily, member 2 - Mental retardation, X-linked 58, 300210 (3)];		0.225	0.0375	0.7375	30		
chrX	38547308	38547308	C	A	hom	222	TSPAN7			0.7	0.7	0.7	rs15765 [];								300096 [Transmembrane 4 superfamily, member 2 - Mental retardation, X-linked 58, 300210 (3)];		0.5375	0.0375	0.425	109		
chrX	38547862	38547862	G	A	hom	222	TSPAN7			0.71	0.71	0.71	rs10333 [];								300096 [Transmembrane 4 superfamily, member 2 - Mental retardation, X-linked 58, 300210 (3)];		0.55	0.0375	0.4125	109		
chrX	38548083	38548083	G	A	hom	222	TSPAN7			0.71	0.71	0.71	rs3269 [];								300096 [Transmembrane 4 superfamily, member 2 - Mental retardation, X-linked 58, 300210 (3)];		0.55	0.0375	0.4125	109		
chrX	38663104	38663104	T	C	hom	221	MID1IP1			0.66	0.66	0.66	rs198783 [];										0.675	0.0375	0.2875	69		
chrX	38663740	38663740	-	GTG	hom	214	MID1IP1			0	0	0											0.3	0.0375	0.6625	35		
chrX	39167003	39167003	C	A	hom	222	LOC286442			0.07	0.07	0.07	rs41303195 [];										0.075	0	0.925	7		
chrX	39933339	39933339	A	G	hom	222	BCOR	synonymous SNV	BCOR:NM_001123383:exon4:c.T1260C:p.D420D,BCOR:NM_001123385:exon4:c.T1260C:p.D420D,BCOR:NM_001123384:exon4:c.T1260C:p.D420D,BCOR:NM_017745:exon4:c.T1260C:p.D420D,	0.93	0.93	0.93	rs5917933 [];					0.8792			300485 [BCL6 corepressor - Microphthalmia, syndromic 2, 300166 (3)];		0.8375	0.0125	0.15	184		
chrX	40506697	40506697	A	G	hom	222	CXorf38	synonymous SNV	CXorf38:NM_144970:exon1:c.T76C:p.L26L [1(prostate)]; 	0.97	0.97	0.97	rs6610447 [];					0.9436	1132306 [1(prostate)]; 				0.8875	0.0125	0.1	135		
chrX	40551614	40551615	AA	-	hom	87.5	MED14			0	0	0											0.0125	0	0.9875	3		
chrX	40552243	40552243	T	C	hom	222	MED14			0.24	0.24	0.24	rs7052408 [];										0.0625	0.025	0.9125	10		
chrX	40556492	40556492	C	G	hom	222	MED14			0.88	0.88	0.88	rs5918029 [];										0.275	0.05	0.675	34		
chrX	40571413	40571413	T	C	hom	222	MED14			0.38	0.38	0.38	rs4827226 [];					0.1883	COSN168732 [1(large_intestine)]; 				0.075	0.025	0.9	14		
chrX	40573157	40573157	G	A	hom	222	MED14	synonymous SNV	MED14:NM_004229:exon5:c.C525T:p.D175D,	0.28	0.28	0.28	rs6520683 [];					0.1788					0.2	0.0375	0.7625	28		
chrX	41031320	41031320	T	G	het	71	USP9X			0	0	0	rs200304284 [];							1165			0	0.425	0.575	45		
chrX	41197542	41197542	A	C	hom	222	DDX3X			0.66	0.66	0.66	rs953114 [];										0.3875	0.0625	0.55	41		
chrX	41198456	41198456	T	C	hom	222	DDX3X			0.28	0.28	0.28	rs2275943 [];										0.1	0.025	0.875	13		
chrX	41202273	41202273	A	G	hom	222	DDX3X			0.28	0.28	0.28	rs6610546 [];										0.1125	0.0125	0.875	13		
chrX	41203119	41203119	G	A	hom	222	DDX3X			0.66	0.66	0.66	rs2275944 [];					0.4334					0.1875	0.0375	0.775	37		
chrX	41208310	41208310	A	C	hom	222	DDX3X			0.28	0.28	0.28	rs5963957 [];										0.2375	0.025	0.7375	25		
chrX	41217084	41217084	A	T	hom	222	DDX3X;NYX		DDX3X:dist=7560;NYX:dist=89629	0.5	0.5	0.5	rs6520743 [];										0.2875	0.0375	0.675	31		
chrX	41548943	41548943	T	C	hom	189	CASK;GPR34			0.95	0.95	0.95	rs5918226 [];								300172 [Calcium/calmodulin-dependent serine protein kinase - Mental retardation and microcephaly with pontine and cerebellarhypoplasia, 300749 (3); FG syndrome 4, 300422 (3)];		0.3875	0.025	0.5875	42		
chrX	41556312	41556312	T	C	hom	222	GPR34			0	0	0									300172 [Calcium/calmodulin-dependent serine protein kinase - Mental retardation and microcephaly with pontine and cerebellarhypoplasia, 300749 (3); FG syndrome 4, 300422 (3)];		0	0	1	0		
chrX	43084766	43084766	T	G	hom	222	PPP1R2P9;MAOA		PPP1R2P9:dist=447280;MAOA:dist=429389	0.58	0.58	0.58	rs2205920 [];							368			0.5375	0.05	0.4125	55		
chrX	43085367	43085367	G	T	hom	222	PPP1R2P9;MAOA		PPP1R2P9:dist=447881;MAOA:dist=428788	0.95	0.95	0.95	rs2410927 [];							2354			0.925	0.0125	0.0625	85		
chrX	43085373	43085373	C	T	hom	222	PPP1R2P9;MAOA		PPP1R2P9:dist=447887;MAOA:dist=428782	0.58	0.58	0.58	rs2410926 [];							2354			0.55	0.05	0.4	56		
chrX	43741616	43741616	G	C	hom	106	MAOB			1	1	1	rs1181251 [];							221			0.875	0	0.125	107		
chrX	44833841	44833841	C	A	hom	182	KDM6A			0.72	0.72	0.72	rs6611055 [];					0.5232					0.225	0.025	0.75	44		
chrX	44935936	44935937	TT	-	het	40.2	KDM6A			0	0	0											0.3625	0.25	0.3875	84		
chrX	44938563	44938563	G	A	hom	222	KDM6A	synonymous SNV	KDM6A:NM_021140:exon20:c.G3111A:p.Q1037Q [1(prostate)]; 	0.23	0.23	0.23	rs20539 [];	-0.0320				0.1885	1179848 [1(prostate)]; 				0.2375	0.025	0.7375	61		
chrX	45008291	45008291	T	C	hom	222	CXorf36			0.55	0.55	0.55	rs6611070 [];										0.5	0.0375	0.4625	51		
chrX	45009961	45009961	T	C	hom	222	CXorf36			0.7	0.7	0.7	rs5905926 [];							1021			0.5125	0.0375	0.45	51		
chrX	45010636	45010636	C	T	hom	222	CXorf36			0.55	0.55	0.55	rs4074014 [];										0.4875	0.0375	0.475	49		
chrX	45050973	45050973	C	T	hom	222	CXorf36			0.64	0.64	0.64	rs4239958 [];					0.4872					0.2375	0.0125	0.75	38		
chrX	45051111	45051111	C	T	hom	222	CXorf36	nonsynonymous SNV	CXorf36:NM_024689:exon2:c.G383A:p.R128K,CXorf36:NM_176819:exon2:c.G383A:p.R128K,	0.43	0.43	0.43	rs1132201 [];	0.5530	0.0261	0.7600	0.0110	0.3248					0.3125	0.0625	0.625	56		
chrX	46306930	46306930	G	T	hom	129	KRBOX4			0.33	0.33	0.33	rs4824581 [];										0.1625	0.075	0.7625	23		
chrX	46502837	46502839	AAG	-	hom	214	SLC9A7			0.02	0.02	0.02	rs200840210 [];					0.0645					0.0125	0.0125	0.975	8		
chrX	46737139	46737139	-	GTGTGT	hom	150	RP2			0	0	0								270			0.3625	0	0.6375	38		
chrX	46740032	46740032	G	A	hom	222	RP2			0.99	0.99	0.99	rs4239962 [];										0.9625	0	0.0375	93		
chrX	46893249	46893249	G	A	hom	222	PHF16			0.98	0.98	0.98	rs5906311 [];										0.3875	0.0375	0.575	45		
chrX	46918917	46918917	-	A	hom	214	PHF16			0	0	0	rs66617346 [];										0.9625	0	0.0375	93		
chrX	46918975	46918975	-	A	hom	214	PHF16			0	0	0	rs59370972 [];										0.9625	0	0.0375	93		
chrX	46919652	46919652	A	-	hom	125	PHF16			0	0	0	rs60606687 [];										0.925	0	0.075	90		
chrX	46920599	46920599	C	A	hom	222	PHF16			0.68	0.68	0.68	rs6725 [];										0.475	0.0625	0.4625	49		
chrX	46949403	46949403	C	T	hom	222	RGN			0.58	0.58	0.58	rs6611330 [];					0.6063	COSN168733 [1(large_intestine)]; 				0.2625	0.0625	0.675	65		
chrX	46951004	46951004	G	T	hom	203	RGN			0.6	0.6	0.6	rs5906327 [];										0.3	0.05	0.65	37		
chrX	46952219	46952219	A	G	hom	190	RGN			0.6	0.6	0.6	rs4480242 [];										0.3	0.05	0.65	37		
chrX	46992041	46992041	C	A	hom	178	RGN;NDUFB11		RGN:dist=39329;NDUFB11:dist=9574	0.56	0.56	0.56	rs6611336 [];										0.625	0.0625	0.3125	66		
chrX	47060844	47060844	C	G	hom	222	UBA1			0.33	0.33	0.33	rs4239963 [];					0.3203			314370 [Ubiquitin-activating enzyme E1 (teA1S9) - Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)];		0.0875	0.05	0.8625	39		
chrX	47061018	47061018	C	G	hom	222	UBA1			0.98	0.98	0.98	rs4239964 [];					0.9841			314370 [Ubiquitin-activating enzyme E1 (teA1S9) - Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)];		0.9375	0	0.0625	202		
chrX	47065186	47065186	G	A	hom	215	INE1			0.33	0.33	0.33	rs4339766 [];							2003	314370 [Ubiquitin-activating enzyme E1 (teA1S9) - Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)];		0.2375	0.0625	0.7	27		
chrX	47086691	47086691	-	C	hom	214	CDK16			0	0	0											0.0375	0.05	0.9125	15		
chrX	47088744	47088744	A	C	het	16.1	CDK16			0	0	0											0	0.3625	0.6375	38		
chrX	47229909	47229909	G	A	hom	160	ZNF157			0.37	0.37	0.37	rs3810666 [];										0.0875	0.025	0.8875	12		
chrX	47229935	47229935	T	C	hom	175	ZNF157			0.37	0.37	0.37	rs3810665 [];										0.0875	0.025	0.8875	12		
chrX	47230204	47230204	T	C	hom	185	ZNF157			0.25	0.25	0.25	rs6608713 [];					0.3089		1884			0.0875	0.025	0.8875	12		
chrX	47306422	47306422	T	C	hom	222	ZNF41			0.4	0.4	0.4	rs3810664 [];										0.1625	0.0375	0.8	20		
chrX	47306859	47306859	A	G	hom	222	ZNF41	synonymous SNV	ZNF41:NM_007130:exon5:c.T2310C:p.S770S,ZNF41:NM_153380:exon5:c.T2310C:p.S770S,	0.0012	0.0012	0.0012	rs148100650 [];					0.0010					0.0125	0	0.9875	1		
chrX	47327111	47327111	T	C	hom	222	ZNF41			0.78	0.78	0.78	rs5905607 [];										0.45	0.0875	0.4625	49		
chrX	47341780	47341780	T	C	hom	221	ZNF41			0.97	0.97	0.97	rs5905609 [];										0.4375	0	0.5625	45		
chrX	47341821	47341821	A	G	hom	222	ZNF41			0.3	0.3	0.3	rs2071780 [];										0.075	0.025	0.9	11		
chrX	47430457	47430457	A	T	hom	222	ARAF			0.38	0.38	0.38	rs2854412 [];					0.3851					0.1625	0.0625	0.775	29		
chrX	47430510	47430510	-	GTGT	hom	197	ARAF			0	0	0								288			0.025	0	0.975	2		
chrX	47430642	47430647	GTGTGT	-	hom	214	ARAF			0	0	0								324			0.1375	0.0375	0.825	15		
chrX	47444879	47444879	G	C	hom	222	SYN1;TIMP1			0.45	0.45	0.45	rs5953060 [];	-0.0050	0.2709	0.0000	0.0000				313440 [Synapsin I - Epilepsy, X-linked, with variable learning disabilities andbehavior disorders, 300491 (3)];		0.2125	0.025	0.7625	22		
chrX	47444985	47444985	T	C	hom	222	TIMP1	synonymous SNV	TIMP1:NM_003254:exon5:c.T372C:p.F124F,	0.45	0.45	0.45	rs4898 [];	-0.3520	0.2772			0.4575			313440 [Synapsin I - Epilepsy, X-linked, with variable learning disabilities andbehavior disorders, 300491 (3)];		0.4625	0.0375	0.5	67		
chrX	47466361	47466361	A	G	hom	222	SYN1	synonymous SNV	SYN1:NM_133499:exon3:c.T510C:p.N170N,SYN1:NM_006950:exon3:c.T510C:p.N170N,	0.35	0.35	0.35	rs1142636 [];					0.3786			313440 [Synapsin I - Epilepsy, X-linked, with variable learning disabilities andbehavior disorders, 300491 (3)];		0.2625	0.0625	0.675	72		
chrX	47485245	47485245	G	A	hom	222	CFP			0.84	0.84	0.84	rs8177079 [];								300383 [Properdin P factor, complement - Properdin deficiency, X-linked, 312060 (3)];		0.7625	0.0375	0.2	75		
chrX	47487913	47487913	-	G	hom	214	CFP			0	0	0	rs11453568 [];								300383 [Properdin P factor, complement - Properdin deficiency, X-linked, 312060 (3)];		0.9625	0	0.0375	89		
chrX	47863552	47863552	-	C	hom	214	SPACA5;ZNF182			0	0	0	rs36101191 [];										0.4375	0	0.5625	46		
chrX	47920356	47920356	A	G	hom	222	ZNF630			1	1	1	rs727079 [];					0.9945					0.4375	0	0.5625	74		
chrX	47967040	47967040	G	A	hom	201	SSX6			0.44	0.44	0.44	rs12156664 [];										0.125	0.025	0.85	17		
chrX	47967162	47967162	C	T	hom	222	SSX6			0.36	0.36	0.36	rs12156676 [];										0.225	0.05	0.725	28		
chrX	47967190	47967190	A	G	hom	222	SSX6			0.36	0.36	0.36	rs12156891 [];										0.225	0.0625	0.7125	29		
chrX	47970842	47970842	A	T	hom	198	SSX6			0.47	0.47	0.47	rs543755 [];							534			0.125	0.0375	0.8375	18		
chrX	48045802	48045803	GT	-	hom	214	SSX5			0	0	0								351			0.55	0.075	0.375	61		
chrX	48046032	48046032	T	C	hom	222	SSX5			0.96	0.96	0.96	rs2314191 [];										0.9875	0	0.0125	100		
chrX	48049666	48049666	C	T	hom	222	SSX5	synonymous SNV	SSX5:NM_021015:exon7:c.G492A:p.S164S,SSX5:NM_175723:exon6:c.G369A:p.S123S,	0.93	0.93	0.93	rs5906557 [];					0.9991					0.9875	0	0.0125	145		
chrX	48053521	48053521	T	C	hom	222	SSX5			0.88	0.88	0.88	rs4239967 [];					0.9967					0.4375	0	0.5625	74		
chrX	48054740	48054740	C	G	hom	222	SSX5	nonsynonymous SNV	SSX5:NM_021015:exon2:c.G55C:p.E19Q,SSX5:NM_175723:exon2:c.G55C:p.E19Q,	0.88	0.88	0.88	rs4824675 [];	0.0950	0.0010	0.1400	0.7210	0.9969					0.975	0	0.025	147		
chrX	48056189	48056189	C	G	hom	222	SSX5			0.96	0.96	0.96	rs4824676 [];										0.975	0	0.025	97		
chrX	48155054	48155055	TG	-	hom	214	SSX1;SSX9		SSX1:dist=28175;SSX9:dist=5930	0	0	0								312			0.175	0.0125	0.8125	24		
chrX	48155136	48155136	G	C	hom	222	SSX1;SSX9		SSX1:dist=28257;SSX9:dist=5849	1	1	1	rs4824689 [];										0.9875	0	0.0125	99		
chrX	48161281	48161281	C	G	hom	222	SSX9			0.95	0.95	0.95	rs4571855 [];										0.4375	0	0.5625	46		
chrX	48164138	48164138	A	G	hom	222	SSX9			0.94	0.94	0.94	rs5906631 [];										0.4375	0	0.5625	46		
chrX	48206014	48206023	GTGTGTGTCT	-	hom	214	SSX3			0	0	0	rs72172699 [];							340			0.125	0	0.875	12		
chrX	48216146	48216146	A	G	hom	222	SSX3			0.8	0.8	0.8	rs5906651 [];										0.925	0.025	0.05	95		
chrX	48432791	48432791	T	C	hom	169	RBM3			0.92	0.92	0.92	rs2661105 [];										0.4	0.0125	0.5875	43		
chrX	48433499	48433499	C	G	hom	222	RBM3			0.46	0.46	0.46	rs2249583 [];										0.5125	0.05	0.4375	52		
chrX	48433529	48433529	C	T	hom	222	RBM3			0.46	0.46	0.46	rs2249585 [];					0.5718					0.5125	0.05	0.4375	72		
chrX	48435308	48435308	G	A	hom	222	RBM3			0.46	0.46	0.46	rs235830 [];										0.25	0.05	0.7	31		
chrX	48435928	48435928	C	T	hom	222	RBM3			0.92	0.92	0.92	rs235829 [];	0.8700	0.2820	1.0000							0.85	0.025	0.125	84		
chrX	48436507	48436507	C	G	hom	222	RBM3			0.81	0.81	0.81	rs8931 [];										0.825	0.025	0.15	78		
chrX	48456223	48456223	G	T	hom	222	WDR13			0.81	0.81	0.81	rs235824 [];										0.8375	0.025	0.1375	84		
chrX	48460314	48460314	A	G	hom	222	WDR13	nonsynonymous SNV	WDR13:NM_001166426:exon5:c.A698G:p.H233R,WDR13:NM_017883:exon6:c.A974G:p.H325R,	1	1	1	rs235842 [];	0.5070	0.0000	0.2800	0.0000	1.0000					0.975	0	0.025	147		
chrX	48460625	48460625	G	C	hom	222	WDR13			0.81	0.81	0.81	rs235841 [];					0.9078					0.4	0.0125	0.5875	69		
chrX	48462951	48462951	C	G	hom	91.3	WDR13			0.46	0.46	0.46	rs235840 [];										0.25	0.025	0.725	28		
chrX	48649449	48649449	T	G	hom	173	GATA1			1	1	1	rs62600348 [];										0.4375	0	0.5625	46		
chrX	48649456	48649456	T	G	hom	164	GATA1			1	1	1	rs66717003 [];										0.4375	0	0.5625	46		
chrX	48689575	48689575	G	A	hom	222	PCSK1N			0.02	0.02	0.02	rs56338702 [];										0.025	0	0.975	3		
chrX	48847497	48847497	T	C	hom	222	GRIPAP1	synonymous SNV	GRIPAP1:NM_020137:exon7:c.A483G:p.E161E,GRIPAP1:NM_207672:exon6:c.A324G:p.E108E,	0.31	0.31	0.31	rs11545861 [];					0.4446					0.4	0.025	0.575	65		
chrX	48898183	48898183	C	G	hom	222	TFE3			0.99	0.99	0.99	rs7056903 [];										0.4375	0	0.5625	46		
chrX	49021256	49021256	A	G	hom	222	MAGIX	nonsynonymous SNV	MAGIX:NM_001099680:exon2:c.A134G:p.H45R,MAGIX:NM_024859:exon4:c.A335G:p.H112R,	1	1	1	rs5906744 [];	-0.6460	0.2709	0.6100	0.0000	0.9982					0.9875	0	0.0125	148		
chrX	49021537	49021537	G	C	hom	222	MAGIX	nonsynonymous SNV	MAGIX:NM_001099682:exon4:c.G289C:p.V97L,MAGIX:NM_001099681:exon4:c.G289C:p.V97L,MAGIX:NM_001099680:exon3:c.G316C:p.V106L,MAGIX:NM_024859:exon5:c.G517C:p.V173L,	1	1	1	rs5905720 [];	0.8800		0.2400	0.0010	0.9983					0.975	0	0.025	146		
chrX	49022700	49022700	T	C	hom	222	MAGIX	nonsynonymous SNV	MAGIX:NM_001099682:exon5:c.T724C:p.F242L,MAGIX:NM_001099681:exon5:c.T739C:p.F247L,MAGIX:NM_001099680:exon4:c.T751C:p.F251L,MAGIX:NM_024859:exon6:c.T967C:p.F323L,	1	1	1	rs4824462 [];	-0.0500	0.0000	1.0000	0.0000						0.95	0	0.05	149		
chrX	49047325	49047325	A	G	hom	222	SYP			0.57	0.57	0.57	rs3817678 [];								313475 [Synaptophysin - Mental retardation, X-linked, with or without epilepsy, 300802 (3)];		0.3	0.05	0.65	32		
chrX	49047619	49047619	T	C	hom	222	SYP			0.57	0.57	0.57	rs2293945 [];								313475 [Synaptophysin - Mental retardation, X-linked, with or without epilepsy, 300802 (3)];		0.3125	0.0625	0.625	34		
chrX	49069366	49069366	C	T	hom	222	CACNA1F			0.47	0.47	0.47	rs2071316 [];					0.2865			300110 [Calcium channel, voltage-dependent, alpha-1F subunit - Night blindness, congenital stationary, X-linked, type 2A, 300071(3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)];		0.125	0.0625	0.8125	33		
chrX	49070813	49070813	G	A	hom	222	CACNA1F			0.47	0.47	0.47	rs2071317 [];								300110 [Calcium channel, voltage-dependent, alpha-1F subunit - Night blindness, congenital stationary, X-linked, type 2A, 300071(3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)];		0.125	0.0625	0.8125	18		
chrX	49071964	49071964	A	G	hom	222	CACNA1F	synonymous SNV	CACNA1F:NM_005183:exon28:c.T3309C:p.H1103H,CACNA1F:NM_001256789:exon28:c.T3276C:p.H1092H,CACNA1F:NM_001256790:exon28:c.T3114C:p.H1038H,	0.55	0.55	0.55	rs2075866 [];					0.2930			300110 [Calcium channel, voltage-dependent, alpha-1F subunit - Night blindness, congenital stationary, X-linked, type 2A, 300071(3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)];		0.25	0.075	0.675	72		
chrX	49074801	49074801	G	A	hom	189	CACNA1F			0.45	0.45	0.45	rs926175 [];								300110 [Calcium channel, voltage-dependent, alpha-1F subunit - Night blindness, congenital stationary, X-linked, type 2A, 300071(3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)];		0.1125	0.075	0.8125	18		
chrX	49077583	49077583	G	A	hom	222	CACNA1F			0.45	0.45	0.45	rs2869212 [];					0.2765			300110 [Calcium channel, voltage-dependent, alpha-1F subunit - Night blindness, congenital stationary, X-linked, type 2A, 300071(3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)];		0.1125	0.0625	0.825	36		
chrX	49081291	49081291	G	A	hom	222	CACNA1F	synonymous SNV	CACNA1F:NM_005183:exon14:c.C1842T:p.G614G,CACNA1F:NM_001256789:exon14:c.C1809T:p.G603G,CACNA1F:NM_001256790:exon14:c.C1647T:p.G549G,	0.45	0.45	0.45	rs2235127 [];					0.2786			300110 [Calcium channel, voltage-dependent, alpha-1F subunit - Night blindness, congenital stationary, X-linked, type 2A, 300071(3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)];		0.2375	0.0875	0.675	70		
chrX	49084492	49084492	C	T	hom	222	CACNA1F			0.38	0.38	0.38	rs6609854 [];					0.2748		211	300110 [Calcium channel, voltage-dependent, alpha-1F subunit - Night blindness, congenital stationary, X-linked, type 2A, 300071(3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)];		0.225	0.0875	0.6875	70		
chrX	49087487	49087487	G	A	hom	222	CACNA1F			0.45	0.45	0.45	rs5905724 [];					0.2785			300110 [Calcium channel, voltage-dependent, alpha-1F subunit - Night blindness, congenital stationary, X-linked, type 2A, 300071(3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)];		0.125	0.075	0.8	37		
chrX	49093528	49093528	T	C	hom	222	CCDC22			0.67	0.67	0.67	rs2294016 [];					0.3734					0.15	0.075	0.775	40		
chrX	49098631	49098631	A	G	hom	222	CCDC22			0.56	0.56	0.56	rs2294018 [];					0.2745					0.125	0.075	0.8	33		
chrX	49103224	49103224	G	A	hom	222	CCDC22	synonymous SNV	CCDC22:NM_014008:exon7:c.G747A:p.Q249Q,	0.47	0.47	0.47	rs2294020 [];					0.2727					0.2125	0.1	0.6875	48		
chrX	49189240	49189242	TAT	-	hom	95.4	GAGE13	nonframeshift deletion	GAGE13:NM_001098412:exon2:c.25_27del:p.9_9del,	0	0	0	rs33925578 [];										0.2	0.2375	0.5625	38		
chrX	49687435	49687435	-	G	hom	214	CLCN5			0	0	0	rs11440111 [];								300008 [Chloride channel-5 - Dent disease, 300009 (3); Nephrolithiasis, type I, 310468 (3);Hypophosphatemic rickets, 300554 (3); Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis, 308990 (3)];		0.4375	0	0.5625	71		
chrX	49969467	49969467	-	CT	het	190	AKAP4;CCNB3		AKAP4:dist=3803;CCNB3:dist=58073	0	0	0	rs71952635 [];							180			0.025	0.5125	0.4625	50		
chrX	50056814	50056814	A	G	hom	206	CCNB3			0.38	0.38	0.38	rs5915179 [];					0.5910					0.2375	0.05	0.7125	49		
chrX	50121148	50121148	-	G	hom	214	DGKK	unknown	UNKNOWN	0	0	0											0.9625	0	0.0375	167		
chrX	50146956	50146956	A	T	hom	222	DGKK			0.02	0.02	0.02	rs41315078 [];										0	0	1	1		
chrX	50336022	50336022	A	T	hom	222	SHROOM4			0.66	0.66	0.66	rs5915277 [];								300579 [Shroom family member 4 - Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)];		0.6625	0.0625	0.275	117		
chrX	50336537	50336537	-	C	hom	211	SHROOM4			0	0	0									300579 [Shroom family member 4 - Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)];		0.6375	0.075	0.2875	106		
chrX	50341598	50341598	G	A	hom	222	SHROOM4			0.65	0.65	0.65	rs2295544 [];								300579 [Shroom family member 4 - Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)];		0.3125	0.05	0.6375	37		
chrX	50341675	50341675	G	C	hom	222	SHROOM4			0.66	0.66	0.66	rs2295543 [];								300579 [Shroom family member 4 - Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)];		0.3125	0.05	0.6375	37		
chrX	50378792	50378792	G	A	hom	155	SHROOM4			0.49	0.49	0.49	rs5915290 [];								300579 [Shroom family member 4 - Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)];		0.175	0.0625	0.7625	24		
chrX	51239296	51239309	TCCTCGAGGCAGCC	-	hom	179	NUDT11	frameshift deletion	NUDT11:NM_018159:wholegene [1(breast),1(skin),1(prostate),2(upper_aerodigestive_tract),1(central_nervous_system)]; 	0	0	0						0.9486	127214 [1(breast),1(skin),1(prostate),2(upper_aerodigestive_tract),1(central_nervous_system)]; 				0.8125	0	0.1875	132		
chrX	51486659	51486659	C	T	hom	222	GSPT2			0.78	0.78	0.78	rs974285 [];										0.5875	0.0625	0.35	69		
chrX	52662823	52662824	AC	-	het	113	SSX8			0	0	0								244			0	0.85	0.15	82		
chrX	52726098	52726099	GT	-	het	136	SSX2			0	0	0								478			0.1625	0.3375	0.5	46		
chrX	52825471	52825471	A	G	hom	222	SPANXN5			0.98	0.98	0.98	rs2806837 [];										0.975	0	0.025	98		
chrX	52825546	52825546	C	G	hom	222	SPANXN5	synonymous SNV	SPANXN5:NM_001009616:exon2:c.G201C:p.L67L,	0.98	0.98	0.98	rs2806838 [];					0.9704					0.9625	0	0.0375	145		
chrX	52891565	52891565	A	G	het	42	XAGE3			0	0	0	rs79831867 [];										0	0.8375	0.1625	115		
chrX	52891584	52891584	C	T	hom	43	XAGE3			0	0	0	rs5943751 [];										0.4125	0.0375	0.55	61		
chrX	52891620	52891620	T	-	het	14.6	XAGE3			0	0	0	rs66488051 [];										0	0.8	0.2	139		
chrX	52891645	52891645	A	G	het	173	XAGE3			0	0	0	rs75808475 [];						COSN215910 [1(central_nervous_system)]; 				0	0.8875	0.1125	156		
chrX	52891653	52891653	C	T	het	185	XAGE3	synonymous SNV	XAGE3:NM_130776:exon5:c.G330A:p.Q110Q [1(large_intestine)]; XAGE3:NM_133179:exon5:c.G330A:p.Q110Q [1(large_intestine)]; 	0	0	0	rs73206488 [];						287951 [1(large_intestine)]; 				0	0.8875	0.1125	157		
chrX	52895580	52895581	GT	-	hom	199	XAGE3			0	0	0	rs5902508 [];							243			0.425	0.0125	0.5625	71		
chrX	53171516	53171516	-	T	het	50.5	TSPYL2;KDM5C		TSPYL2:dist=53788;KDM5C:dist=48987	0	0	0								2369			0.025	0.35	0.625	34		
chrX	53220836	53220836	G	T	hom	222	KDM5C			0.82	0.82	0.82	rs1886889 [];								314690 [Lysine-specific demethylase 5C - Mental retardation, X-linked, syndromic, JARID1C-related, 300534 (3)];		0.925	0	0.075	152		
chrX	53222044	53222044	-	C	hom	102	KDM5C			0	0	0	rs150558161 [];								314690 [Lysine-specific demethylase 5C - Mental retardation, X-linked, syndromic, JARID1C-related, 300534 (3)];		0.9	0	0.1	138		
chrX	53226311	53226311	T	C	hom	168	KDM5C			0.81	0.81	0.81	rs5933555 [];								314690 [Lysine-specific demethylase 5C - Mental retardation, X-linked, syndromic, JARID1C-related, 300534 (3)];		0.4375	0	0.5625	46		
chrX	53228148	53228148	C	A	hom	222	KDM5C			0.75	0.75	0.75	rs1977364 [];					0.9752			314690 [Lysine-specific demethylase 5C - Mental retardation, X-linked, syndromic, JARID1C-related, 300534 (3)];		0.425	0	0.575	104		
chrX	53263460	53263460	C	T	hom	222	IQSEC2	nonsynonymous SNV	IQSEC2:NM_001111125:exon15:c.G4408A:p.A1470T,	0.01	0.01	0.01	rs191886831 [];	0.4640	0.0008	0.0400	0.0000				300522 [IQ motif- and Sec7 domain-containing protein 2 - Mental retardation, X-linked 1, 309530 (3)];		0.0125	0.0125	0.975	2		
chrX	53271147	53271147	T	G	hom	222	IQSEC2			0.7	0.7	0.7	rs2274307 [];								300522 [IQ motif- and Sec7 domain-containing protein 2 - Mental retardation, X-linked 1, 309530 (3)];		0.3625	0.025	0.6125	41		
chrX	53436232	53436232	G	T	hom	222	SMC1A			0.98	0.98	0.98	rs1264008 [];					0.9417			300040 [Segregation of mitotic chromosomes 1 (SMC1, yeast, homolog of; - Cornelia de Lange syndrome 2, 300590 (3)];		0.3875	0.0125	0.6	95		
chrX	53449337	53449337	-	G	hom	195	SMC1A			0	0	0	rs11462431 [];								300040 [Segregation of mitotic chromosomes 1 (SMC1, yeast, homolog of; - Cornelia de Lange syndrome 2, 300590 (3)];		0.4375	0	0.5625	45		
chrX	53563589	53563589	A	G	hom	222	HUWE1	synonymous SNV	HUWE1:NM_031407:exon79:c.T12177C:p.G4059G,	0.99	0.99	0.99	rs426298 [];	-0.2100				0.9997			300697 [HECT, UBA, and WWE domains-containing protein 1 - Mental retardation, X-linked syndromic, Turner type, 300706 (3)];		0.95	0	0.05	207		
chrX	53565686	53565686	-	CTCTCTCT	hom	214	HUWE1			0	0	0								252	300697 [HECT, UBA, and WWE domains-containing protein 1 - Mental retardation, X-linked syndromic, Turner type, 300706 (3)];		0.025	0	0.975	2		
chrX	53607754	53607754	A	C	hom	222	HUWE1			0.36	0.36	0.36	rs266786 [];					0.4548			300697 [HECT, UBA, and WWE domains-containing protein 1 - Mental retardation, X-linked syndromic, Turner type, 300706 (3)];		0.175	0.05	0.775	49		
chrX	53654402	53654402	T	C	hom	222	HUWE1	nonsynonymous SNV	HUWE1:NM_031407:exon17:c.A1448G:p.N483S,	0.01	0.01	0.01	rs41307640 [];	0.3270	0.0002	1.0000	0.0020	0.0275			300697 [HECT, UBA, and WWE domains-containing protein 1 - Mental retardation, X-linked syndromic, Turner type, 300706 (3)];		0.0375	0	0.9625	10		
chrX	53713365	53713365	A	C	hom	70	HUWE1			1	1	1	rs7877957 [];								300697 [HECT, UBA, and WWE domains-containing protein 1 - Mental retardation, X-linked syndromic, Turner type, 300706 (3)];		0.0375	0	0.9625	3		
chrX	53963624	53963624	T	C	hom	222	PHF8			0.12	0.12	0.12	rs7892782 [];								300560 [PHD finger protein 8 - Mental retardation syndrome, X-linked, Siderius type, 300263 (3)];		0.0625	0.025	0.9125	14		
chrX	53964588	53964588	T	C	hom	222	PHF8			0.11	0.11	0.11	rs41306892 [];								300560 [PHD finger protein 8 - Mental retardation syndrome, X-linked, Siderius type, 300263 (3)];		0.0625	0.025	0.9125	14		
chrX	53966984	53966984	G	C	hom	222	PHF8			0.11	0.11	0.11	rs7886772 [];					0.0950			300560 [PHD finger protein 8 - Mental retardation syndrome, X-linked, Siderius type, 300263 (3)];		0.0375	0.025	0.9375	8		
chrX	53969109	53969109	-	GAGA	hom	214	PHF8			0	0	0									300560 [PHD finger protein 8 - Mental retardation syndrome, X-linked, Siderius type, 300263 (3)];		0.0625	0.025	0.9125	12		
chrX	53969347	53969347	A	G	hom	222	PHF8			0.11	0.11	0.11	rs7883019 [];							200	300560 [PHD finger protein 8 - Mental retardation syndrome, X-linked, Siderius type, 300263 (3)];		0.0625	0.025	0.9125	13		
chrX	53989230	53989230	C	T	hom	210	PHF8			0.12	0.12	0.12	rs41315088 [];					0.0935			300560 [PHD finger protein 8 - Mental retardation syndrome, X-linked, Siderius type, 300263 (3)];		0.0375	0.025	0.9375	8		
chrX	54028839	54028839	T	C	hom	222	PHF8			0.12	0.12	0.12	rs112731110 [];							494	300560 [PHD finger protein 8 - Mental retardation syndrome, X-linked, Siderius type, 300263 (3)];		0.0375	0.025	0.9375	5		
chrX	54107692	54107692	T	C	hom	222	FAM120C			1	1	1	rs2516098 [];										0.4375	0	0.5625	46		
chrX	54117740	54117740	C	A	hom	222	FAM120C			1	1	1	rs2495797 [];					0.9999					0.9375	0	0.0625	142		
chrX	54161859	54161859	C	T	hom	222	FAM120C			0.99	0.99	0.99	rs4826523 [];										0.4375	0	0.5625	46		
chrX	54209387	54209387	A	G	hom	181	FAM120C	nonsynonymous SNV	FAM120C:NM_198456:exon1:c.T245C:p.I82T,FAM120C:NM_017848:exon1:c.T245C:p.I82T,	1	1	1	rs2495783 [];	0.1380	0.0000	0.5300	0.0000						0.9375	0	0.0625	161		
chrX	54224402	54224403	AA	-	hom	24.5	WNK3			0	0	0											0	0.0125	0.9875	1		
chrX	54265542	54265542	-	ACAAAACAAA	hom	214	WNK3			0	0	0								441			0.05	0	0.95	4		
chrX	54556793	54556793	G	C	hom	222	GNL3L			0.01	0.01	0.01	rs12839758 [];										0.025	0.0375	0.9375	5		
chrX	54800654	54800655	AA	-	hom	20.6	ITIH6			0	0	0											0.2	0	0.8	17		
chrX	54834957	54834957	A	C	hom	222	MAGED2			0.43	0.43	0.43	rs743974 [];										0.125	0.0125	0.8625	13		
chrX	54835686	54835686	G	T	hom	222	MAGED2			0.0042	0.0042	0.0042	rs41309825 [];										0.0125	0	0.9875	1		
chrX	54836361	54836361	A	G	hom	222	MAGED2	synonymous SNV	MAGED2:NM_201222:exon3:c.A252G:p.S84S,MAGED2:NM_014599:exon3:c.A252G:p.S84S,MAGED2:NM_177433:exon3:c.A252G:p.S84S,	0.45	0.45	0.45	rs1043031 [];					0.3372					0.2875	0.0375	0.675	48		
chrX	54836505	54836505	A	G	hom	222	MAGED2	synonymous SNV	MAGED2:NM_201222:exon3:c.A396G:p.T132T,MAGED2:NM_014599:exon3:c.A396G:p.T132T,MAGED2:NM_177433:exon3:c.A396G:p.T132T,	0.54	0.54	0.54	rs1043034 [];					0.3395					0.2875	0.0375	0.675	48		
chrX	54837340	54837340	C	T	hom	222	MAGED2	synonymous SNV	MAGED2:NM_201222:exon4:c.C624T:p.A208A,MAGED2:NM_014599:exon4:c.C624T:p.A208A,MAGED2:NM_177433:exon4:c.C624T:p.A208A,	0.49	0.49	0.49	rs1043044 [];					0.3384					0.2875	0.0375	0.675	51		
chrX	54838077	54838077	C	T	hom	222	MAGED2	synonymous SNV	MAGED2:NM_201222:exon6:c.C981T:p.S327S,MAGED2:NM_014599:exon6:c.C981T:p.S327S,MAGED2:NM_177433:exon6:c.C981T:p.S327S,	0.47	0.47	0.47	rs2071932 [];					0.3378					0.2875	0.0375	0.675	50		
chrX	54840013	54840013	C	T	hom	222	MAGED2			0.49	0.49	0.49	rs763183 [];					0.3381					0.125	0.0125	0.8625	18		
chrX	55116466	55116466	C	G	hom	222	PAGE2	nonsynonymous SNV	PAGE2:NM_207339:exon2:c.C13G:p.L5V,	0.95	0.95	0.95	rs1845444 [];	-0.9520	0.0000	1.0000	0.0000	0.9943					0.95	0	0.05	143		
chrX	55172373	55172373	A	G	het	223	FAM104B			0	0	0	rs1047069 [];										0	0.9375	0.0625	86		
chrX	55246965	55246965	C	T	hom	222	PAGE5			0.86	0.86	0.86	rs5914272 [];					0.9736					0.9	0.025	0.075	119		
chrX	55247030	55247030	C	G	hom	222	PAGE5			0.87	0.87	0.87	rs5914273 [];					0.9680					0.9	0.025	0.075	139		
chrX	55248090	55248090	C	A	hom	223	PAGE5			0.7	0.7	0.7	rs4826274 [];										0.2375	0.05	0.7125	32		
chrX	55248376	55248376	A	G	hom	222	PAGE5			0.52	0.52	0.52	rs5914275 [];										0.2125	0.0625	0.725	29		
chrX	55249049	55249049	T	C	hom	222	PAGE5			0.49	0.49	0.49	rs2148982 [];					0.6510					0.6	0.0875	0.3125	101		
chrX	55289774	55289774	T	C	hom	222	PAGE3			0.86	0.86	0.86	rs4826381 [];	0.0030	0.0000	0.9100	0.0010	0.9682					0.9125	0.025	0.0625	143		
chrX	55291168	55291168	G	C	hom	222	PAGE3			0.49	0.49	0.49	rs2887654 [];										0.5375	0.0875	0.375	59		
chrX	55514818	55514818	C	T	hom	222	USP51	synonymous SNV	USP51:NM_201286:exon2:c.G555A:p.E185E,	0.53	0.53	0.53	rs3126255 [];					0.6888					0.5875	0.075	0.3375	103		
chrX	55651001	55651001	T	C	hom	222	FOXR2	nonsynonymous SNV	FOXR2:NM_198451:exon1:c.T857C:p.V286A,	0.86	0.86	0.86	rs2375465 [];	-0.0900	0.0008	1.0000	0.0010	0.9729					0.925	0.0125	0.0625	141		
chrX	55748820	55748820	A	G	hom	199	RRAGB			0.87	0.87	0.87	rs1473761 [];										0.4125	0	0.5875	44		
chrX	55757744	55757744	T	G	hom	222	RRAGB			0.87	0.87	0.87	rs5960480 [];										0.4125	0	0.5875	44		
chrX	56295959	56295960	TG	-	hom	190	KLF8			0	0	0	rs200952140 [];							240			0.2	0.0875	0.7125	79		
chrX	56296781	56296781	-	ACACAC	hom	180	KLF8			0	0	0								306			0.1125	0	0.8875	23		
chrX	56843771	56843771	G	A	hom	222	LOC550643			0.57	0.57	0.57	rs7044 [];							305			0.6	0.075	0.325	64		
chrX	56844640	56844640	A	G	hom	222	LOC550643			0.59	0.59	0.59	rs5913999 [];										0.5625	0.075	0.3625	61		
chrX	57019891	57019891	T	G	hom	222	SPIN3			0.55	0.55	0.55	rs6612746 [];										0.5875	0.075	0.3375	67		
chrX	57020115	57020115	C	T	hom	222	SPIN3			0.87	0.87	0.87	rs1325856 [];										0.9625	0	0.0375	94		
chrX	57405163	57405163	T	C	hom	222	FAAH2	synonymous SNV	FAAH2:NM_174912:exon6:c.T822C:p.R274R,	0.93	0.93	0.93	rs4826543 [];					0.9994					0.9875	0	0.0125	145		
chrX	57474943	57474943	A	T	hom	222	FAAH2			0.92	0.92	0.92	rs1821118 [];					0.9991					0.4375	0	0.5625	74		
chrX	57475132	57475132	T	C	hom	222	FAAH2	synonymous SNV	FAAH2:NM_174912:exon10:c.T1404C:p.P468P,	0.55	0.55	0.55	rs1367830 [];					0.7308					0.5875	0.075	0.3375	103		
chrX	57515439	57515439	T	C	hom	222	FAAH2			0.55	0.55	0.55	rs1048358 [];										0.6125	0.075	0.3125	68		
chrX	57619648	57619648	G	T	hom	222	ZXDB	synonymous SNV	ZXDB:NM_007157:exon1:c.G1167T:p.P389P,	1	1	1	rs1057328 [];					0.9997					0.9625	0	0.0375	147		
chrX	65393658	65393658	A	G	hom	222	HEPH			1	1	1	rs5918591 [];										0.4375	0	0.5625	72		
chrX	65420609	65420609	A	G	hom	222	HEPH			0.98	0.98	0.98	rs1264215 [];					0.9359					0.4375	0	0.5625	74		
chrX	65478923	65478923	-	A	hom	214	HEPH			0	0	0	rs35431478 [];										0.35	0.0375	0.6125	41		
chrX	65815591	65815591	T	C	hom	222	EDA2R			0.77	0.77	0.77	rs1485682 [];										0.7	0.0625	0.2375	75		
chrX	65815817	65815817	G	A	hom	222	EDA2R			0.71	0.71	0.71	rs11093958 [];										0.7125	0.0625	0.225	74		
chrX	65817522	65817522	A	G	hom	222	EDA2R			0.77	0.77	0.77	rs12855916 [];										0.675	0.0625	0.2625	72		
chrX	65817740	65817740	A	C	hom	222	EDA2R			0.77	0.77	0.77	rs4827380 [];										0.6875	0.075	0.2375	74		
chrX	65819223	65819223	A	G	hom	176	EDA2R			0.68	0.68	0.68	rs4827499 [];										0.35	0.0375	0.6125	40		
chrX	65819294	65819294	-	T	hom	214	EDA2R			0	0	0											0.3125	0.0375	0.65	50		
chrX	65822607	65822607	T	C	hom	222	EDA2R	nonsynonymous SNV	EDA2R:NM_001199687:exon5:c.A385G:p.T129A,EDA2R:NM_001242310:exon4:c.A385G:p.T129A,EDA2R:NM_021783:exon5:c.A385G:p.T129A,	0.95	0.95	0.95	rs1385698 [];	0.1700		0.1400	0.0000	0.9996					0.925	0	0.075	137		
chrX	65824986	65824986	C	T	hom	222	EDA2R	nonsynonymous SNV	EDA2R:NM_001199687:exon3:c.G170A:p.R57K,EDA2R:NM_001242310:exon2:c.G170A:p.R57K,EDA2R:NM_021783:exon3:c.G170A:p.R57K,	0.69	0.69	0.69	rs1385699 [];	1.8410	0.1249	1.0000	0.1260	0.7977					0.65	0.0625	0.2875	111		
chrX	66941597	66941597	T	G	hom	218	AR			0.91	0.91	0.91	rs1337076 [];								313700 [Androgen receptor (dihydrotestosterone receptor) - Androgen insensitivity, 300068 (3); Spinal and bulbar muscularatrophy of Kennedy, 313200 (3); Androgen insensitivity, partial, with or without breast cancer, 312300 (3); {Prostate cancer, susceptibility to},176807 (3); Hypospadias 1, X-linked, 300633 (3)];		0.4375	0	0.5625	46		
chrX	67412906	67412906	G	A	hom	222	OPHN1			1	1	1	rs1191948 [];								300127 [Oligophrenin-1 - Mental retardation, X-linked, with cerebellar hypoplasia anddistinctive facial appearance, 300486 (3)];		0.425	0.0125	0.5625	46		
chrX	67429847	67429847	T	-	hom	23.5	OPHN1			0	0	0									300127 [Oligophrenin-1 - Mental retardation, X-linked, with cerebellar hypoplasia anddistinctive facial appearance, 300486 (3)];		0.2125	0	0.7875	24		
chrX	67431921	67431921	C	T	hom	222	OPHN1			0.12	0.12	0.12	rs3788859 [];					0.0933			300127 [Oligophrenin-1 - Mental retardation, X-linked, with cerebellar hypoplasia anddistinctive facial appearance, 300486 (3)];		0.025	0.025	0.95	15		
chrX	67719085	67719085	G	T	hom	173	YIPF6			0.64	0.64	0.64	rs12843249 [];										0.3125	0.0375	0.65	37		
chrX	67936140	67936140	T	G	het	28	STARD8			0	0	0											0	0.4375	0.5625	46		
chrX	67937275	67937275	C	T	hom	222	STARD8	synonymous SNV	STARD8:NM_014725:exon5:c.C279T:p.P93P,STARD8:NM_001142503:exon6:c.C519T:p.P173P,STARD8:NM_001142504:exon5:c.C279T:p.P93P,	0.05	0.05	0.05	rs41310627 [];					0.0911					0.0875	0.05	0.8625	20		
chrX	67945398	67945399	AT	-	het	38.5	STARD8			0	0	0								420			0.0125	0.35	0.6375	33		
chrX	68061231	68061231	-	CA	hom	31	EFNB1			0	0	0									300035 [eph-related receptor tyrosine kinase ligand 2 (ephrin B1) - Craniofrontonasal dysplasia, 304110 (3)];		0.1625	0.1125	0.725	41		
chrX	68381264	68381264	C	A	hom	222	PJA1	nonsynonymous SNV	PJA1:NM_022368:exon3:c.G1254T:p.E418D,PJA1:NM_145119:exon2:c.G1818T:p.E606D,PJA1:NM_001032396:exon2:c.G1653T:p.E551D,	0.11	0.11	0.11	rs11539157 [];	0.3060	0.9951	0.5800	0.9890	0.2369					0.35	0.05	0.6	55		
chrX	68381787	68381787	C	T	hom	222	PJA1	nonsynonymous SNV	PJA1:NM_022368:exon3:c.G731A:p.S244N,PJA1:NM_145119:exon2:c.G1295A:p.S432N,PJA1:NM_001032396:exon2:c.G1130A:p.S377N,	0.13	0.13	0.13	rs5937160 [];	1.0290	0.0004	0.5600	0.0380	0.2365					0.35	0.0375	0.6125	53		
chrX	68382836	68382836	G	A	hom	222	PJA1	synonymous SNV	PJA1:NM_022368:exon2:c.C246T:p.S82S,PJA1:NM_145119:exon2:c.C246T:p.S82S,PJA1:NM_001032396:exon2:c.C81T:p.S27S,	0.13	0.13	0.13	rs7067170 [];					0.2368					0.3625	0.0375	0.6	56		
chrX	68725397	68725397	T	G	het	3.01	FAM155B	nonsynonymous SNV	FAM155B:NM_015686:exon1:c.T272G:p.V91G,	0	0	0		0.5100	0.0184	0.3800	0.0150						0	0.0125	0.9875	1		
chrX	69247897	69247898	CT	-	hom	214	EDA			0.41	0.41	0.41	rs145138166 [];					0.4203			300451 [Ectodysplasin A - Ectodermal dysplasia, anhidrotic, X-linked, 305100 (3); Toothagenesis, selective, X-linked 1, 313500 (3)];		0.3625	0.05	0.5875	83		
chrX	69250308	69250308	C	T	hom	222	EDA			0.23	0.23	0.23	rs2296765 [];					0.3733			300451 [Ectodysplasin A - Ectodermal dysplasia, anhidrotic, X-linked, 305100 (3); Toothagenesis, selective, X-linked 1, 313500 (3)];		0.15	0.025	0.825	54		
chrX	69250466	69250466	G	T	hom	222	EDA			0	0	0									300451 [Ectodysplasin A - Ectodermal dysplasia, anhidrotic, X-linked, 305100 (3); Toothagenesis, selective, X-linked 1, 313500 (3)];		0	0	1	0		
chrX	69257972	69257972	G	C	hom	222	EDA			0.13	0.13	0.13	rs3764746 [];								300451 [Ectodysplasin A - Ectodermal dysplasia, anhidrotic, X-linked, 305100 (3); Toothagenesis, selective, X-linked 1, 313500 (3)];		0.0375	0.0125	0.95	6		
chrX	69258515	69258515	T	G	hom	222	EDA			0.4	0.4	0.4	rs3795170 [];								300451 [Ectodysplasin A - Ectodermal dysplasia, anhidrotic, X-linked, 305100 (3); Toothagenesis, selective, X-linked 1, 313500 (3)];		0.4	0.05	0.55	63		
chrX	69261818	69261818	A	G	hom	222	AWAT2			0.41	0.41	0.41	rs2281933 [];					0.3805					0.4	0.05	0.55	67		
chrX	69262345	69262345	C	A	hom	189	AWAT2			0.0012	0.0012	0.0012	rs55925441 [];										0	0	1	0		
chrX	69262855	69262857	TCT	-	hom	214	AWAT2			0	0	0	rs72284868 [];										0.4	0.0125	0.5875	43		
chrX	69424664	69424664	G	T	hom	222	DGAT2L6			0.06	0.06	0.06	rs5980905 [];										0.0375	0.0375	0.925	8		
chrX	69510335	69510335	C	T	hom	222	KIF4A	synonymous SNV	KIF4A:NM_012310:exon2:c.C27T:p.P9P,	0.92	0.92	0.92	rs1199470 [];					0.9905					0.9625	0	0.0375	203		
chrX	69607224	69607224	-	T	hom	165	KIF4A			0	0	0											0.0375	0.0125	0.95	4		
chrX	69626017	69626017	G	A	hom	222	KIF4A			0.07	0.07	0.07	rs5980929 [];										0.0375	0.0125	0.95	4		
chrX	69637865	69637865	G	T	hom	222	KIF4A			0.06	0.06	0.06	rs5980934 [];					0.0856					0.0375	0.0125	0.95	18		
chrX	69639698	69639698	G	T	hom	222	KIF4A			0.99	0.99	0.99	rs1886892 [];										0.4375	0	0.5625	46		
chrX	69639832	69639832	C	T	hom	222	KIF4A			0.04	0.04	0.04	rs5980700 [];										0.0375	0.0125	0.95	4		
chrX	69640700	69640700	C	T	hom	222	KIF4A			0.04	0.04	0.04	rs1063088 [];										0.0625	0.0125	0.925	22		
chrX	69645230	69645230	C	T	hom	222	GDPD2	synonymous SNV	GDPD2:NM_001171192:exon3:c.C132T:p.L44L,GDPD2:NM_017711:exon3:c.C132T:p.L44L,	0.04	0.04	0.04	rs45513993 [];					0.0864					0.075	0.0125	0.9125	14		
chrX	69645372	69645372	G	C	hom	222	GDPD2			0.07	0.07	0.07	rs5980938 [];										0.0375	0.0125	0.95	4		
chrX	69645983	69645983	A	G	hom	222	GDPD2			0.04	0.04	0.04	rs73216706 [];					0.0864					0.0375	0.0125	0.95	11		
chrX	69647169	69647169	T	C	hom	222	GDPD2	synonymous SNV	GDPD2:NM_001171192:exon10:c.T792C:p.D264D,GDPD2:NM_001171191:exon8:c.T555C:p.D185D,GDPD2:NM_017711:exon10:c.T792C:p.D264D,GDPD2:NM_001171193:exon9:c.T555C:p.D185D,	0.07	0.07	0.07	rs5980939 [];					0.0871					0.075	0.0125	0.9125	14		
chrX	69652762	69652762	A	G	hom	222	GDPD2	synonymous SNV	GDPD2:NM_001171192:exon16:c.A1692G:p.R564R,GDPD2:NM_001171191:exon13:c.A1302G:p.R434R,GDPD2:NM_017711:exon15:c.A1539G:p.R513R,GDPD2:NM_001171193:exon14:c.A1302G:p.R434R,	0.88	0.88	0.88	rs2296542 [];					0.9510					0.9	0.025	0.075	138		
chrX	69749852	69749852	A	G	hom	222	TEX11		TEX11:NM_001003811:exon31:c.2566-3T>C,NM_031276:exon30:c.2521-3T>C	0.8	0.8	0.8	rs1536250 [];					0.9034					0.875	0.0125	0.1125	131		
chrX	69749853	69749853	T	A	hom	222	TEX11		TEX11:NM_001003811:exon31:c.2566-4A>T,NM_031276:exon30:c.2521-4A>T	0.82	0.82	0.82	rs1536251 [];					0.9077					0.875	0.0125	0.1125	131		
chrX	69774517	69774517	A	T	hom	222	TEX11	synonymous SNV	TEX11:NM_001003811:exon27:c.T2319A:p.T773T,TEX11:NM_031276:exon26:c.T2274A:p.T758T,	0.98	0.98	0.98	rs4844240 [];					0.9996					0.9625	0	0.0375	139		
chrX	69844797	69844797	G	A	hom	222	TEX11			0.68	0.68	0.68	rs1325094 [];					0.6000	COSN168751 [1(large_intestine)]; 				0.2625	0.0375	0.7	49		
chrX	69902468	69902468	-	T	hom	182	TEX11			0	0	0											0	0	1	0		
chrX	70093038	70093038	C	T	hom	217	TEX11			0.41	0.41	0.41	rs5937008 [];					0.4976					0.15	0.05	0.8	39		
chrX	70146398	70146398	A	G	hom	222	SLC7A3	synonymous SNV	SLC7A3:NM_001048164:exon10:c.T1599C:p.S533S,SLC7A3:NM_032803:exon10:c.T1599C:p.S533S,	0.79	0.79	0.79	rs4360450 [];					0.6452					0.6125	0.05	0.3375	98		
chrX	70148590	70148590	T	C	hom	222	SLC7A3			0.72	0.72	0.72	rs5936604 [];										0.25	0.0375	0.7125	30		
chrX	70148927	70148927	T	A	hom	194	SLC7A3			0.9	0.9	0.9	rs5936605 [];										0.4125	0	0.5875	44		
chrX	70151043	70151044	AC	-	hom	33.4	SLC7A3			0	0	0								439			0.0625	0	0.9375	5		
chrX	70279492	70279492	A	C	hom	222	SNX12			0.61	0.61	0.61	rs6780 [];										0.6375	0.0875	0.275	66		
chrX	70282696	70282696	A	G	hom	222	SNX12			0.61	0.61	0.61	rs34211894 [];					0.5544					0.6	0.0875	0.3125	101		
chrX	70321631	70321631	T	G	hom	222	FOXO4			0.56	0.56	0.56	rs5980742 [];					0.4597					0.175	0.0625	0.7625	29		
chrX	70324157	70324157	C	T	hom	222	CXorf65	synonymous SNV	CXorf65:NM_001025265:exon5:c.G417A:p.A139A,	0.15	0.15	0.15	rs1130009 [];					0.3200					0.2375	0.0875	0.675	58		
chrX	70324397	70324397	G	A	hom	222	CXorf65			0.18	0.18	0.18	rs12857595 [];										0.1125	0.0625	0.825	17		
chrX	70331101	70331101	-	AAGA	hom	214	IL2RG			0	0	0	rs67165954 [];								308380 [Interleukin-2 receptor, gamma - Severe combined immunodeficiency, X-linked, 300400 (3); Combinedimmunodeficiency, X-linked, moderate, 312863 (3)];		0.1	0.0625	0.8375	16		
chrX	70338399	70338399	A	G	hom	222	MED12			0.53	0.53	0.53	rs11796153 [];										0.45	0.1	0.45	92		
chrX	70339498	70339498	C	T	hom	222	MED12			0.15	0.15	0.15	rs12850852 [];					0.3188			300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1125	0.0625	0.825	43		
chrX	70341123	70341123	-	ACTTTATCTGCTTC	hom	214	MED12			0	0	0	rs71951253 [];								300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.05	0.0625	0.8875	14		
chrX	70341169	70341169	A	C	hom	222	MED12			0.16	0.16	0.16	rs62609586 [];					0.3206			300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.275	0.0875	0.6375	125		
chrX	70342820	70342820	A	G	hom	222	MED12			0.15	0.15	0.15	rs7053139 [];								300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1125	0.0625	0.825	17		
chrX	70343621	70343621	A	G	hom	222	MED12			0.16	0.16	0.16	rs12841977 [];					0.2594			300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1125	0.0625	0.825	17		
chrX	70344331	70344331	G	C	hom	222	MED12			0.36	0.36	0.36	rs59024650 [];								300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.125	0.0625	0.8125	18		
chrX	70344763	70344763	G	T	hom	222	MED12			0.16	0.16	0.16	rs5030616 [];								300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1125	0.0625	0.825	17		
chrX	70345683	70345683	T	G	hom	222	MED12			0.16	0.16	0.16	rs73214869 [];								300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1125	0.0625	0.825	17		
chrX	70348344	70348344	G	A	hom	222	MED12			0.16	0.16	0.16	rs5030618 [];								300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1125	0.0625	0.825	17		
chrX	70349947	70349947	A	C	hom	222	MED12	synonymous SNV	MED12:NM_005120:exon28:c.A3930C:p.P1310P,	0.15	0.15	0.15	rs5030619 [];					0.3176			300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.25	0.0875	0.6625	123		
chrX	70352417	70352417	T	C	hom	222	MED12			0.16	0.16	0.16	rs10521349 [];					0.3148			300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1125	0.0625	0.825	43		
chrX	70352516	70352516	A	G	hom	203	MED12			0.16	0.16	0.16	rs12843026 [];								300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1125	0.0625	0.825	17		
chrX	70356642	70356642	T	C	hom	222	MED12			0.55	0.55	0.55	rs12852829 [];								300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1875	0.075	0.7375	27		
chrX	70361967	70361967	G	A	hom	222	MED12			0.19	0.19	0.19	rs36072155 [];					0.3317			300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1125	0.0625	0.825	33		
chrX	70367328	70367328	A	G	hom	159	NLGN3			0.55	0.55	0.55	rs11795613 [];								300336 [Neuroligin 3 - {Autism susceptibility, X-linked 1}, 300425 (3);{Asperger syndrome susceptibility, X-linked 1}, 300494 (3)];		0.1875	0.075	0.7375	27		
chrX	70375023	70375023	G	A	hom	222	NLGN3			0.01	0.01	0.01	rs185402974 [];					0.0199			300336 [Neuroligin 3 - {Autism susceptibility, X-linked 1}, 300425 (3);{Asperger syndrome susceptibility, X-linked 1}, 300494 (3)];		0.0125	0	0.9875	1		
chrX	70390008	70390009	CA	-	het	23.5	NLGN3			0	0	0								387	300336 [Neuroligin 3 - {Autism susceptibility, X-linked 1}, 300425 (3);{Asperger syndrome susceptibility, X-linked 1}, 300494 (3)];		0	0.2625	0.7375	42		
chrX	70469182	70469182	G	A	hom	222	ZMYM3			1	1	1	rs2341539 [];							373			0.9875	0	0.0125	153		
chrX	70594942	70594942	-	A	het	23.5	BCYRN1			0	0	0									313650 [TAF1 RNA polymerase II, TATA box-binding protein-associated factor, - Dystonia-Parkinsonism, X-linked, 314250 (3)];		0	0.0625	0.9375	5		
chrX	70608033	70608033	G	A	hom	222	BCYRN1			0.0012	0.0012	0.0012	rs28382172 [];								313650 [TAF1 RNA polymerase II, TATA box-binding protein-associated factor, - Dystonia-Parkinsonism, X-linked, 314250 (3)];		0	0	1	0		
chrX	70794777	70794777	C	A	hom	222	OGT			0	0	0											0	0	1	0		
chrX	71347955	71347955	T	C	hom	222	NHSL2;RGAG4			0.44	0.44	0.44	rs7472250 [];										0.325	0.0125	0.6625	39		
chrX	71348837	71348837	G	A	hom	222	RGAG4			0.39	0.39	0.39	rs9887642 [];										0.75	0.0125	0.2375	74		
chrX	71349143	71349143	A	C	hom	222	RGAG4			0.44	0.44	0.44	rs9887370 [];										0.775	0.0125	0.2125	75		
chrX	71349753	71349753	G	A	hom	222	RGAG4	synonymous SNV	RGAG4:NM_001024455:exon1:c.C1638T:p.R546R,	0.38	0.38	0.38	rs12397326 [];					0.7855					0.775	0.0125	0.2125	114		
chrX	71349774	71349774	T	C	hom	222	RGAG4	synonymous SNV	RGAG4:NM_001024455:exon1:c.A1617G:p.G539G,	0.44	0.44	0.44	rs12393722 [];					0.7925					0.775	0.0125	0.2125	115		
chrX	71351443	71351443	A	G	hom	222	RGAG4			0.44	0.44	0.44	rs62614085 [];										0.7625	0.0125	0.225	77		
chrX	71351519	71351519	C	A	hom	141	RGAG4			0.99	0.99	0.99	rs12390168 [];										0.9	0	0.1	85		
chrX	71353658	71353658	C	T	hom	222	NHSL2			0.38	0.38	0.38	rs7392268 [];										0.7875	0.0125	0.2	73		
chrX	71360865	71360865	C	T	hom	222	NHSL2			0.37	0.37	0.37	rs7392389 [];										0.7625	0.0125	0.225	71		
chrX	71364479	71364479	A	C	hom	222	FLJ44635			0.96	0.96	0.96	rs11094247 [];					1.0000					0.4375	0	0.5625	74		
chrX	71379702	71379702	T	C	hom	222	FLJ44635	nonsynonymous SNV	FLJ44635:NM_207422:exon2:c.T23C:p.I8T,	0.42	0.42	0.42	rs7884806 [];					0.7378					0.775	0.0125	0.2125	121		
chrX	71379853	71379853	C	T	hom	222	FLJ44635	synonymous SNV	FLJ44635:NM_207422:exon2:c.C174T:p.S58S,	0.42	0.42	0.42	rs7880917 [];					0.7390					0.775	0.0125	0.2125	120		
chrX	71380152	71380152	C	T	hom	222	FLJ44635			0.42	0.42	0.42	rs7881332 [];					0.7383	COSN414096 [1(urinary_tract)]; 				0.75	0.025	0.225	92		
chrX	71401607	71401607	G	A	hom	222	PIN4	nonsynonymous SNV	PIN4:NM_006223:exon1:c.G47A:p.R16Q,PIN4:NM_001170747:exon1:c.G47A:p.R16Q,	0.76	0.76	0.76	rs6525589 [];	-0.9750	0.0000	1.0000	0.0000	0.9631					0.9375	0	0.0625	140		
chrX	71401614	71401614	C	A	hom	222	PIN4	nonsynonymous SNV	PIN4:NM_006223:exon1:c.C54A:p.S18R,PIN4:NM_001170747:exon1:c.C54A:p.S18R,	0.76	0.76	0.76	rs7058353 [];	-1.6670	0.0000	0.9800	0.0000	0.9633					0.925	0	0.075	140		
chrX	71493691	71493691	C	T	hom	222	RPS4X	synonymous SNV	RPS4X:NM_001007:exon5:c.G492A:p.L164L,	0.37	0.37	0.37	rs16897731 [];					0.7657					0.7125	0.0625	0.225	117		
chrX	71495344	71495344	C	T	hom	222	RPS4X			0.62	0.62	0.62	rs3827426 [];					0.7843					0.325	0.0375	0.6375	60		
chrX	71495389	71495389	-	CTA	hom	214	RPS4X			0	0	0	rs146599276 [];										0.8125	0.0125	0.175	130		
chrX	71495869	71495869	A	G	hom	222	RPS4X			0.64	0.64	0.64	rs3747303 [];										0.325	0.0375	0.6375	40		
chrX	71521867	71521867	G	C	hom	222	CITED1	nonsynonymous SNV	CITED1:NM_001144885:exon4:c.C366G:p.H122Q,CITED1:NM_004143:exon3:c.C288G:p.H96Q,CITED1:NM_001144887:exon3:c.C288G:p.H96Q,CITED1:NM_001144886:exon3:c.C288G:p.H96Q,	0.75	0.75	0.75	rs3012627 [];	0.1910	0.0000	1.0000	0.0000	0.8793					0.825	0.0125	0.1625	132		
chrX	71549512	71549512	G	C	hom	222	HDAC8			0.68	0.68	0.68	rs660392 [];					0.8216					0.75	0.0625	0.1875	84		
chrX	71813205	71813205	-	T	het	64.5	PHKA1			0	0	0								2565			0.1875	0.1125	0.7	28		
chrX	71915583	71915583	G	A	hom	222	PHKA1	synonymous SNV	PHKA1:NM_001172436:exon4:c.C429T:p.L143L,PHKA1:NM_002637:exon4:c.C429T:p.L143L,PHKA1:NM_001122670:exon4:c.C429T:p.L143L,	0.02	0.02	0.02	rs138066694 [];					0.0480					0	0	1	4		
chrX	72297562	72297563	AC	-	het	30.5	PABPC1L2A			0	0	0								354			0.5875	0.2125	0.2	80		
chrX	72298326	72298326	T	C	hom	9.49	PABPC1L2A			0.99	0.99	0.99	rs182890337 [];										0.1625	0	0.8375	17		
chrX	72903471	72903471	C	G	hom	222	CHIC1			0	0	0											0	0	1	0		
chrX	73043162	73043162	-	TT	het	133	TSIX;XIST			0	0	0											0	0.0125	0.9875	1		
chrX	73290216	73290216	A	-	hom	70.5	JPX			0	0	0	rs59904201 [];							396			0.475	0.075	0.45	50		
chrX	73499888	73499888	T	A	hom	222	FTX			0.9	0.9	0.9	rs174154 [];							747			0.8	0.025	0.175	77		
chrX	73499963	73499963	T	C	hom	222	FTX			0.89	0.89	0.89	rs174153 [];							747			0.8125	0.025	0.1625	78		
chrX	73501562	73501562	T	C	hom	222	FTX			0.89	0.89	0.89	rs174151 [];										0.85	0.025	0.125	86		
chrX	73749319	73749319	T	G	hom	222	SLC16A2			0.4	0.4	0.4	rs5937843 [];					0.7941			300095 [Solute carrier family 16 (monocarboxylic acid transporters), - Allan-Herndon-Dudley syndrome, 300523 (3)];		0.275	0.0625	0.6625	76		
chrX	73958629	73958629	G	A	hom	222	KIAA2022			0.47	0.47	0.47	rs2209549 [];										0.775	0.0125	0.2125	127		
chrX	74375871	74375871	G	C	hom	180	ABCB7			0.93	0.93	0.93	rs1039123 [];										0.4375	0	0.5625	46		
chrX	74494470	74494470	T	G	hom	222	UPRT	synonymous SNV	UPRT:NM_145052:exon1:c.T381G:p.R127R,	0.93	0.93	0.93	rs4892396 [];					0.9990					0.95	0	0.05	140		
chrX	74494483	74494483	A	G	hom	222	UPRT			0.84	0.84	0.84	rs5981831 [];					0.9722					0.9125	0	0.0875	137		
chrX	74523367	74523367	A	G	hom	222	UPRT			0.85	0.85	0.85	rs972561 [];					0.9723					0.9125	0	0.0875	109		
chrX	74523726	74523726	T	G	hom	222	UPRT			0.04	0.04	0.04	rs112073726 [];										0.075	0.0375	0.8875	10		
chrX	74523871	74523871	G	A	hom	222	UPRT			0.93	0.93	0.93	rs5937351 [];										0.9875	0	0.0125	96		
chrX	74524280	74524280	C	A	hom	222	UPRT			0.85	0.85	0.85	rs6647687 [];										0.9375	0	0.0625	90		
chrX	74545290	74545290	C	T	hom	222	UPRT;ZDHHC15		UPRT:dist=20558;ZDHHC15:dist=42972	0.86	0.86	0.86	rs4255296 [];										0.9125	0	0.0875	85		
chrX	74598903	74598903	G	A	hom	222	ZDHHC15			0.43	0.43	0.43	rs5937369 [];								300576 [Zinc finger DHHC domain-containing protein 15 - Mental retardation, X-linked-91, 300577 (3)];		0.325	0.0125	0.6625	37		
chrX	75395172	75395172	T	C	hom	202	PBDC1			0.73	0.73	0.73	rs2301863 [];										0.3875	0	0.6125	42		
chrX	75395187	75395187	C	T	hom	203	PBDC1			0.44	0.44	0.44	rs2301862 [];										0.2625	0.05	0.6875	35		
chrX	76814423	76814423	T	G	het	5.46	ATRX			0	0	0	rs201586778 [];								300032 [ATR-X gene (helicase 2; X-linked nuclear protein) - Alpha-thalassemia/mental retardation syndrome, 301040 (3);Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3); Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3)];		0	0.0125	0.9875	1		
chrX	77086468	77086487	TTTTATTTTATTTTATTTTA	-	hom	209	MAGT1			0	0	0	rs201564456 [];							576	300715 [Magnesium transporter 1 - Mental retardation, X-linked 95, 300716 (3)];		0.075	0.0125	0.9125	9		
chrX	77264534	77264534	T	G	het	24	ATP7A			0	0	0									300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0	0.4	0.6	39		
chrX	77266222	77266222	A	C	het	33	ATP7A			0	0	0								2440	300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0	0.2875	0.7125	24		
chrX	77286831	77286831	T	-	hom	25.5	ATP7A			1	1	1	rs5902762 [];								300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0.4375	0	0.5625	46		
chrX	77296047	77296047	G	C	hom	222	ATP7A			1	1	1	rs5913631 [];								300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0.4375	0	0.5625	98		
chrX	77298857	77298857	G	A	hom	222	ATP7A	nonsynonymous SNV	ATP7A:NM_000052:exon21:c.G4048A:p.E1350K,	1	1	1	rs4826245 [];	0.6310	0.0000	1.0000	0.0000				300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0.9625	0	0.0375	208		
chrX	77528317	77528317	G	A	hom	222	CYSLTR1	synonymous SNV	CYSLTR1:NM_006639:exon3:c.C927T:p.F309F,	0.67	0.67	0.67	rs320995 [];					0.7881					0.6875	0.075	0.2375	109		
chrX	78011737	78011737	T	C	hom	222	LPAR4			0.82	0.82	0.82	rs1140040 [];										0.7125	0.025	0.2625	70		
chrX	78203401	78203401	C	A	hom	222	P2RY10			0.78	0.78	0.78	rs2251819 [];										0.3125	0.0125	0.675	35		
chrX	78216605	78216605	C	T	hom	222	P2RY10	synonymous SNV	P2RY10:NM_198333:exon2:c.C588T:p.V196V,P2RY10:NM_014499:exon4:c.C588T:p.V196V,	0	0	0											0	0	1	0		
chrX	78426471	78426471	C	T	hom	222	GPR174			0.49	0.49	0.49	rs3810712 [];					0.5905	COSN414121 [1(urinary_tract)]; 				0.5875	0.1	0.3125	72		
chrX	78426488	78426488	T	C	hom	222	GPR174			0.49	0.49	0.49	rs3810711 [];					0.5944	COSN414122 [1(urinary_tract)]; 				0.6	0.1	0.3	76		
chrX	78426988	78426988	T	C	hom	222	GPR174	nonsynonymous SNV	GPR174:NM_032553:exon1:c.T484C:p.S162P [1(prostate)]; 	0.49	0.49	0.49	rs3827440 [];	-0.5440	0.0001	0.2600	0.0000	0.5945	1179849 [1(prostate)]; 				0.5875	0.1	0.3125	105		
chrX	78616214	78616214	C	G	hom	222	ITM2A			0.45	0.45	0.45	rs13789 [];										0.6375	0.025	0.3375	64		
chrX	78616371	78616371	T	G	hom	222	ITM2A			0.25	0.25	0.25	rs1045345 [];										0.25	0.05	0.7	27		
chrX	78616455	78616455	-	T	hom	214	ITM2A			0	0	0											0.5625	0.05	0.3875	55		
chrX	78618050	78618050	A	G	hom	222	ITM2A			0.91	0.91	0.91	rs1751134 [];					0.8711					0.425	0.0125	0.5625	65		
chrX	79698593	79698593	C	G	hom	222	FAM46D	nonsynonymous SNV	FAM46D:NM_152630:exon3:c.C555G:p.D185E,FAM46D:NM_001170574:exon5:c.C555G:p.D185E,	0.43	0.43	0.43	rs1113265 [];	-2.2910	0.0272	1.0000	0.0030	0.7099					0.575	0.075	0.35	98		
chrX	79931832	79931835	GTGT	-	hom	214	BRWD3			0.59	0.59	0.59	rs35220611 [];							376	300553 [Bromodomain-and WD repeat-containing protein 3 - Mental retardation, X-linked 93, 300659 (3)];		0.55	0.0625	0.3875	101		
chrX	79937084	79937084	G	A	hom	222	BRWD3			0.68	0.68	0.68	rs3122406 [];								300553 [Bromodomain-and WD repeat-containing protein 3 - Mental retardation, X-linked 93, 300659 (3)];		0.25	0.05	0.7	33		
chrX	79942600	79942603	TATA	-	hom	214	BRWD3			0	0	0	rs3029738 [];							225	300553 [Bromodomain-and WD repeat-containing protein 3 - Mental retardation, X-linked 93, 300659 (3)];		0.2	0.0375	0.7625	28		
chrX	79943569	79943569	T	C	hom	222	BRWD3	nonsynonymous SNV	BRWD3:NM_153252:exon34:c.A3863G:p.K1288R,	0.99	0.99	0.99	rs3122407 [];	1.1020	0.0000		0.0010	1.0000			300553 [Bromodomain-and WD repeat-containing protein 3 - Mental retardation, X-linked 93, 300659 (3)];		0.95	0	0.05	209		
chrX	79999797	79999797	-	CAC	hom	214	BRWD3			0	0	0	rs67376083 [];								300553 [Bromodomain-and WD repeat-containing protein 3 - Mental retardation, X-linked 93, 300659 (3)];		0.4375	0	0.5625	91		
chrX	80064918	80064918	-	C	hom	214	BRWD3			0	0	0									300553 [Bromodomain-and WD repeat-containing protein 3 - Mental retardation, X-linked 93, 300659 (3)];		0.2125	0.0375	0.75	58		
chrX	80184962	80184962	C	T	hom	222	BRWD3;HMGN5		BRWD3:dist=119729;HMGN5:dist=184238	0.04	0.04	0.04	rs111546024 [];										0.025	0.05	0.925	8		
chrX	80185102	80185102	A	G	hom	222	BRWD3;HMGN5		BRWD3:dist=119869;HMGN5:dist=184098	0.28	0.28	0.28	rs5959051 [];										0.0375	0.0625	0.9	11		
chrX	80185715	80185715	C	A	hom	222	BRWD3;HMGN5		BRWD3:dist=120482;HMGN5:dist=183485	0.06	0.06	0.06	rs61744953 [];										0.0375	0.05	0.9125	9		
chrX	80186198	80186198	C	T	hom	222	BRWD3;HMGN5		BRWD3:dist=120965;HMGN5:dist=183002	0.06	0.06	0.06	rs111500995 [];										0.0375	0.05	0.9125	9		
chrX	80186605	80186605	C	G	hom	222	BRWD3;HMGN5		BRWD3:dist=121372;HMGN5:dist=182595	0.34	0.34	0.34	rs5959745 [];										0.1125	0.0375	0.85	17		
chrX	80553229	80553229	C	T	hom	222	SH3BGRL			0.56	0.56	0.56	rs1044828 [];										0.6375	0.0125	0.35	63		
chrX	82764040	82764040	A	G	hom	222	POU3F4	synonymous SNV	POU3F4:NM_000307:exon1:c.A708G:p.E236E,	0.92	0.92	0.92	rs5921978 [];										0.9625	0	0.0375	145		
chrX	82764042	82764042	G	C	hom	222	POU3F4	nonsynonymous SNV	POU3F4:NM_000307:exon1:c.G710C:p.G237A [1(upper_aerodigestive_tract)]; 	0.89	0.89	0.89	rs5921979 [];	1.0570	0.0001	1.0000	0.0000		1180653 [1(upper_aerodigestive_tract)]; 				0.9625	0	0.0375	145		
chrX	82764610	82764610	T	C	hom	222	POU3F4			0	0	0								749			0	0	1	0		
chrX	83124802	83124802	A	T	hom	105	CYLC1			0.99	0.99	0.99	rs5968237 [];										0.3125	0	0.6875	34		
chrX	83352970	83352970	T	C	hom	181	RPS6KA6			0.74	0.74	0.74	rs10521366 [];										0.3625	0	0.6375	38		
chrX	83403178	83403178	G	C	hom	222	RPS6KA6			0.44	0.44	0.44	rs1539517 [];					0.7088					0.2875	0.0125	0.7	32		
chrX	83723541	83723541	A	G	hom	222	HDX	nonsynonymous SNV	HDX:NM_001177479:exon4:c.T1190C:p.F397S,HDX:NM_144657:exon3:c.T1190C:p.F397S,HDX:NM_001177478:exon3:c.T1016C:p.F339S,	0.1	0.1	0.1	rs35161124 [];	0.6020	0.5119	0.0000	0.1880	0.1925					0.175	0.0875	0.7375	36		
chrX	84258843	84258843	C	G	hom	198	APOOL			0.75	0.75	0.75	rs3747422 [];					0.6847					0.325	0.0125	0.6625	59		
chrX	84343874	84343874	-	TTACT	hom	214	APOOL			0	0	0											0	0	1	0		
chrX	84344249	84344249	A	G	hom	222	APOOL			0.65	0.65	0.65	rs5968443 [];							1991			0.7375	0.0125	0.25	72		
chrX	84350010	84350010	A	G	hom	181	SATL1			0.65	0.65	0.65	rs4828326 [];					0.6799					0.7375	0.0125	0.25	113		
chrX	84358864	84358864	C	T	hom	222	SATL1			0.76	0.76	0.76	rs5922146 [];					0.6816					0.75	0.0125	0.2375	117		
chrX	84363140	84363140	A	G	hom	222	SATL1	nonsynonymous SNV	SATL1:NM_001012980:exon1:c.T835C:p.W279R,	0.73	0.73	0.73	rs10126146 [];	-3.8980	0.0000	0.5500	0.0040	0.6824					0.7875	0.0125	0.2	122		
chrX	84534383	84534383	A	C	hom	222	POF1B			1	1	1	rs2227090 [];					0.9976					0.95	0	0.05	136		
chrX	84563135	84563135	T	A	hom	222	POF1B	nonsynonymous SNV	POF1B:NM_024921:exon10:c.A1045T:p.M349L,	0.9	0.9	0.9	rs363774 [];	0.3300	0.0000	1.0000	0.0000	0.7723					0.8	0.0125	0.1875	122		
chrX	85116895	85116895	T	C	hom	222	CHM			0.19	0.19	0.19	rs41312562 [];										0.225	0.0125	0.7625	25		
chrX	85166212	85166221	ATATATATGA	-	hom	73.4	CHM			0	0	0								771			0.0125	0.0125	0.975	3		
chrX	85219021	85219021	T	C	hom	222	CHM	synonymous SNV	CHM:NM_000390:exon5:c.A351G:p.A117A,	0.17	0.17	0.17	rs10217950 [];					0.2436					0.2375	0.025	0.7375	52		
chrX	86071151	86071151	C	G	hom	222	DACH2			0.24	0.24	0.24	rs12837683 [];					0.4264					0.1375	0.0875	0.775	37		
chrX	86083044	86083047	AGTT	-	hom	214	DACH2			0	0	0								214			0.7625	0.0375	0.2	75		
chrX	86083760	86083760	G	T	hom	222	DACH2			0.24	0.24	0.24	rs7062863 [];										0.3125	0.1125	0.575	41		
chrX	86084856	86084856	T	C	hom	222	DACH2			0.71	0.71	0.71	rs5969011 [];										0.7875	0.0375	0.175	77		
chrX	86085179	86085179	G	A	hom	222	DACH2			0.29	0.29	0.29	rs11092827 [];										0.3125	0.1125	0.575	41		
chrX	86086609	86086609	G	A	hom	222	DACH2			0.32	0.32	0.32	rs5923653 [];										0.3	0.1125	0.5875	40		
chrX	86086810	86086810	-	G	hom	70.5	DACH2			0	0	0	rs67991204 [];										0.7375	0.025	0.2375	72		
chrX	86087385	86087385	A	T	hom	222	DACH2			0.71	0.71	0.71	rs3087525 [];										0.775	0.0375	0.1875	78		
chrX	86869103	86869103	A	G	hom	222	KLHL4			0.33	0.33	0.33	rs5924064 [];										0.2375	0.0125	0.75	25		
chrX	86869348	86869348	C	A	hom	218	KLHL4			0.33	0.33	0.33	rs5922464 [];										0.2375	0.0125	0.75	25		
chrX	86872866	86872866	G	T	hom	184	KLHL4			0.33	0.33	0.33	rs5924069 [];										0.2375	0.0125	0.75	25		
chrX	86873222	86873222	G	T	hom	184	KLHL4			0.08	0.08	0.08	rs62608283 [];										0.0875	0.0125	0.9	9		
chrX	86887244	86887244	C	T	hom	222	KLHL4	synonymous SNV	KLHL4:NM_057162:exon7:c.C1359T:p.T453T,KLHL4:NM_019117:exon7:c.C1359T:p.T453T,	0.59	0.59	0.59	rs222084 [];					0.7432					0.7125	0.025	0.2625	110		
chrX	86924871	86924871	A	T	hom	222	KLHL4			0.52	0.52	0.52	rs6614705 [];										0.2125	0.0375	0.75	25		
chrX	88008423	88008423	A	C	hom	222	CPXCR1	nonsynonymous SNV	CPXCR1:NM_001184771:exon3:c.A8C:p.Y3S,CPXCR1:NM_033048:exon3:c.A8C:p.Y3S,	0.9	0.9	0.9	rs5940915 [];	0.7890	0.0000		0.0000	0.8713					0.825	0.0125	0.1625	121		
chrX	88009322	88009322	A	G	hom	222	CPXCR1			0.9	0.9	0.9	rs5984613 [];					0.8728					0.8125	0.0125	0.175	107		
chrX	88009690	88009693	GACA	-	hom	214	CPXCR1			0	0	0											0	0	1	0		
chrX	88009700	88009700	T	C	hom	222	CPXCR1			0.33	0.33	0.33	rs12556970 [];										0.225	0.0875	0.6875	26		
chrX	89177024	89177024	A	G	hom	222	TGIF2LX			0.52	0.52	0.52	rs200945458 [];										0.2625	0.0625	0.675	31		
chrX	89177673	89177673	G	A	hom	222	TGIF2LX	nonsynonymous SNV	TGIF2LX:NM_138960:exon2:c.G589A:p.V197I,	0.74	0.74	0.74	rs2290380 [];	-0.3200	0.0000		0.0000	0.6819					0.6875	0.0625	0.25	105		
chrX	91876129	91876130	AC	-	het	18.5	PCDH11X			0	0	0								288			0	0.2875	0.7125	26		
chrX	95990839	95990839	A	T	hom	222	DIAPH2			0.23	0.23	0.23	rs20386 [];					0.1780	COSN168769 [1(large_intestine)]; 				0.0375	0.025	0.9375	10		
chrX	95990883	95990883	A	G	hom	222	DIAPH2			0.26	0.26	0.26	rs5949989 [];										0.0375	0.025	0.9375	5		
chrX	96013128	96013128	C	T	hom	222	DIAPH2			0.22	0.22	0.22	rs2297827 [];					0.1643	COSN168770 [1(large_intestine)]; 				0.0375	0.025	0.9375	10		
chrX	96013129	96013129	C	T	hom	222	DIAPH2			0.17	0.17	0.17	rs80139166 [];					0.0691	COSN168771 [1(large_intestine)]; 				0.0125	0.0125	0.975	5		
chrX	96018062	96018062	T	-	hom	24.5	DIAPH2			0	0	0											0.025	0	0.975	2		
chrX	96197175	96197175	G	A	hom	222	DIAPH2			1	1	1	rs5920973 [];					0.9999					0.425	0	0.575	71		
chrX	96856457	96856457	-	A	hom	214	DIAPH2			0	0	0											0.5	0.05	0.45	49		
chrX	96860054	96860054	G	C	hom	222	DIAPH2;XRCC6P5		DIAPH2:dist=4457;XRCC6P5:dist=1856546	0.85	0.85	0.85	rs5967330 [];										0.4125	0	0.5875	42		
chrX	99849017	99849017	G	A	hom	222	TNMD	synonymous SNV	TNMD:NM_022144:exon3:c.G306A:p.V102V,	0.5	0.5	0.5	rs2073162 [];					0.3649					0.3375	0.0625	0.6	60		
chrX	99849051	99849051	T	C	hom	222	TNMD			0.51	0.51	0.51	rs2073163 [];					0.3651					0.1125	0.05	0.8375	26		
chrX	99853014	99853014	A	-	hom	214	TNMD			0	0	0	rs5903166 [];										0.3375	0.0625	0.6	35		
chrX	99853281	99853281	C	T	hom	222	TNMD			0.46	0.46	0.46	rs1155974 [];										0.3375	0.0625	0.6	35		
chrX	99854289	99854290	AA	-	hom	143	TNMD			0	0	0	rs58182382 [];										0.3375	0	0.6625	29		
chrX	99884828	99884828	G	A	hom	222	TSPAN6			0.53	0.53	0.53	rs8575 [];										0.375	0.0625	0.5625	42		
chrX	99919733	99919733	G	A	hom	183	SRPX2			0.8	0.8	0.8	rs2022475 [];					0.9778			300642 [SUSHI repeat-containing protein, X-linked, 2 - Rolandic epilepsy, mental retardation, and speech dyspraxia, 300643(3)];		0.425	0.0125	0.5625	101		
chrX	99926122	99926122	G	A	hom	222	SRPX2			0.97	0.97	0.97	rs5967163 [];								300642 [SUSHI repeat-containing protein, X-linked, 2 - Rolandic epilepsy, mental retardation, and speech dyspraxia, 300643(3)];		0.9875	0	0.0125	158		
chrX	99929532	99929532	G	C	hom	222	SYTL4			0.34	0.34	0.34	rs8780 [];										0.3375	0.0875	0.575	42		
chrX	99930893	99930893	-	ACACACACACAC	hom	214	SYTL4			0	0	0								393			0	0	1	0		
chrX	99941369	99941369	T	C	hom	222	SYTL4			0.35	0.35	0.35	rs5921626 [];										0.3625	0.0625	0.575	39		
chrX	99941705	99941705	T	C	hom	222	SYTL4	nonsynonymous SNV	SYTL4:NM_001174068:exon12:c.A1258G:p.I420V,SYTL4:NM_080737:exon14:c.A1258G:p.I420V,SYTL4:NM_001129896:exon13:c.A1258G:p.I420V,	0.95	0.95	0.95	rs2022039 [];	-1.3330	0.7677		0.0030	0.9988					0.975	0	0.025	146		
chrX	99941980	99941980	T	C	hom	222	SYTL4			0.95	0.95	0.95	rs2022040 [];										0.9875	0	0.0125	91		
chrX	99943103	99943103	A	C	hom	222	SYTL4			0.35	0.35	0.35	rs5920842 [];										0.3625	0.0625	0.575	39		
chrX	99943244	99943244	G	C	hom	222	SYTL4			0.34	0.34	0.34	rs5921627 [];										0.35	0.05	0.6	37		
chrX	99956157	99956157	T	C	hom	222	SYTL4			0.41	0.41	0.41	rs5967170 [];										0.2	0.05	0.75	25		
chrX	99957136	99957136	T	C	hom	222	SYTL4			0.33	0.33	0.33	rs5967171 [];										0.2	0.05	0.75	25		
chrX	99957238	99957238	G	C	hom	206	SYTL4			0.4	0.4	0.4	rs1343214 [];										0.2	0.05	0.75	25		
chrX	99986618	99986618	-	A	hom	61.6	SYTL4			0	0	0	rs67784303 [];										0.15	0.0375	0.8125	17		
chrX	100105008	100105008	T	C	hom	222	NOX1			1	1	1	rs1476011 [];										0.425	0	0.575	45		
chrX	100168406	100168407	CA	-	het	74.5	XKRX			0	0	0								399			0	0	1	0		
chrX	100240575	100240575	T	A	hom	222	ARL13A			0.02	0.02	0.02	rs17257516 [];										0.025	0	0.975	2		
chrX	100242305	100242305	G	A	hom	222	ARL13A			0.81	0.81	0.81	rs5921702 [];										0.375	0.0375	0.5875	43		
chrX	100243459	100243459	G	T	hom	222	ARL13A	nonsynonymous SNV	ARL13A:NM_001012990:exon8:c.G837T:p.M279I,ARL13A:NM_001162490:exon8:c.G837T:p.M279I,	0.91	0.91	0.91	rs3934462 [];					0.9146					0.9125	0	0.0875	126		
chrX	100245606	100245606	A	G	hom	222	ARL13A			0.86	0.86	0.86	rs6523438 [];					0.8595					0.85	0.0375	0.1125	120		
chrX	100350301	100350301	C	T	het	225	TMEM35			0	0	0	rs62602432 [];							202			0.25	0.1	0.65	34		
chrX	100350312	100350313	GC	-	het	114	TMEM35			0	0	0								202			0.125	0.2125	0.6625	33		
chrX	100350684	100350684	A	-	hom	214	TMEM35			0.41	0.41	0.41	rs34994578 [];										0.525	0.0625	0.4125	54		
chrX	100356022	100356026	TAACT	-	hom	214	CENPI			0.12	0.12	0.12	rs200931377 [];					0.2040					0.0875	0.0125	0.9	22		
chrX	100357194	100357194	C	G	hom	160	CENPI			0.41	0.41	0.41	rs12156858 [];										0.1875	0.0625	0.75	29		
chrX	100357201	100357201	T	C	hom	156	CENPI			0.41	0.41	0.41	rs12156663 [];										0.1875	0.0625	0.75	29		
chrX	100396344	100396344	T	A	hom	184	CENPI			0.12	0.12	0.12	rs11798509 [];							1922			0.0875	0.0375	0.875	13		
chrX	100400023	100400023	A	G	hom	222	CENPI			0.67	0.67	0.67	rs2295376 [];					0.7491					0.3	0.025	0.675	60		
chrX	100475276	100475276	-	GT	het	25.5	DRP2			0	0	0								339			0.0375	0.0125	0.95	4		
chrX	100505617	100505617	G	C	hom	133	DRP2			0.32	0.32	0.32	rs3747280 [];					0.3573		245			0.175	0.0375	0.7875	35		
chrX	100505881	100505881	C	G	hom	222	DRP2			0.12	0.12	0.12	rs4827893 [];					0.2157					0.0875	0.025	0.8875	18		
chrX	100511098	100511098	C	T	hom	222	DRP2			0.32	0.32	0.32	rs3213505 [];					0.3563					0.4	0.0375	0.5625	69		
chrX	100514986	100514986	G	A	hom	222	DRP2			0.44	0.44	0.44	rs5967281 [];					0.3737					0.2125	0	0.7875	19		
chrX	100515332	100515332	A	G	hom	222	DRP2			0.33	0.33	0.33	rs5967282 [];							187			0.2	0.0125	0.7875	19		
chrX	100515792	100515792	A	G	hom	222	DRP2			0.44	0.44	0.44	rs4828078 [];										0.4625	0	0.5375	42		
chrX	100531204	100531204	T	C	hom	222	TAF7L			0.33	0.33	0.33	rs3761514 [];										0.1625	0.0375	0.8	18		
chrX	100531414	100531419	TCATCC	-	hom	214	TAF7L	nonframeshift deletion	TAF7L:NM_024885:exon10:c.1047_1052del:p.349_351del,TAF7L:NM_001168474:exon10:c.789_794del:p.263_265del,	0.13	0.13	0.13	rs199759165 [];							312			0.225	0.025	0.75	65		
chrX	100532924	100532924	A	G	hom	222	TAF7L			0.36	0.36	0.36	rs3788765 [];										0.1625	0.0375	0.8	18		
chrX	100532985	100532985	T	C	hom	222	TAF7L			0.35	0.35	0.35	rs3788764 [];					0.3609					0.1625	0.0375	0.8	33		
chrX	100547933	100547933	A	G	hom	222	TAF7L	nonsynonymous SNV	TAF7L:NM_024885:exon1:c.T101C:p.L34P,	0.99	0.99	0.99	rs5951328 [];	-1.4180	0.0000	0.3600	0.0000	0.9886					0.95	0	0.05	205		
chrX	100604757	100604757	T	G	hom	222	BTK			0.3	0.3	0.3	rs700 [];						COSN168778 [1(large_intestine)]; 		300300 [Bruton agammaglobulinemia tyrosine kinase - Agammaglobulinemia, X-linked 1, 300755 (3); Agammaglobulinemiaand isolated hormone deficiency, 307200 (3)];		0.35	0.05	0.6	83		
chrX	100609547	100609547	G	A	hom	222	BTK			0.73	0.73	0.73	rs2071223 [];						COSN168779 [1(large_intestine)]; 		300300 [Bruton agammaglobulinemia tyrosine kinase - Agammaglobulinemia, X-linked 1, 300755 (3); Agammaglobulinemiaand isolated hormone deficiency, 307200 (3)];		0.2375	0.0375	0.725	31		
chrX	100617372	100617372	T	C	hom	222	BTK			0.75	0.75	0.75	rs2071222 [];							395	300300 [Bruton agammaglobulinemia tyrosine kinase - Agammaglobulinemia, X-linked 1, 300755 (3); Agammaglobulinemiaand isolated hormone deficiency, 307200 (3)];		0.2875	0.05	0.6625	37		
chrX	100742272	100742272	T	C	hom	222	ARMCX4			0.62	0.62	0.62	rs2253062 [];										0.275	0.05	0.675	35		
chrX	100742551	100742551	G	A	hom	222	ARMCX4			0.49	0.49	0.49	rs2361298 [];										0.25	0.0375	0.7125	32		
chrX	100743037	100743037	C	T	hom	222	ARMCX4			0.65	0.65	0.65	rs963618 [];										0.5625	0.0625	0.375	64		
chrX	100743826	100743826	A	G	hom	222	ARMCX4	nonsynonymous SNV	ARMCX4:NM_001256155:exon2:c.A250G:p.R84G,	0.62	0.62	0.62	rs5951332 [];	-0.4070	0.0003	1.0000							0.575	0.0625	0.3625	66		
chrX	100809684	100809684	-	AA	hom	214	ARMCX1			0	0	0											0.35	0.0375	0.6125	39		
chrX	100911066	100911066	C	T	hom	222	ARMCX2	synonymous SNV	ARMCX2:NM_177949:exon6:c.G1509A:p.Q503Q,ARMCX2:NM_014782:exon5:c.G1509A:p.Q503Q,	0.96	0.96	0.96	rs3850315 [];					0.9191					0.8625	0.025	0.1125	130		
chrX	100912776	100912776	G	A	hom	222	ARMCX2			0.19	0.19	0.19	rs5951282 [];										0.1625	0.0375	0.8	23		
chrX	100914185	100914185	T	C	hom	222	ARMCX2			1	1	1	rs7877615 [];										0.4375	0	0.5625	46		
chrX	100914701	100914701	-	C	hom	214	ARMCX2			0	0	0	rs61487673 [];										0.4375	0	0.5625	46		
chrX	101087051	101087051	G	C	hom	222	NXF5			0.13	0.13	0.13	rs6616305 [];										0.125	0.0375	0.8375	18		
chrX	101087497	101087497	A	T	hom	222	NXF5			0.12	0.12	0.12	rs76289014 [];										0.125	0.0375	0.8375	18		
chrX	101087498	101087498	T	C	hom	222	NXF5			0.12	0.12	0.12	rs2027832 [];										0.125	0.0375	0.8375	18		
chrX	101087618	101087618	T	C	hom	222	NXF5			0.14	0.14	0.14	rs2027833 [];										0.125	0.0375	0.8375	18		
chrX	101090953	101090953	G	A	hom	222	NXF5			0.14	0.14	0.14	rs6621219 [];										0.125	0.0375	0.8375	18		
chrX	101091164	101091164	T	C	hom	222	NXF5			0.14	0.14	0.14	rs6621220 [];					0.1925					0.2375	0.05	0.7125	44		
chrX	101093049	101093049	A	-	hom	102	NXF5			1	1	1	rs66689050 [];										0.4375	0	0.5625	46		
chrX	101093122	101093122	-	G	hom	36.7	NXF5			0	0	0	rs145072756 [];										0.4125	0	0.5875	43		
chrX	101095482	101095482	A	G	hom	71	NXF5	synonymous SNV	NXF5:NM_032946:exon10:c.T687C:p.S229S,	0	0	0	rs146382081 [];					0.0780					0.3	0	0.7	36		
chrX	101096219	101096219	G	A	hom	126	NXF5			0	0	0	rs201887839 [];					0.1883					0.0875	0.025	0.8875	14		
chrX	101097890	101097890	T	C	hom	222	NXF5			0.14	0.14	0.14	rs5945086 [];										0.125	0.0375	0.8375	18		
chrX	101098376	101098376	T	C	hom	222	NXF5			0.46	0.46	0.46	rs5945087 [];										0.225	0.075	0.7	30		
chrX	101137796	101137796	G	A	hom	222	ZMAT1			0.14	0.14	0.14	rs75619572 [];										0.2375	0.05	0.7125	28		
chrX	101138283	101138283	T	-	hom	214	ZMAT1			0.46	0.46	0.46	rs56868909 [];										0.4875	0.0875	0.425	53		
chrX	101138792	101138792	T	C	hom	222	ZMAT1	nonsynonymous SNV	ZMAT1:NM_001011657:exon7:c.A1607G:p.Q536R,	1	1	1	rs5944882 [];	-0.2600	0.0000	1.0000	0.0000						0.9625	0	0.0375	144		
chrX	101382005	101382005	G	C	hom	222	TCEAL2	nonsynonymous SNV	TCEAL2:NM_080390:exon3:c.G203C:p.G68A,	0.13	0.13	0.13	rs5944856 [];	-2.0870	0.0053	0.2900	0.0210	0.1855		491			0.2125	0.05	0.7375	40		
chrX	101382411	101382411	T	C	hom	222	TCEAL2	synonymous SNV	TCEAL2:NM_080390:exon3:c.T609C:p.Y203Y,	0.08	0.08	0.08	rs5944857 [];					0.1246					0.225	0.05	0.725	41		
chrX	101382417	101382417	G	A	hom	222	TCEAL2	synonymous SNV	TCEAL2:NM_080390:exon3:c.G615A:p.R205R,	0.08	0.08	0.08	rs5944858 [];					0.1060					0.225	0.05	0.725	39		
chrX	101395781	101395781	-	G	hom	214	TCEAL6	frameshift insertion	TCEAL6:NM_001006938:exon3:c.522_523insC:p.Q175fs,	0	0	0	rs11408120 [];					0.9680					0.975	0	0.025	167		
chrX	101396602	101396623	GGGTCCCAATTTGGCCTTGGCC	-	hom	214	TCEAL6			0.14	0.14	0.14	rs200376832 [];										0.0875	0.0375	0.875	14		
chrX	101409586	101409586	-	G	hom	203	BEX5			0	0	0	rs11424734 [];										0.4375	0	0.5625	46		
chrX	101410777	101410777	G	C	hom	178	BEX5			0.73	0.73	0.73	rs929009 [];										0.2625	0.0875	0.65	38		
chrX	101410823	101410823	-	C	hom	214	BEX5			0	0	0	rs11451071 [];										0.9375	0	0.0625	92		
chrX	101410995	101410995	T	C	hom	222	BEX5			0.73	0.73	0.73	rs6621362 [];										0.625	0.1	0.275	73		
chrX	101576166	101576166	-	CA	hom	127	NXF2;NXF2B			0	0	0											0.05	0.0125	0.9375	6		
chrX	101817814	101817814	G	A	hom	222	NXF4			0.07	0.07	0.07	rs17284949 [];										0.1375	0.05	0.8125	17		
chrX	101820794	101820794	A	G	hom	222	NXF4			0.4	0.4	0.4	rs5945733 [];										0.2125	0.0625	0.725	26		
chrX	101821792	101821792	G	C	hom	222	NXF4			0.14	0.14	0.14	rs6418223 [];										0.0875	0.0375	0.875	13		
chrX	101823022	101823022	C	G	hom	222	NXF4			0.37	0.37	0.37	rs5987617 [];										0.4875	0.0875	0.425	52		
chrX	101823177	101823177	G	A	hom	222	NXF4			0.4	0.4	0.4	rs5945893 [];										0.4875	0.075	0.4375	51		
chrX	101856569	101856569	C	T	hom	222	ARMCX5;ARMCX5-GPRASP2			0.0012	0.0012	0.0012	rs41310699 [];										0	0	1	0		
chrX	101856718	101856718	A	T	hom	222	ARMCX5;ARMCX5-GPRASP2			1	1	1	rs2379211 [];										0.4375	0	0.5625	46		
chrX	101909785	101909785	C	G	hom	222	GPRASP1	nonsynonymous SNV	GPRASP1:NM_001099410:exon4:c.C944G:p.A315G,GPRASP1:NM_001099411:exon3:c.C944G:p.A315G,GPRASP1:NM_014710:exon5:c.C944G:p.A315G,GPRASP1:NM_001184727:exon6:c.C944G:p.A315G,	0.03	0.03	0.03	rs17339512 [];	-0.1070	0.0125	0.1100	0.0390	0.0612					0.075	0.0125	0.9125	12		
chrX	101913610	101913611	AA	-	hom	60.5	GPRASP1			0	0	0											0.0125	0.175	0.8125	16		
chrX	101975725	101975725	G	C	hom	222	BHLHB9			0.03	0.03	0.03	rs73254202 [];										0.0625	0.0125	0.925	8		
chrX	102082173	102082173	C	T	hom	222	LINC00630			0.71	0.71	0.71	rs4907856 [];										0.4125	0	0.5875	41		
chrX	102120342	102120342	A	G	hom	222	LINC00630			0.9	0.9	0.9	rs5945905 [];										0.775	0.0625	0.1625	77		
chrX	102339606	102339606	T	C	hom	222	NXF3			0.81	0.81	0.81	rs1029305 [];					0.6975					0.3	0.05	0.65	59		
chrX	102585902	102585902	G	C	hom	222	TCEAL7			0.63	0.63	0.63	rs1045761 [];										0.4	0.075	0.525	50		
chrX	102863108	102863108	T	G	hom	106	TCEAL3			0.99	0.99	0.99	rs221939 [];										0.3875	0	0.6125	38		
chrX	102863126	102863126	G	A	hom	48.5	TCEAL3			0.03	0.03	0.03	rs12845537 [];										0.025	0.0375	0.9375	5		
chrX	102930684	102930684	A	-	hom	42.5	MORF4L2			0	0	0											0.5375	0	0.4625	47		
chrX	102930960	102930960	A	G	hom	222	MORF4L2			0.4	0.4	0.4	rs874 [];										0.4375	0.025	0.5375	42		
chrX	102941747	102941747	A	G	hom	184	MORF4L2			0.82	0.82	0.82	rs5987565 [];										0.25	0.025	0.725	28		
chrX	102942666	102942666	A	G	hom	143	MORF4L2-AS1			0.84	0.84	0.84	rs2057101 [];										0.2375	0.0125	0.75	23		
chrX	102946721	102946721	C	T	hom	222	MORF4L2-AS1			0.84	0.84	0.84	rs1543384 [];										0.2375	0.0375	0.725	26		
chrX	103031701	103031701	-	G	hom	214	PLP1			0	0	0	rs55692651 [];							200	300401 [Proteolipid protein 1 - Pelizaeus-Merzbacher disease, 312080 (3); Spastic paraplegia-2,312920 (3)];		0.4375	0	0.5625	46		
chrX	103046527	103046527	G	-	hom	214	PLP1			1	1	1	rs11317331 [];								300401 [Proteolipid protein 1 - Pelizaeus-Merzbacher disease, 312080 (3); Spastic paraplegia-2,312920 (3)];		0.9875	0	0.0125	156		
chrX	103172391	103172391	G	A	hom	222	MIR1256			0.01	0.01	0.01	rs186859038 [];										0.025	0	0.975	3		
chrX	103173633	103173633	A	C	hom	222	MIR1256			0.29	0.29	0.29	rs151143781 [];										0.3125	0.0625	0.625	35		
chrX	103219004	103219004	C	T	hom	222	MIR1256			0.58	0.58	0.58	rs1180753 [];							2324			0.3125	0.0125	0.675	34		
chrX	103267865	103267865	C	T	hom	222	H2BFWT	nonsynonymous SNV	H2BFWT:NM_001002916:exon1:c.G368A:p.R123H,	0.58	0.58	0.58	rs553509 [];	-0.9440	0.8365	0.0300	0.0170	0.6654					0.625	0.025	0.35	105		
chrX	103268241	103268241	G	A	hom	222	H2BFWT			0.33	0.33	0.33	rs7885967 [];					0.4303					0.4125	0.0625	0.525	73		
chrX	103294760	103294760	C	T	hom	222	H2BFM	stopgain SNV	H2BFM:NM_001164416:exon1:c.C217T:p.Q73X,	0.33	0.33	0.33	rs2301384 [];	-2.5870	1.0000	0.0400		0.4408					0.4125	0.0625	0.525	74		
chrX	103348230	103348230	C	T	hom	222	SLC25A53			0.33	0.33	0.33	rs5916825 [];										0.425	0.0625	0.5125	46		
chrX	103348398	103348398	-	C	hom	214	SLC25A53			0	0	0	rs67397909 [];										0.9875	0	0.0125	96		
chrX	103401770	103401770	A	C	hom	222	SLC25A53			0.62	0.62	0.62	rs7882194 [];										0.2875	0.0125	0.7	31		
chrX	104463832	104463832	C	A	hom	222	TEX13A	synonymous SNV	TEX13A:NM_031274:exon5:c.G1044T:p.G348G,	0.01	0.01	0.01	rs1060551 [];	-0.3760	0.0019	0.0000		0.0116					0.0125	0.025	0.9625	4		
chrX	104464283	104464283	-	CACAT	hom	134	TEX13A	frameshift insertion	TEX13A:NM_031274:exon3:c.594_595insATGTG:p.D199fs,	0	0	0											0.65	0	0.35	82		
chrX	105153001	105153001	A	G	hom	222	NRK	synonymous SNV	NRK:NM_198465:exon13:c.A1368G:p.K456K,	1	1	1	rs209372 [];										0.9625	0	0.0375	145		
chrX	105179132	105179132	C	T	hom	222	NRK			0.53	0.53	0.53	rs209095 [];					0.6170					0.2375	0.025	0.7375	46		
chrX	105202600	105202600	A	T	hom	222	NRK			0.53	0.53	0.53	rs209111 [];										0.5375	0.025	0.4375	55		
chrX	105415129	105415129	A	G	hom	222	MUM1L1			0.99	0.99	0.99	rs5916976 [];										0.9375	0	0.0625	87		
chrX	106184602	106184607	GAGAGA	-	hom	214	MORC4			0	0	0								391			0.0125	0.05	0.9375	7		
chrX	106200202	106200202	G	A	hom	222	MORC4	nonsynonymous SNV	MORC4:NM_001085354:exon12:c.C1418T:p.T473I,MORC4:NM_024657:exon12:c.C1418T:p.T473I,	0.71	0.71	0.71	rs6622126 [];	-0.9380	0.0000	0.1900	0.0000	0.4295					0.325	0.05	0.625	65		
chrX	106221490	106221490	C	T	hom	222	MORC4			0.15	0.15	0.15	rs12012022 [];										0.0875	0.0375	0.875	13		
chrX	107019298	107019298	-	G	hom	166	TSC22D3			0	0	0	rs66853123 [];										0.4375	0	0.5625	46		
chrX	107225500	107225500	C	T	hom	222	TEX13B			0.02	0.02	0.02	rs41312560 [];										0.0125	0	0.9875	1		
chrX	107328436	107328436	G	A	hom	222	PSMD10			0.79	0.79	0.79	rs807178 [];					0.6696					0.2625	0.025	0.7125	45		
chrX	107415825	107415825	T	C	hom	222	COL4A6			0.99	0.99	0.99	rs2881142 [];					1.0000					0.4375	0	0.5625	74		
chrX	107418281	107418281	C	T	hom	222	COL4A6			0.51	0.51	0.51	rs2295914 [];					0.7718					0.35	0	0.65	60		
chrX	107418906	107418906	A	G	hom	222	COL4A6	synonymous SNV	COL4A6:NM_033641:exon29:c.T2808C:p.R936R,COL4A6:NM_001847:exon29:c.T2811C:p.R937R,	0.99	0.99	0.99	rs4623610 [];					0.9999					0.95	0	0.05	143		
chrX	107430579	107430579	G	A	hom	222	COL4A6			0.59	0.59	0.59	rs1266715 [];										0.35	0	0.65	37		
chrX	107433688	107433688	A	G	hom	222	COL4A6	nonsynonymous SNV	COL4A6:NM_033641:exon20:c.T1360C:p.S454P [1(stomach)]; COL4A6:NM_001847:exon20:c.T1363C:p.S455P [1(stomach)]; 	0.59	0.59	0.59	rs1042065 [];	-0.3780	0.0000	1.0000	0.0000	0.7949	150805 [1(stomach)]; 				0.725	0	0.275	108		
chrX	107437848	107437848	G	C	hom	222	COL4A6			0.48	0.48	0.48	rs1266719 [];	-1.6180				0.7742					0.35	0	0.65	73		
chrX	107438119	107438119	G	T	hom	222	COL4A6			0.59	0.59	0.59	rs1266720 [];										0.35	0	0.65	37		
chrX	107448639	107448639	G	T	hom	222	COL4A6			0.6	0.6	0.6	rs1266730 [];					0.7947	COSN168790 [1(large_intestine)]; 				0.35	0	0.65	74		
chrX	107455014	107455014	C	T	hom	222	COL4A6			0.99	0.99	0.99	rs1266736 [];					0.9999					0.4375	0	0.5625	61		
chrX	107463091	107463102	CCATATTGTATT	-	hom	214	COL4A6			0.49	0.49	0.49	rs201304389 [];										0.35	0	0.65	37		
chrX	107510915	107510915	G	-	hom	214	COL4A6			0.89	0.89	0.89	rs11351626 [];							725			0.9375	0	0.0625	87		
chrX	107511012	107511012	G	A	hom	222	COL4A6			0.89	0.89	0.89	rs1266765 [];							725			0.9625	0	0.0375	89		
chrX	107511430	107511430	C	T	hom	222	COL4A6			0.49	0.49	0.49	rs1266766 [];							1067			0.7125	0	0.2875	66		
chrX	107940920	107940920	-	AT	hom	214	COL4A5			0	0	0	rs66932703 [];										0.4375	0	0.5625	46		
chrX	108708516	108708516	C	T	hom	222	GUCY2F	nonsynonymous SNV	GUCY2F:NM_001522:exon3:c.G887A:p.R296Q,	0.92	0.92	0.92	rs502209 [];	0.6690	0.0000	0.6500	0.0000	0.8320					0.8375	0.025	0.1375	124		
chrX	108719344	108719344	-	A	het	5.08	GUCY2F			0	0	0											0	0.05	0.95	5		
chrX	108786314	108786314	G	A	hom	222	NXT2			0.35	0.35	0.35	rs5943382 [];										0.3125	0.05	0.6375	33		
chrX	108787014	108787014	T	C	hom	222	NXT2			0.19	0.19	0.19	rs3204027 [];										0.3125	0.0625	0.625	34		
chrX	108885808	108885809	AC	-	het	9.93	ACSL4			0.03	0.03	0.03								207	300157 [Acyl-CoA synthetase long-chain family member 4 - Mental retardation, X-linked nonspecific, 63, 300387 (3)];		0	0.275	0.725	32		
chrX	108904729	108904729	C	T	hom	222	ACSL4			1	1	1	rs839408 [];					0.9923			300157 [Acyl-CoA synthetase long-chain family member 4 - Mental retardation, X-linked nonspecific, 63, 300387 (3)];		0.4375	0	0.5625	96		
chrX	108917757	108917757	T	C	hom	222	ACSL4			0.31	0.31	0.31	rs5942830 [];					0.5668			300157 [Acyl-CoA synthetase long-chain family member 4 - Mental retardation, X-linked nonspecific, 63, 300387 (3)];		0.2	0.0625	0.7375	37		
chrX	108917773	108917773	A	G	hom	222	ACSL4			0.31	0.31	0.31	rs5943413 [];								300157 [Acyl-CoA synthetase long-chain family member 4 - Mental retardation, X-linked nonspecific, 63, 300387 (3)];		0.2	0.0625	0.7375	26		
chrX	109246605	109246605	C	T	hom	208	TMEM164			0.48	0.48	0.48	rs4893444 [];										0.1625	0.05	0.7875	20		
chrX	109416702	109416702	T	-	hom	6.54	TMEM164			0	0	0											0.075	0	0.925	8		
chrX	109419165	109419165	G	A	hom	222	TMEM164			0.64	0.64	0.64	rs2795995 [];										0.3	0.05	0.65	33		
chrX	109694302	109694302	G	A	hom	222	RGAG1	nonsynonymous SNV	RGAG1:NM_020769:exon3:c.G457A:p.A153T,	0.0024	0.0024	0.0024	rs41304450 [];	-1.2970			0.0010	0.0116					0.0625	0	0.9375	7		
chrX	109918926	109918926	T	A	hom	222	CHRDL1			0.0006	0.0006	0.0006	rs189875535 [];							342			0.0625	0	0.9375	5		
chrX	109918955	109918956	GA	-	het	21.5	CHRDL1			0	0	0								290			0	0.1375	0.8625	11		
chrX	109964875	109964875	T	-	hom	214	CHRDL1			0	0	0											0	0	1	0		
chrX	110248758	110248758	G	T	hom	222	PAK3			0.91	0.91	0.91	rs4893477 [];								300142 [p21-activated kinase-3 - Mental retardation, X-linked 30/47, 300558 (3)];		0.9625	0	0.0375	89		
chrX	110248776	110248776	C	T	hom	222	PAK3			0.92	0.92	0.92	rs4893478 [];								300142 [p21-activated kinase-3 - Mental retardation, X-linked 30/47, 300558 (3)];		0.9625	0	0.0375	89		
chrX	110339676	110339676	C	A	hom	67	PAK3			0.84	0.84	0.84	rs6642857 [];								300142 [p21-activated kinase-3 - Mental retardation, X-linked 30/47, 300558 (3)];		0.1375	0	0.8625	12		
chrX	110340603	110340603	-	T	het	32.5	PAK3			0	0	0									300142 [p21-activated kinase-3 - Mental retardation, X-linked 30/47, 300558 (3)];		0	0.0125	0.9875	1		
chrX	110368113	110368113	-	A	hom	214	PAK3			0	0	0									300142 [p21-activated kinase-3 - Mental retardation, X-linked 30/47, 300558 (3)];		0.9	0	0.1	84		
chrX	110368657	110368657	T	A	hom	222	PAK3			0.93	0.93	0.93	rs1361321 [];								300142 [p21-activated kinase-3 - Mental retardation, X-linked 30/47, 300558 (3)];		0.9875	0	0.0125	91		
chrX	110368829	110368829	A	G	hom	222	PAK3			1	1	1	rs77566096 [];								300142 [p21-activated kinase-3 - Mental retardation, X-linked 30/47, 300558 (3)];		0.95	0	0.05	88		
chrX	110371452	110371452	T	C	hom	222	PAK3			0.86	0.86	0.86	rs5943137 [];								300142 [p21-activated kinase-3 - Mental retardation, X-linked 30/47, 300558 (3)];		0.95	0.0125	0.0375	89		
chrX	110489520	110489520	A	G	hom	222	CAPN6			0.98	0.98	0.98	rs6642884 [];										0.95	0.0125	0.0375	93		
chrX	110543861	110543861	-	T	het	163	DCX			0	0	0									300121 [Doublecortin - Lissencephaly, X-linked, 300067 (3); Subcortical laminalheteropia, X-linked, 300067 (3)];		0	0.0875	0.9125	14		
chrX	111155476	111155476	G	A	hom	222	TRPC5			0.11	0.11	0.11	rs7050962 [];					0.0587					0.025	0	0.975	4		
chrX	111156163	111156163	C	T	hom	222	TRPC5			0.15	0.15	0.15	rs41311741 [];										0.05	0.0125	0.9375	5		
chrX	111923376	111923376	C	T	hom	127	LHFPL1			0.74	0.74	0.74	rs75345634 [];							297			0.1	0.5375	0.3625	59		
chrX	112083904	112083904	T	C	hom	222	AMOT			0	0	0											0.0125	0.0125	0.975	2		
chrX	114082535	114082535	G	A	hom	222	HTR2C			0.92	0.92	0.92	rs5946005 [];					0.8389					0.325	0.0375	0.6375	61		
chrX	114400318	114400318	T	G	hom	222	LRCH2			0.94	0.94	0.94	rs4361922 [];										0.4375	0	0.5625	46		
chrX	115302335	115302335	A	T	hom	222	AGTR2			0.16	0.16	0.16	rs3736556 [];										0.1125	0.05	0.8375	18		
chrX	115305728	115305728	G	C	hom	222	AGTR2			0.2	0.2	0.2	rs12845035 [];										0.2375	0.05	0.7125	31		
chrX	115586325	115586325	G	A	hom	222	SLC6A14			0.45	0.45	0.45	rs5905287 [];										0.1875	0.05	0.7625	22		
chrX	115590299	115590299	C	G	hom	222	SLC6A14			0.49	0.49	0.49	rs2011162 [];										0.5625	0.075	0.3625	60		
chrX	115590829	115590829	C	T	hom	222	SLC6A14			0.35	0.35	0.35	rs5905289 [];										0.375	0.0625	0.5625	39		
chrX	117031744	117031744	A	G	hom	222	KLHL13			0.05	0.05	0.05	rs62609214 [];										0.025	0.025	0.95	5		
chrX	117032973	117032973	C	G	hom	222	KLHL13	synonymous SNV	KLHL13:NM_033495:exon7:c.G1866C:p.L622L,KLHL13:NM_001168303:exon7:c.G1740C:p.L580L,KLHL13:NM_001168299:exon8:c.G1875C:p.L625L,KLHL13:NM_001168302:exon8:c.G1818C:p.L606L,KLHL13:NM_001168300:exon7:c.G1848C:p.L616L,KLHL13:NM_001168301:exon8:c.G1818C:p.L606L,	0.17	0.17	0.17	rs6645983 [];					0.0762					0.1125	0.025	0.8625	22		
chrX	117053499	117053499	C	T	hom	222	KLHL13	synonymous SNV	KLHL13:NM_033495:exon4:c.G555A:p.V185V,KLHL13:NM_001168303:exon4:c.G429A:p.V143V,KLHL13:NM_001168299:exon5:c.G564A:p.V188V,KLHL13:NM_001168302:exon5:c.G507A:p.V169V,KLHL13:NM_001168300:exon4:c.G537A:p.V179V,KLHL13:NM_001168301:exon5:c.G507A:p.V169V,	0.22	0.22	0.22	rs6645994 [];					0.0762					0.1125	0.025	0.8625	20		
chrX	117106630	117106630	A	G	hom	222	KLHL13			0.14	0.14	0.14	rs6646017 [];										0.025	0.025	0.95	5		
chrX	117480024	117480024	A	G	hom	222	WDR44			0.5	0.5	0.5	rs1716784 [];										0.05	0.0125	0.9375	7		
chrX	117480160	117480160	T	C	hom	222	WDR44			0.5	0.5	0.5	rs1716785 [];										0.125	0	0.875	13		
chrX	117521338	117521338	G	A	hom	222	WDR44	synonymous SNV	WDR44:NM_019045:exon3:c.G147A:p.E49E,WDR44:NM_001184965:exon3:c.G147A:p.E49E,	0.17	0.17	0.17	rs17318100 [];					0.1276					0.1	0	0.9	14		
chrX	117528056	117528056	G	A	hom	222	WDR44	nonsynonymous SNV	WDR44:NM_019045:exon5:c.G865A:p.A289T,WDR44:NM_001184965:exon5:c.G865A:p.A289T,WDR44:NM_001184966:exon4:c.G790A:p.A264T,	0.17	0.17	0.17	rs17271416 [];	-0.0440	0.0000	0.8400	0.0010	0.1284					0.1	0	0.9	14		
chrX	117528142	117528142	C	T	hom	222	WDR44	synonymous SNV	WDR44:NM_019045:exon5:c.C951T:p.T317T [1(stomach)]; WDR44:NM_001184965:exon5:c.C951T:p.T317T [1(stomach)]; WDR44:NM_001184966:exon4:c.C876T:p.T292T [1(stomach)]; 	0.53	0.53	0.53	rs6603401 [];	0.2200	0.2772			0.2100	150812 [1(stomach)]; 150813 [1(stomach)]; 				0.1375	0.0125	0.85	29		
chrX	117531099	117531099	C	A	hom	222	WDR44			0.53	0.53	0.53	rs5956969 [];					0.2099	COSN168793 [1(large_intestine)]; 				0.0625	0	0.9375	16		
chrX	117532516	117532516	C	T	hom	202	WDR44			0.32	0.32	0.32	rs6646189 [];										0.05	0	0.95	6		
chrX	117541110	117541110	A	G	hom	222	WDR44			0.32	0.32	0.32	rs5956052 [];										0.05	0	0.95	6		
chrX	117566782	117566782	C	T	hom	222	WDR44	synonymous SNV	WDR44:NM_019045:exon13:c.C1776T:p.N592N,WDR44:NM_001184965:exon13:c.C1776T:p.N592N,WDR44:NM_001184966:exon12:c.C1701T:p.N567N,	0.17	0.17	0.17	rs10521584 [];	-0.3150	0.2894			0.1286					0.1	0	0.9	14		
chrX	117570955	117570957	CTG	-	hom	214	WDR44			0.32	0.32	0.32	rs10590176 [];										0.05	0	0.95	6		
chrX	117578556	117578562	TTTCTTT	-	hom	214	WDR44			0.16	0.16	0.16	rs201429333 [];							2206			0.0375	0	0.9625	4		
chrX	117584008	117584008	C	A	hom	185	WDR44			1	1	1	rs5910351 [];										0.4375	0	0.5625	46		
chrX	117700141	117700141	A	G	hom	222	DOCK11	synonymous SNV	DOCK11:NM_144658:exon8:c.A867G:p.A289A [1(prostate)]; 	0.37	0.37	0.37	rs2286977 [];					0.3699	1179702 [1(prostate)]; 				0.375	0.0625	0.5625	68		
chrX	117727327	117727327	T	C	hom	222	DOCK11			0.25	0.25	0.25	rs5909551 [];					0.3676					0.15	0.0375	0.8125	29		
chrX	117742356	117742356	C	T	hom	222	DOCK11			0.57	0.57	0.57	rs5910394 [];					0.5792					0.225	0.0375	0.7375	39		
chrX	117810831	117810831	C	T	hom	222	DOCK11			0.59	0.59	0.59	rs5957040 [];							989			0.3125	0.0375	0.65	35		
chrX	117817266	117817266	C	T	hom	222	DOCK11			0.92	0.92	0.92	rs4372173 [];										0.3875	0.0375	0.575	44		
chrX	117874898	117874898	T	C	hom	186	IL13RA1			0.96	0.96	0.96	rs2246663 [];										0.3875	0.0375	0.575	45		
chrX	117910526	117910526	-	TT	het	29.5	IL13RA1			0	0	0											0.0125	0.075	0.9125	7		
chrX	118117063	118117063	T	C	hom	182	LONRF3			0.25	0.25	0.25	rs12391696 [];										0.1125	0.05	0.8375	15		
chrX	118143043	118143043	A	G	hom	222	LONRF3			0.4	0.4	0.4	rs2168379 [];					0.3790					0.125	0.05	0.825	33		
chrX	118147233	118147233	G	T	hom	222	LONRF3			0.37	0.37	0.37	rs2290514 [];										0.125	0.05	0.825	17		
chrX	118148229	118148229	A	G	hom	222	LONRF3	synonymous SNV	LONRF3:NM_001031855:exon10:c.A2034G:p.A678A,LONRF3:NM_024778:exon9:c.A1911G:p.A637A,	0.41	0.41	0.41	rs2278954 [];	-2.5850	0.2772			0.3790					0.325	0.075	0.6	64		
chrX	118533299	118533299	A	G	hom	89.5	SLC25A43			0.86	0.86	0.86	rs217975 [];										0.75	0.0125	0.2375	71		
chrX	118533366	118533366	G	A	hom	154	SLC25A43			0.71	0.71	0.71	rs217976 [];										0.6	0.0375	0.3625	64		
chrX	118544448	118544448	T	C	hom	187	SLC25A43			0.98	0.98	0.98	rs16274 [];										0.4	0	0.6	42		
chrX	118587003	118587003	C	T	hom	222	SLC25A43	nonsynonymous SNV	SLC25A43:NM_145305:exon5:c.C1001T:p.P334L,	0.55	0.55	0.55	rs3810755 [];	0.6530	0.0000	0.8700	0.0000	0.5796					0.6125	0.0375	0.35	90		
chrX	118587321	118587321	A	G	hom	222	SLC25A43			0.46	0.46	0.46	rs3747455 [];										0.5	0.0125	0.4875	46		
chrX	118587669	118587669	T	G	hom	222	SLC25A43			0.55	0.55	0.55	rs3747454 [];							1810			0.5625	0.0375	0.4	53		
chrX	118588371	118588371	C	T	hom	222	SLC25A43			0.55	0.55	0.55	rs10907045 [];										0.575	0.0375	0.3875	53		
chrX	118601473	118601473	T	C	hom	222	SLC25A5-AS1			0.78	0.78	0.78	rs392020 [];										0.7	0.0625	0.2375	71		
chrX	118601707	118601707	A	G	hom	222	SLC25A5-AS1			0.64	0.64	0.64	rs6603508 [];										0.575	0.025	0.4	54		
chrX	118603844	118603844	T	G	hom	222	SLC25A5	nonsynonymous SNV	SLC25A5:NM_001152:exon2:c.T332G:p.L111R,	0.77	0.77	0.77	rs371749 [];	0.9400	0.0022	1.0000	0.0000						0.15	0.6375	0.2125	115		
chrX	118604436	118604436	T	C	hom	222	SLC25A5	synonymous SNV	SLC25A5:NM_001152:exon3:c.T699C:p.T233T,	0.78	0.78	0.78	rs12390 [];					0.7570					0.7	0.0625	0.2375	115		
chrX	118604558	118604558	-	A	hom	214	SLC25A5			0	0	0											0.3	0.05	0.65	34		
chrX	118605196	118605196	-	TGATGGTGG	het	87.5	SLC25A5			0	0	0											0	0.7625	0.2375	72		
chrX	118605217	118605217	G	A	het	23	SLC25A5			0	0	0											0	0.4125	0.5875	40		
chrX	118605245	118605245	A	C	het	19.1	SLC25A5			0	0	0											0	0.35	0.65	35		
chrX	118672126	118672126	C	T	hom	222	CXorf56			0.61	0.61	0.61	rs5910608 [];										0.5875	0.0625	0.35	60		
chrX	118678364	118678364	G	A	hom	222	CXorf56	synonymous SNV	CXorf56:NM_001170570:exon3:c.C333T:p.G111G,CXorf56:NM_001170569:exon4:c.C228T:p.G76G,CXorf56:NM_022101:exon4:c.C375T:p.G125G,	0.6	0.6	0.6	rs5910611 [];					0.6295					0.6	0.0625	0.3375	107		
chrX	118699320	118699320	A	G	hom	222	CXorf56			0.94	0.94	0.94	rs5910616 [];					0.8579					0.7875	0.05	0.1625	125		
chrX	118718417	118718417	-	TT	het	98.5	UBE2A			0	0	0											0	0.0875	0.9125	11		
chrX	118751063	118751072	GTGTGTGTGT	-	hom	214	SEPT6			0	0	0								489			0.0625	0.075	0.8625	14		
chrX	118751732	118751732	T	C	hom	222	SEPT6			0.73	0.73	0.73	rs305154 [];							389			0.7375	0.05	0.2125	77		
chrX	118751950	118751950	G	A	hom	222	SEPT6			0.75	0.75	0.75	rs305153 [];										0.775	0.05	0.175	80		
chrX	118752148	118752148	-	TT	het	217	SEPT6			0	0	0											0.0125	0.3375	0.65	32		
chrX	118752312	118752312	T	C	hom	222	SEPT6			0.75	0.75	0.75	rs7060 [];										0.7625	0.0625	0.175	80		
chrX	118827317	118827317	A	C	hom	222	SEPT6			0.59	0.59	0.59	rs17261138 [];										0.525	0.075	0.4	57		
chrX	118920809	118920809	C	T	hom	178	RPL39			0.36	0.36	0.36	rs7885997 [];										0.1625	0.0625	0.775	22		
chrX	118921530	118921530	A	C	hom	222	RPL39			0.28	0.28	0.28	rs73214964 [];										0.15	0.0625	0.7875	20		
chrX	118921593	118921593	T	C	hom	200	RPL39			0.28	0.28	0.28	rs34447789 [];										0.15	0.0625	0.7875	20		
chrX	118925705	118925705	C	T	hom	173	RPL39			0.3	0.3	0.3	rs2240448 [];										0.15	0.05	0.8	20		
chrX	119065893	119065893	G	A	hom	199	NKAP			0.65	0.65	0.65	rs194302 [];					0.5431					0.5125	0.0625	0.425	87		
chrX	119070411	119070411	T	A	hom	222	NKAP			0.58	0.58	0.58	rs194307 [];					0.5317					0.2375	0.05	0.7125	41		
chrX	119070567	119070567	A	T	hom	222	NKAP			0.58	0.58	0.58	rs194308 [];					0.5042					0.525	0.0625	0.4125	80		
chrX	119070874	119070874	C	T	hom	222	NKAP			0.16	0.16	0.16	rs194309 [];										0.1125	0.025	0.8625	12		
chrX	119070911	119070911	C	T	hom	222	NKAP			0.17	0.17	0.17	rs194310 [];										0.1125	0.025	0.8625	12		
chrX	119254837	119254837	T	A	hom	222	RHOXF1;RHOXF2		RHOXF1:dist=4990;RHOXF2:dist=37630	0.51	0.51	0.51	rs4825695 [];										0.2625	0.0625	0.675	33		
chrX	119254874	119254874	T	C	hom	222	RHOXF1;RHOXF2		RHOXF1:dist=5027;RHOXF2:dist=37593	0.13	0.13	0.13	rs4825696 [];										0.125	0.0125	0.8625	15		
chrX	119392796	119392796	G	A	hom	222	TMEM255A			0.99	0.99	0.99	rs5910811 [];										0.9375	0	0.0625	91		
chrX	119421164	119421164	-	ACACACACACACAC	hom	205	TMEM255A			0	0	0								261			0.075	0.025	0.9	8		
chrX	119560140	119560140	T	C	hom	222	LAMP2			0.32	0.32	0.32	rs2748 [];								309060 [Lysosome-associated membrane protein-2 - Glycogen storage disease IIb, 300257 (3)];		0.3125	0.025	0.6625	72		
chrX	119560599	119560599	T	C	hom	222	LAMP2			0.7	0.7	0.7	rs42885 [];								309060 [Lysosome-associated membrane protein-2 - Glycogen storage disease IIb, 300257 (3)];		0.4625	0.0375	0.5	85		
chrX	119571073	119571073	G	A	hom	222	LAMP2			0.29	0.29	0.29	rs14410 [];								309060 [Lysosome-associated membrane protein-2 - Glycogen storage disease IIb, 300257 (3)];		0.3	0.025	0.675	70		
chrX	119571279	119571281	AAA	-	het	86.5	LAMP2			0	0	0									309060 [Lysosome-associated membrane protein-2 - Glycogen storage disease IIb, 300257 (3)];		0	0.0875	0.9125	10		
chrX	119571541	119571541	T	C	hom	222	LAMP2			0.78	0.78	0.78	rs42889 [];								309060 [Lysosome-associated membrane protein-2 - Glycogen storage disease IIb, 300257 (3)];		0.5	0.0375	0.4625	90		
chrX	119572587	119572587	-	ACAAAA	hom	214	LAMP2			0	0	0								360	309060 [Lysosome-associated membrane protein-2 - Glycogen storage disease IIb, 300257 (3)];		0.1625	0.0125	0.825	36		
chrX	119590533	119590533	T	A	hom	222	LAMP2	synonymous SNV	LAMP2:NM_013995:exon2:c.A156T:p.V52V,LAMP2:NM_002294:exon2:c.A156T:p.V52V,LAMP2:NM_001122606:exon2:c.A156T:p.V52V,	0.39	0.39	0.39	rs12097 [];					0.4261			309060 [Lysosome-associated membrane protein-2 - Glycogen storage disease IIb, 300257 (3)];		0.3625	0.0375	0.6	113		
chrX	119746008	119746008	T	C	hom	222	MCTS1			0.13	0.13	0.13	rs2233113 [];					0.2179					0.0875	0.0375	0.875	21		
chrX	119760629	119760629	A	T	hom	222	C1GALT1C1	nonsynonymous SNV	C1GALT1C1:NM_152692:exon3:c.T393A:p.D131E,C1GALT1C1:NM_001011551:exon2:c.T393A:p.D131E,	0.13	0.13	0.13	rs17261572 [];	0.2430	0.2923		0.0010	0.2278				RCV000011539.1 [other]; 	0.1875	0.05	0.7625	42		
chrX	120181641	120181641	G	A	hom	222	GLUD2	nonsynonymous SNV	GLUD2:NM_012084:exon1:c.G103A:p.G35R [1(central_nervous_system)]; 	0.07	0.07	0.07	rs191769566 [];	0.1430	0.0009	0.5700	0.0130		216177 [1(central_nervous_system)]; 				0.025	0.0125	0.9625	6		
chrX	122318387	122318387	-	G	hom	214	GRIA3			0	0	0	rs66632982 [];								305915 [Glutamate receptor, ionotropic, AMPA 3 - Mental retardation, X-linked 94, 300699 (3)];		0.975	0	0.025	210		
chrX	122319917	122319917	T	C	hom	222	GRIA3			0.42	0.42	0.42	rs2269551 [];						COSN168802 [1(large_intestine)]; 		305915 [Glutamate receptor, ionotropic, AMPA 3 - Mental retardation, X-linked 94, 300699 (3)];		0.125	0.025	0.85	15		
chrX	122336448	122336448	T	C	hom	222	GRIA3			0.42	0.42	0.42	rs2285127 [];								305915 [Glutamate receptor, ionotropic, AMPA 3 - Mental retardation, X-linked 94, 300699 (3)];		0.125	0.0375	0.8375	37		
chrX	122336604	122336604	-	G	hom	214	GRIA3	frameshift insertion	GRIA3:NM_001256743:exon3:c.385_386insG:p.P129fs,	0	0	0									305915 [Glutamate receptor, ionotropic, AMPA 3 - Mental retardation, X-linked 94, 300699 (3)];		0.975	0	0.025	157		
chrX	123047709	123047709	G	A	het	46	XIAP			0	0	0	rs72610614 [];								300079 [Inhibitor of apoptosis, X-linked - Lymphoproliferative syndrome, X-linked, 2, 300635 (3)];		0	0.2125	0.7875	28		
chrX	123047728	123047728	T	C	het	3.01	XIAP			0	0	0	rs112828867 [];								300079 [Inhibitor of apoptosis, X-linked - Lymphoproliferative syndrome, X-linked, 2, 300635 (3)];		0	0.1	0.9	14		
chrX	123506104	123506104	T	A	hom	222	SH2D1A			0.79	0.79	0.79	rs7876065 [];								300490 [SH2 domain protein 1A - Lymphoproliferative syndrome, X-linked, 308240 (3)];		0.875	0	0.125	137		
chrX	123513104	123513104	T	G	hom	222	TENM1			0.98	0.98	0.98	rs5958476 [];										0.925	0.025	0.05	91		
chrX	123516789	123516789	-	TATT	het	178	TENM1			0	0	0								2028			0.1	0.05	0.85	15		
chrX	123587110	123587110	C	A	hom	222	TENM1			0.63	0.63	0.63	rs2223416 [];										0.2125	0.075	0.7125	30		
chrX	125686536	125686536	T	C	hom	81.5	DCAF12L1	nonsynonymous SNV	DCAF12L1:NM_178470:exon1:c.A56G:p.D19G,	0.11	0.11	0.11	rs11095722 [];	-1.3500	0.0000	0.5300	0.0000	0.0269					0.025	0	0.975	4		
chrX	128880614	128880614	T	C	hom	222	XPNPEP2	synonymous SNV	XPNPEP2:NM_003399:exon6:c.T447C:p.P149P,	0.54	0.54	0.54	rs3747343 [];					0.2683					0.25	0.0375	0.7125	43		
chrX	128889464	128889464	G	A	hom	222	XPNPEP2			0.14	0.14	0.14	rs5932674 [];										0.0875	0	0.9125	11		
chrX	128925156	128925156	T	G	hom	60	SASH3			0.26	0.26	0.26	rs5932684 [];							507			0.075	0.0375	0.8875	13		
chrX	128927890	128927890	T	C	hom	171	SASH3			0.75	0.75	0.75	rs859577 [];										0.4	0.0625	0.5375	44		
chrX	128928232	128928232	A	G	hom	222	SASH3			0.03	0.03	0.03	rs34813627 [];										0.1125	0.0375	0.85	15		
chrX	128938958	128938958	T	C	hom	222	ZDHHC9			0.67	0.67	0.67	rs1053486 [];								300646 [Zinc finger DHHC domain-containing protein 9 - Mental retardation, X-linked, ZDHHC9-related, 300799 (3)];		0.95	0	0.05	154		
chrX	128948893	128948893	T	C	hom	222	ZDHHC9			0.94	0.94	0.94	rs5932686 [];								300646 [Zinc finger DHHC domain-containing protein 9 - Mental retardation, X-linked, ZDHHC9-related, 300799 (3)];		0.4375	0	0.5625	46		
chrX	128957640	128957640	T	C	hom	222	ZDHHC9			0.81	0.81	0.81	rs2275605 [];					0.9894			300646 [Zinc finger DHHC domain-containing protein 9 - Mental retardation, X-linked, ZDHHC9-related, 300799 (3)];		0.425	0	0.575	104		
chrX	129147079	129147079	T	C	hom	222	BCORL1	nonsynonymous SNV	BCORL1:NM_021946:exon3:c.T331C:p.F111L,	1	1	1	rs4830173 [];	1.0250	0.0000	0.3700	0.0000						0.9375	0	0.0625	139		
chrX	129147373	129147373	G	A	hom	222	BCORL1	nonsynonymous SNV	BCORL1:NM_021946:exon3:c.G625A:p.G209S,	0.04	0.04	0.04	rs5932715 [];	0.6030	0.0054		0.0010	0.1027					0.1	0.025	0.875	15		
chrX	129269980	129269980	G	A	hom	222	AIFM1			0.44	0.44	0.44	rs209998 [];					0.3964			300169 [Apoptosis-inducing factor, mitochondrion-associated, 1 - Combined oxidative phosphorylation deficiency 6, 300816 (3)];		0.15	0.075	0.775	60		
chrX	129279648	129279648	C	T	hom	222	AIFM1			0.09	0.09	0.09	rs12559753 [];								300169 [Apoptosis-inducing factor, mitochondrion-associated, 1 - Combined oxidative phosphorylation deficiency 6, 300816 (3)];		0.1	0.0375	0.8625	17		
chrX	129283520	129283520	A	G	hom	222	AIFM1	synonymous SNV	AIFM1:NM_145812:exon3:c.T261C:p.D87D,AIFM1:NM_004208:exon3:c.T273C:p.D91D,AIFM1:NM_001130847:exon3:c.T273C:p.D91D,	0.46	0.46	0.46	rs1139851 [];					0.3971			300169 [Apoptosis-inducing factor, mitochondrion-associated, 1 - Combined oxidative phosphorylation deficiency 6, 300816 (3)];		0.375	0.0875	0.5375	115		
chrX	129290699	129290699	T	C	hom	222	AIFM1			0.45	0.45	0.45	rs189994 [];								300169 [Apoptosis-inducing factor, mitochondrion-associated, 1 - Combined oxidative phosphorylation deficiency 6, 300816 (3)];		0.15	0.075	0.775	26		
chrX	129337831	129337831	C	T	hom	222	ZNF280C			0.48	0.48	0.48	rs593323 [];										0.375	0.0625	0.5625	47		
chrX	129338766	129338766	G	A	hom	222	ZNF280C			0.5	0.5	0.5	rs608117 [];										0.375	0.0625	0.5625	47		
chrX	129349295	129349295	T	G	hom	222	ZNF280C	synonymous SNV	ZNF280C:NM_017666:exon15:c.A1851C:p.G617G,	0.49	0.49	0.49	rs209238 [];					0.4010					0.3625	0.0875	0.55	79		
chrX	129498836	129498836	T	A	hom	222	SLC25A14			0.38	0.38	0.38	rs2235800 [];										0.1875	0.0625	0.75	22		
chrX	129645345	129645345	A	G	hom	222	FAM45B;ENOX2		FAM45B:dist=13924;ENOX2:dist=112012	0.38	0.38	0.38	rs3021206 [];										0.2125	0.075	0.7125	24		
chrX	129649749	129649749	G	C	hom	222	FAM45B;ENOX2		FAM45B:dist=18328;ENOX2:dist=107608	0.29	0.29	0.29	rs6637741 [];										0.2	0.0625	0.7375	22		
chrX	129649781	129649781	C	G	hom	222	FAM45B;ENOX2		FAM45B:dist=18360;ENOX2:dist=107576	0.33	0.33	0.33	rs3007749 [];										0.2	0.0625	0.7375	22		
chrX	129658039	129658039	C	T	hom	218	FAM45B;ENOX2		FAM45B:dist=26618;ENOX2:dist=99318	0.29	0.29	0.29	rs7892036 [];										0.2	0.0625	0.7375	22		
chrX	129658104	129658104	A	G	hom	222	FAM45B;ENOX2		FAM45B:dist=26683;ENOX2:dist=99253	0.38	0.38	0.38	rs3007751 [];										0.2	0.0625	0.7375	22		
chrX	129658335	129658335	T	G	hom	175	FAM45B;ENOX2		FAM45B:dist=26914;ENOX2:dist=99022	0.32	0.32	0.32	rs3007752 [];										0.1	0.0625	0.8375	13		
chrX	130220176	130220176	G	A	hom	222	ARHGAP36			0.23	0.23	0.23	rs16999801 [];										0.05	0.0125	0.9375	6		
chrX	130223137	130223137	G	A	hom	222	ARHGAP36			0.82	0.82	0.82	rs3810727 [];										0.8375	0.0625	0.1	84		
chrX	130223760	130223760	C	T	hom	222	ARHGAP36			0.16	0.16	0.16	rs3788 [];										0.1375	0.0125	0.85	13		
chrX	130413442	130413442	G	C	hom	215	IGSF1			0.22	0.22	0.22	rs10521765 [];										0.175	0.0125	0.8125	20		
chrX	130416958	130416958	C	T	hom	222	IGSF1	synonymous SNV	IGSF1:NM_001555:exon6:c.G948A:p.V316V,IGSF1:NM_001170961:exon6:c.G948A:p.V316V,IGSF1:NM_001170962:exon5:c.G921A:p.V307V,	0.92	0.92	0.92	rs5932877 [];					0.9991					0.975	0	0.025	143		
chrX	130418703	130418703	-	T	hom	214	IGSF1			0	0	0											0.325	0.0375	0.6375	34		
chrX	130419646	130419646	A	G	hom	222	IGSF1			0.96	0.96	0.96	rs4830221 [];										0.4375	0	0.5625	46		
chrX	130420006	130420006	T	C	hom	222	IGSF1	synonymous SNV	IGSF1:NM_001555:exon4:c.A114G:p.P38P,IGSF1:NM_001170961:exon4:c.A114G:p.P38P,IGSF1:NM_001170963:exon4:c.A114G:p.P38P,IGSF1:NM_205833:exon4:c.A114G:p.P38P,IGSF1:NM_001170962:exon3:c.A87G:p.P29P,	0.96	0.96	0.96	rs5930458 [];					0.9999					0.9875	0	0.0125	144		
chrX	130420415	130420415	T	C	hom	222	IGSF1	synonymous SNV	IGSF1:NM_001555:exon3:c.A93G:p.S31S,IGSF1:NM_001170961:exon3:c.A93G:p.S31S,IGSF1:NM_001170963:exon3:c.A93G:p.S31S,IGSF1:NM_205833:exon3:c.A93G:p.S31S,	0.98	0.98	0.98	rs4495600 [];					0.9999					0.95	0	0.05	142		
chrX	130423359	130423359	C	G	hom	165	IGSF1			0.47	0.47	0.47	rs6637829 [];										0.1875	0.0375	0.775	24		
chrX	130938985	130938985	T	C	hom	222	LOC286467			0.56	0.56	0.56	rs6634843 [];										0.2625	0.075	0.6625	33		
chrX	131203783	131203783	T	C	hom	222	MST4			0.27	0.27	0.27	rs5930544 [];										0.1625	0.025	0.8125	19		
chrX	131206590	131206590	-	T	hom	132	MST4			0	0	0	rs3215613 [];										0.1625	0.025	0.8125	19		
chrX	131206620	131206620	T	C	hom	222	MST4			0.04	0.04	0.04	rs5977622 [];										0	0	1	0		
chrX	131211235	131211235	T	A	hom	222	FRMD7			0.26	0.26	0.26	rs3764771 [];										0.3	0.05	0.65	35		
chrX	131212512	131212512	A	G	hom	222	FRMD7	synonymous SNV	FRMD7:NM_194277:exon12:c.T1533C:p.I511I [1(prostate)]; 	0.26	0.26	0.26	rs5977623 [];					0.3080	1132405 [1(prostate)]; 				0.3	0.0625	0.6375	51		
chrX	131216454	131216454	G	A	hom	222	FRMD7	nonsynonymous SNV	FRMD7:NM_194277:exon9:c.C842T:p.S281L,	0.05	0.05	0.05	rs5977625 [];	2.3050	0.9353	0.9300	0.9960	0.0412					0	0.0125	0.9875	3		
chrX	131216684	131216684	G	T	hom	222	FRMD7			0.04	0.04	0.04	rs5977626 [];										0	0	1	0		
chrX	131231257	131231257	G	A	hom	182	FRMD7			0.19	0.19	0.19	rs2064650 [];					0.1952					0.075	0.0375	0.8875	20		
chrX	131231431	131231431	-	AC	hom	80.4	FRMD7			0	0	0	rs72287532 [];							309			0.0125	0.1125	0.875	13		
chrX	131337535	131337552	GAGAGAGAGAGAGAGAGA	-	hom	214	RAP2C			0	0	0								504			0.0375	0	0.9625	3		
chrX	131351850	131351850	G	A	hom	48	RAP2C			0.11	0.11	0.11	rs5977659 [];										0	0	1	0		
chrX	131803353	131803354	TC	-	hom	194	HS6ST2-AS1			0	0	0	rs10550199 [];							198			0.225	0.1	0.675	35		
chrX	132161673	132161673	C	T	hom	222	USP26	synonymous SNV	USP26:NM_031907:exon1:c.G576A:p.E192E,	0.32	0.32	0.32	rs41304540 [];					0.4965					0.45	0.0875	0.4625	84		
chrX	132435030	132435030	T	G	hom	168	GPC4			0.03	0.03	0.03	rs41299096 [];										0.025	0.025	0.95	5		
chrX	132435036	132435036	A	G	hom	171	GPC4			0.03	0.03	0.03	rs41300203 [];										0.025	0.025	0.95	5		
chrX	133511988	133511988	G	A	hom	222	PHF6			0.82	0.82	0.82	rs5978001 [];					0.7439			300414 [PHD finger protein 6 - Borjeson-Forssman-Lehmann syndrome, 301900 (3)];		0.325	0.0625	0.6125	62		
chrX	133528116	133528116	A	C	hom	193	PHF6			0.41	0.41	0.41	rs6529627 [];								300414 [PHD finger protein 6 - Borjeson-Forssman-Lehmann syndrome, 301900 (3)];		0.0875	0.0125	0.9	9		
chrX	133552501	133552501	A	G	hom	222	PHF6			0.16	0.16	0.16	rs10521778 [];								300414 [PHD finger protein 6 - Borjeson-Forssman-Lehmann syndrome, 301900 (3)];		0.075	0.025	0.9	10		
chrX	133561102	133561102	-	T	hom	214	PHF6			0	0	0									300414 [PHD finger protein 6 - Borjeson-Forssman-Lehmann syndrome, 301900 (3)];		0.2125	0.025	0.7625	39		
chrX	133561242	133561242	G	A	hom	222	PHF6			0.41	0.41	0.41	rs6638230 [];								300414 [PHD finger protein 6 - Borjeson-Forssman-Lehmann syndrome, 301900 (3)];		0.2375	0.025	0.7375	48		
chrX	133620489	133620489	-	T	het	63.7	HPRT1			0	0	0									308000 [Hypoxanthine phosphoribosyltransferase 1 - Lesch-Nyhan syndrome, 300322 (3); HPRT-related gout, 300323 (3)];		0.025	0.0125	0.9625	123		
chrX	133678852	133678852	G	A	hom	152	MGC16121			0.81	0.81	0.81	rs2503985 [];										0.35	0	0.65	37		
chrX	133680547	133680547	G	A	hom	144	MGC16121			0.54	0.54	0.54	rs757309 [];										0.2125	0.0125	0.775	26		
chrX	133941766	133941766	G	A	hom	222	FAM122C			0.0042	0.0042	0.0042	rs143181255 [];					0.0111					0.0125	0.0125	0.975	2		
chrX	134022913	134022913	A	C	hom	222	MOSPD1			0.38	0.38	0.38	rs6529647 [];										0.2875	0.05	0.6625	29		
chrX	134022943	134022943	A	G	hom	222	MOSPD1			0.24	0.24	0.24	rs7062231 [];										0.2375	0.0375	0.725	24		
chrX	134025744	134025744	A	G	hom	222	MOSPD1			0.5	0.5	0.5	rs6529648 [];										0.1625	0.0375	0.8	17		
chrX	134155904	134155904	G	T	hom	222	FAM127C			0.32	0.32	0.32	rs62599865 [];	0.3600		0.0000							0.425	0.05	0.525	49		
chrX	134156121	134156121	G	C	hom	222	FAM127C			0.7	0.7	0.7	rs2475853 [];	-0.0010		0.0000		0.7387					0.775	0.025	0.2	100		
chrX	134185997	134185997	T	A	hom	222	FAM127B	nonsynonymous SNV	FAM127B:NM_001078172:exon1:c.A142T:p.S48C [1(stomach)]; FAM127B:NM_001134321:exon1:c.A142T:p.S48C [1(stomach)]; 	0.74	0.74	0.74	rs2498776 [];	0.4460	0.0007	0.0600	0.0460	0.7429	150824 [1(stomach)]; 				0.7875	0.025	0.1875	118		
chrX	134229381	134229381	T	C	hom	222	LINC00087			0.64	0.64	0.64	rs1135844 [];										0.6625	0.0625	0.275	74		
chrX	134305213	134305213	C	T	hom	222	CXorf48			0.03	0.03	0.03	rs41300926 [];										0.075	0.0125	0.9125	7		
chrX	134421168	134421168	C	T	hom	222	ZNF75D	synonymous SNV	ZNF75D:NM_001185063:exon4:c.G1149A:p.T383T,ZNF75D:NM_007131:exon6:c.G1434A:p.T478T,	0.2	0.2	0.2	rs1129093 [];					0.4238					0.4	0.075	0.525	67		
chrX	134429722	134429722	C	G	hom	222	ZNF75D			0.03	0.03	0.03	rs183434271 [];										0.075	0.0125	0.9125	7		
chrX	134477613	134477613	A	C	hom	222	ZNF75D;ZNF449		ZNF75D:dist=47648;ZNF449:dist=1083	0.64	0.64	0.64	rs1419828 [];										0.675	0.025	0.3	70		
chrX	134493284	134493284	C	T	hom	222	ZNF449			0.63	0.63	0.63	rs4829777 [];										0.675	0.0375	0.2875	67		
chrX	134493747	134493747	A	T	hom	222	ZNF449			0.21	0.21	0.21	rs4829778 [];						COSN414006 [1(urinary_tract)]; 				0.4125	0.0625	0.525	42		
chrX	134557791	134557791	G	A	hom	222	LINC00086			0.58	0.58	0.58	rs6635045 [];										0.5375	0.05	0.4125	60		
chrX	134654818	134654818	T	C	hom	222	DDX26B			0.95	0.95	0.95	rs1890584 [];										0.9375	0.025	0.0375	93		
chrX	134683864	134683864	A	G	hom	222	DDX26B			0.86	0.86	0.86	rs6635060 [];										0.425	0.0125	0.5625	46		
chrX	134978425	134978425	G	A	hom	222	SAGE1	synonymous SNV	SAGE1:NM_018666:exon2:c.G24A:p.T8T,	0.19	0.19	0.19	rs5930805 [];					0.2606					0.0875	0.0125	0.9	21		
chrX	134986700	134986700	T	C	hom	222	SAGE1	synonymous SNV	SAGE1:NM_018666:exon4:c.T285C:p.N95N,	0.19	0.19	0.19	rs12014884 [];					0.2609					0.0875	0.0125	0.9	21		
chrX	134986770	134986770	-	GATCTGTGTATGTCTAC	hom	106	SAGE1			0	0	0											0	0	1	0		
chrX	134986782	134986782	-	AGATCTGTGTATGTC	hom	214	SAGE1			0	0	0											0.0125	0	0.9875	1		
chrX	134988362	134988362	T	C	het	5.46	SAGE1			0	0	0											0	0	1	0		
chrX	134988393	134988393	T	A	hom	222	SAGE1			0.19	0.19	0.19	rs5930814 [];										0.025	0.0125	0.9625	4		
chrX	134990944	134990944	T	C	hom	222	SAGE1			0.19	0.19	0.19	rs5974569 [];										0.025	0.0125	0.9625	4		
chrX	134991078	134991078	A	G	hom	222	SAGE1	synonymous SNV	SAGE1:NM_018666:exon13:c.A1497G:p.Q499Q,	0.19	0.19	0.19	rs5974570 [];					0.2607					0.1	0.0125	0.8875	22		
chrX	134993589	134993589	A	G	hom	222	SAGE1			0.99	0.99	0.99	rs4829798 [];										0.4375	0	0.5625	46		
chrX	134994005	134994005	T	C	hom	222	SAGE1	nonsynonymous SNV	SAGE1:NM_018666:exon18:c.T2414C:p.L805S,	0.19	0.19	0.19	rs4829799 [];	0.1460	0.0000	0.8200	0.0000	0.2606					0.1	0.0125	0.8875	22		
chrX	134994054	134994054	G	A	hom	222	SAGE1	synonymous SNV	SAGE1:NM_018666:exon18:c.G2463A:p.K821K,	0.13	0.13	0.13	rs4829584 [];					0.1860					0.1	0.0125	0.8875	17		
chrX	135046818	135046818	C	T	hom	222	MMGT1			0.11	0.11	0.11	rs3747461 [];										0.05	0.025	0.925	7		
chrX	135080636	135080636	-	T	hom	214	SLC9A6			0	0	0									300231 [Solute carrier family 9 (sodium/hydrogen exchanger), member 6 - Mental retardation, X-linked syndromic, Christianson type, 300243 (3)];		0.2875	0.05	0.6625	58		
chrX	135426693	135426693	A	G	hom	222	GPR112	nonsynonymous SNV	GPR112:NM_153834:exon6:c.A828G:p.I276M,	0.43	0.43	0.43	rs4829829 [];	-2.1900	0.0003	0.1900	0.0040	0.4761					0.425	0.1	0.475	80		
chrX	135426968	135426968	C	A	hom	222	GPR112	nonsynonymous SNV	GPR112:NM_153834:exon6:c.C1103A:p.P368H,	0.43	0.43	0.43	rs5930931 [];	0.2380	0.0029	0.0200	0.5990	0.4756					0.4375	0.1	0.4625	79		
chrX	135429503	135429503	C	A	hom	222	GPR112	nonsynonymous SNV	GPR112:NM_153834:exon6:c.C3638A:p.T1213N,	0.45	0.45	0.45	rs4829830 [];	-0.3470	0.0012	0.1900	0.0110	0.4786					0.45	0.0875	0.4625	80		
chrX	135430044	135430044	T	C	hom	222	GPR112	synonymous SNV	GPR112:NM_153834:exon6:c.T4179C:p.T1393T,	0.51	0.51	0.51	rs877761 [];					0.4802					0.45	0.0875	0.4625	80		
chrX	135430483	135430483	T	C	hom	222	GPR112	nonsynonymous SNV	GPR112:NM_153834:exon6:c.T4618C:p.S1540P,	0.45	0.45	0.45	rs912002 [];	1.1950	0.0311	0.0000	0.9940	0.4790					0.45	0.1	0.45	81		
chrX	135431236	135431236	T	C	hom	222	GPR112	nonsynonymous SNV	GPR112:NM_153834:exon6:c.T5371C:p.F1791L [1(prostate)]; 	0.47	0.47	0.47	rs5930932 [];	-1.0130	0.0012	0.4200	0.0000	0.4799	1132400 [1(prostate)]; 				0.45	0.1	0.45	80		
chrX	135431358	135431358	C	T	hom	222	GPR112	synonymous SNV	GPR112:NM_153834:exon6:c.C5493T:p.P1831P,	0.46	0.46	0.46	rs5930933 [];					0.4798					0.45	0.0875	0.4625	80		
chrX	135435476	135435476	T	-	hom	5.79	GPR112			0	0	0	rs5903915 [];										0.075	0	0.925	37		
chrX	135438388	135438388	A	G	hom	222	GPR112			0.46	0.46	0.46	rs6635268 [];					0.4797					0.1875	0.075	0.7375	44		
chrX	135474420	135474420	C	A	hom	222	GPR112	synonymous SNV	GPR112:NM_153834:exon17:c.C7941A:p.T2647T,	0.72	0.72	0.72	rs1329546 [];					0.6057					0.575	0.0375	0.3875	109		
chrX	135474445	135474447	GAT	-	hom	214	GPR112	nonframeshift deletion	GPR112:NM_153834:exon17:c.7966_7968del:p.2656_2656del,	0	0	0	rs34255702 [];					0.6067					0.575	0.05	0.375	112		
chrX	135480126	135480126	T	C	hom	222	GPR112	synonymous SNV	GPR112:NM_153834:exon20:c.T8271C:p.F2757F,	0.75	0.75	0.75	rs5974595 [];					0.6069					0.5875	0.0375	0.375	98		
chrX	135496398	135496398	G	A	hom	222	GPR112	synonymous SNV	GPR112:NM_153834:exon25:c.G9117A:p.T3039T,	0.75	0.75	0.75	rs5930942 [];					0.6064					0.5875	0.0375	0.375	98		
chrX	135574099	135574100	GC	-	hom	15.4	BRS3			0	0	0											0.0125	0	0.9875	1		
chrX	135723584	135723584	C	T	hom	222	LOC100128420			0.28	0.28	0.28	rs975379 [];										0.0875	0.0375	0.875	11		
chrX	135730555	135730555	T	C	hom	222	CD40LG	synonymous SNV	CD40LG:NM_000074:exon1:c.T148C:p.L50L,	0.19	0.19	0.19	rs1126535 [];					0.1815			300386 [Tumor necrosis factor ligand superfamily, member 5 - Immunodeficiency, X-linked, with hyper-IgM, 308230 (3)];		0.075	0.0375	0.8875	15		
chrX	135741185	135741185	T	C	hom	222	CD40LG			0.26	0.26	0.26	rs3092923 [];					0.0914			300386 [Tumor necrosis factor ligand superfamily, member 5 - Immunodeficiency, X-linked, with hyper-IgM, 308230 (3)];		0.025	0.025	0.95	7		
chrX	135742080	135742083	CCCC	-	hom	71.5	CD40LG			0	0	0									300386 [Tumor necrosis factor ligand superfamily, member 5 - Immunodeficiency, X-linked, with hyper-IgM, 308230 (3)];		0.05	0.0625	0.8875	14		
chrX	135961587	135961587	G	-	het	64.5	RBMX			0.74	0.74	0.74	rs201673579 [];										0	0.55	0.45	77		
chrX	136112707	136112707	A	G	hom	222	GPR101	nonsynonymous SNV	GPR101:NM_054021:exon1:c.T1127C:p.L376P,	0.16	0.16	0.16	rs5931046 [];	0.7680	0.0046	0.2200	0.7010	0.1476					0.125	0	0.875	22		
chrX	137793424	137793424	C	-	hom	89.6	FGF13			1	1	1	rs5903979 [];										0.725	0	0.275	66		
chrX	137793449	137793449	C	G	hom	43.1	FGF13			0.99	0.99	0.99	rs5012047 [];										0.775	0	0.225	72		
chrX	137793455	137793455	T	G	hom	29.1	FGF13			1	1	1	rs5012046 [];										0.6875	0	0.3125	65		
chrX	137793458	137793458	T	A	hom	22.3	FGF13			1	1	1	rs5012045 [];										0.675	0	0.325	64		
chrX	137793568	137793568	-	GTGCCGCGCGGA	hom	85.4	FGF13			0	0	0								228			0	0	1	0		
chrX	137793642	137793642	C	G	hom	185	FGF13			1	1	1	rs12849923 [];							228			0.9375	0	0.0625	88		
chrX	137793653	137793653	C	G	hom	200	FGF13			1	1	1	rs12849929 [];							228			0.9375	0	0.0625	88		
chrX	137793835	137793835	G	A	hom	222	FGF13			0.09	0.09	0.09	rs187191248 [];										0.1	0.025	0.875	11		
chrX	138633280	138633280	A	G	hom	222	F9	nonsynonymous SNV	F9:NM_000133:exon6:c.A580G:p.T194A,	0.16	0.16	0.16	rs6048 [];	-0.1180	0.0695	0.5400	0.0080	0.2983				RCV000011334.1 [other]; 	0.2625	0.075	0.6625	74		
chrX	138724725	138724725	G	A	hom	222	MCF2			1	1	1	rs926563 [];										0.9375	0	0.0625	119		
chrX	138809002	138809002	T	C	hom	222	ATP11C			0.76	0.76	0.76	rs2805901 [];										0.925	0	0.075	89		
chrX	138811003	138811003	G	A	hom	222	ATP11C			0.95	0.95	0.95	rs2094702 [];					0.9992					0.975	0	0.025	121		
chrX	138825675	138825675	T	C	hom	215	ATP11C			0.99	0.99	0.99	rs1268015 [];					0.9998					0.4375	0	0.5625	67		
chrX	138897130	138897130	A	C	hom	222	ATP11C	nonsynonymous SNV	ATP11C:NM_001010986:exon5:c.T342G:p.C114W,ATP11C:NM_173694:exon5:c.T342G:p.C114W,	0.99	0.99	0.99	rs2491014 [];	0.9710	0.0000	1.0000	0.0000	0.9778					0.9125	0	0.0875	131		
chrX	139099429	139099429	T	G	hom	222	CXorf66;LOC389895		CXorf66:dist=51752;LOC389895:dist=74397	0.94	0.94	0.94	rs5907565 [];										0.9625	0	0.0375	89		
chrX	139099699	139099699	C	T	hom	197	CXorf66;LOC389895		CXorf66:dist=52022;LOC389895:dist=74127	0.76	0.76	0.76	rs56013383 [];										0.3375	0.0375	0.625	40		
chrX	139099828	139099828	T	A	hom	222	CXorf66;LOC389895		CXorf66:dist=52151;LOC389895:dist=73998	0.95	0.95	0.95	rs5909002 [];										0.9	0	0.1	84		
chrX	139100148	139100148	A	C	hom	44	CXorf66;LOC389895		CXorf66:dist=52471;LOC389895:dist=73678	0.68	0.68	0.68	rs17402 [];										0.5375	0.025	0.4375	51		
chrX	139100293	139100293	G	A	hom	36	CXorf66;LOC389895		CXorf66:dist=52616;LOC389895:dist=73533	0	0	0	rs17400 [];										0	0.075	0.925	7		
chrX	139795904	139795904	C	G	hom	222	RP1-177G6.2			0.0036	0.0036	0.0036	rs141725862 [];	-1.6550			0.0020						0.025	0	0.975	2		
chrX	139863318	139863318	C	T	hom	222	RP1-177G6.2;CDR1		2:dist=66322;CDR1:dist=2107	0.88	0.88	0.88	rs5907055 [];										0.9625	0	0.0375	89		
chrX	140270418	140270418	T	C	hom	222	LDOC1			0.64	0.64	0.64	rs710106 [];										0.4625	0.1125	0.425	55		
chrX	140271268	140271268	G	C	hom	222	LDOC1			0.66	0.66	0.66	rs2038375 [];										0.4625	0.1	0.4375	52		
chrX	140336486	140336486	T	C	hom	11.3	SPANXC			0.17	0.17	0.17	rs192318327 [];					0.0909		2783			0.075	0	0.925	8		
chrX	140336497	140336497	C	A	hom	11.3	SPANXC			0	0	0								2783			0.075	0	0.925	8		
chrX	140336502	140336502	G	A	hom	11.3	SPANXC			0.11	0.11	0.11	rs184514288 [];					0.0784		2783			0.0625	0	0.9375	6		
chrX	140336540	140336540	T	A	hom	82	SPANXC	nonsynonymous SNV	SPANXC:NM_022661:exon1:c.A51T:p.E17D,	0.1	0.1	0.1	rs3179143 [];	0.2760	0.0000	0.7600	0.0010						0.225	0.0125	0.7625	33		
chrX	140336615	140336615	T	A	hom	222	SPANXC			0.16	0.16	0.16	rs55683664 [];					0.1796					0.2375	0	0.7625	34		
chrX	140714231	140714231	A	G	hom	222	SPANXA2-OT1			0.3	0.3	0.3	rs2239834 [];										0.2125	0.0375	0.75	22		
chrX	140714251	140714251	A	G	hom	222	SPANXA2-OT1			0.3	0.3	0.3	rs2239835 [];										0.2125	0.0375	0.75	22		
chrX	140714769	140714769	A	G	hom	222	SPANXA2-OT1			0.3	0.3	0.3	rs2239837 [];										0.2	0.05	0.75	22		
chrX	140714777	140714777	G	C	hom	222	SPANXA2-OT1			0.28	0.28	0.28	rs2239838 [];										0.15	0.0375	0.8125	17		
chrX	140785855	140785855	A	G	het	225	SPANXD;SPANXE			0.15	0.15	0.15	rs146412887 [];										0	0.0875	0.9125	22		
chrX	140983031	140983031	A	G	hom	193	MAGEC3			0.81	0.81	0.81	rs176023 [];					0.9845					0.4125	0	0.5875	72		
chrX	140983064	140983064	G	A	hom	222	MAGEC3	nonsynonymous SNV	MAGEC3:NM_138702:exon5:c.G919A:p.A307T,	0.76	0.76	0.76	rs176024 [];	-0.5680	0.0002	0.1300	0.0000	0.9518					0.8375	0.0125	0.15	131		
chrX	140983103	140983103	C	T	hom	222	MAGEC3	synonymous SNV	MAGEC3:NM_138702:exon5:c.C958T:p.L320L,	0.25	0.25	0.25	rs176025 [];					0.2629					0.225	0.025	0.75	44		
chrX	140983127	140983127	G	A	hom	222	MAGEC3	nonsynonymous SNV	MAGEC3:NM_138702:exon5:c.G982A:p.A328T,	0.68	0.68	0.68	rs176026 [];	0.6230	0.0000	0.4600	0.8110	0.9291					0.825	0.025	0.15	133		
chrX	140993264	140993264	G	A	hom	222	MAGEC1	nonsynonymous SNV	MAGEC1:NM_005462:exon4:c.G74A:p.C25Y,	0.15	0.15	0.15	rs176036 [];	-1.1720	0.0005	0.1500	0.3840	0.2079					0.1625	0.075	0.7625	44		
chrX	140993642	140993642	C	T	hom	222	MAGEC1	nonsynonymous SNV	MAGEC1:NM_005462:exon4:c.C452T:p.T151I,	0.33	0.33	0.33	rs176037 [];	0.0000	0.0000	0.4400	0.1270	0.4527					0.45	0.0375	0.5125	75		
chrX	140993852	140993852	C	G	het	14.2	MAGEC1	nonsynonymous SNV	MAGEC1:NM_005462:exon4:c.C662G:p.T221S,	0	0	0	rs176038 [];	-2.4900	0.0000	0.8100	0.0010						0.0125	0.475	0.5125	78		
chrX	140993905	140993905	C	T	het	26	MAGEC1	nonsynonymous SNV	MAGEC1:NM_005462:exon4:c.C715T:p.P239S [2(stomach)]; 	0.41	0.41	0.41	rs176040 [];	-2.2120	0.0001	0.7300	0.0000		150830 [2(stomach)]; 				0.225	0.3	0.475	77		
chrX	140993913	140993913	C	G	het	105	MAGEC1	synonymous SNV	MAGEC1:NM_005462:exon4:c.C723G:p.S241S [1(stomach)]; 	0	0	0	rs176041 [];						150831 [1(stomach)]; 				0.25	0.3125	0.4375	83		
chrX	140993945	140993945	T	C	hom	25	MAGEC1	nonsynonymous SNV	MAGEC1:NM_005462:exon4:c.T755C:p.F252S,	0	0	0	rs145765891 [];	-2.2020	0.0002	0.6500	0.0010	0.3661					0.3375	0.0375	0.625	45		
chrX	140993947	140993947	T	C	hom	25	MAGEC1	nonsynonymous SNV	MAGEC1:NM_005462:exon4:c.T757C:p.S253P,	0	0	0	rs148942485 [];	0.0460	0.0027	1.0000	0.2530	0.3633					0.35	0.0375	0.6125	47		
chrX	140993989	140993989	T	C	hom	222	MAGEC1	nonsynonymous SNV	MAGEC1:NM_005462:exon4:c.T799C:p.S267P,	0.38	0.38	0.38	rs77648555 [];	-1.8340	0.0001	1.0000	0.0000	0.5422					0.375	0.1	0.525	76		
chrX	140994037	140994037	C	A	hom	222	MAGEC1	nonsynonymous SNV	MAGEC1:NM_005462:exon4:c.C847A:p.L283I,	0.36	0.36	0.36	rs176045 [];	-1.6190	0.0000	0.4200	0.0100						0.2625	0.2125	0.525	71		
chrX	140994136	140994136	T	C	het	7.8	MAGEC1	synonymous SNV	MAGEC1:NM_005462:exon4:c.T946C:p.L316L,	0	0	0	rs78484597 [];										0.0125	0.3625	0.625	50		
chrX	140994171	140994171	C	G	hom	222	MAGEC1	nonsynonymous SNV	MAGEC1:NM_005462:exon4:c.C981G:p.H327Q,	0.68	0.68	0.68	rs176047 [];	-2.3540	0.0001	1.0000	0.0000	0.7289					0.675	0.05	0.275	110		
chrX	140994407	140994407	C	G	hom	222	MAGEC1	nonsynonymous SNV	MAGEC1:NM_005462:exon4:c.C1217G:p.S406C,	0.06	0.06	0.06	rs62611965 [];	0.1480	0.0023	0.0100	0.7070	0.0942					0.0375	0.0125	0.95	13		
chrX	140994419	140994419	T	C	hom	222	MAGEC1	nonsynonymous SNV	MAGEC1:NM_005462:exon4:c.T1229C:p.I410T,	0.06	0.06	0.06	rs138268726 [];	0.1270	0.0024	0.0200	0.0630	0.0943					0.0375	0.0125	0.95	13		
chrX	140994517	140994517	C	G	hom	222	MAGEC1	nonsynonymous SNV	MAGEC1:NM_005462:exon4:c.C1327G:p.L443V,	0.07	0.07	0.07	rs62611966 [];	0.1570	0.0007	0.0000	0.1760	0.0994					0.0375	0.0125	0.95	13		
chrX	140995315	140995315	C	T	hom	222	MAGEC1	nonsynonymous SNV	MAGEC1:NM_005462:exon4:c.C2125T:p.H709Y,	0.07	0.07	0.07	rs56256227 [];	-1.0950	0.0001	0.0000	0.0000	0.0985					0.0375	0.0125	0.95	13		
chrX	140996672	140996672	C	T	hom	222	MAGEC1			0.07	0.07	0.07	rs41300301 [];										0.0375	0.0125	0.95	5		
chrX	141290865	141290865	C	T	hom	222	MAGEC2	synonymous SNV	MAGEC2:NM_016249:exon3:c.G909A:p.P303P,	0.73	0.73	0.73	rs3765272 [];					0.7001					0.6375	0.0375	0.325	105		
chrX	141293039	141293039	T	C	hom	222	MAGEC2			0.66	0.66	0.66	rs11095951 [];										0.6125	0.0375	0.35	64		
chrX	142122058	142122058	T	G	hom	222	SPANXN4			0.33	0.33	0.33	rs62601929 [];					0.3160					0.0875	0.075	0.8375	28		
chrX	142122140	142122140	A	C	hom	222	SPANXN4			0.38	0.38	0.38	rs35294720 [];										0.0875	0.0875	0.825	20		
chrX	142795225	142795225	G	A	hom	222	SPANXN2	synonymous SNV	SPANXN2:NM_001009615:exon2:c.C453T:p.D151D,	0.65	0.65	0.65	rs3859898 [];					0.5525					0.625	0.0625	0.3125	95		
chrX	142795697	142795697	T	G	hom	222	SPANXN2			0.59	0.59	0.59	rs67375287 [];										0.275	0.05	0.675	33		
chrX	142795709	142795709	G	T	hom	222	SPANXN2			0.7	0.7	0.7	rs12389451 [];										0.275	0.05	0.675	33		
chrX	142804305	142804305	-	T	hom	214	SPANXN2			0	0	0	rs66592761 [];										0.6	0.025	0.375	63		
chrX	142804326	142804326	C	T	hom	222	SPANXN2			0.59	0.59	0.59	rs851091 [];										0.6375	0.0625	0.3	68		
chrX	142804493	142804493	T	C	hom	222	SPANXN2			0.62	0.62	0.62	rs851090 [];										0.6375	0.0625	0.3	67		
chrX	142967468	142967468	T	G	hom	222	UBE2NL	stopgain SNV	UBE2NL:NM_001012989:exon1:c.T266G:p.L89X,	0.62	0.62	0.62	rs237520 [];	0.6950	1.0000	1.0000		0.6738					0.625	0.025	0.35	97		
chrX	142968008	142968012	TTTAT	-	hom	214	UBE2NL			0.58	0.58	0.58	rs201920118 [];										0.5875	0.025	0.3875	58		
chrX	142968082	142968082	A	C	hom	222	UBE2NL			0.59	0.59	0.59	rs237521 [];										0.5875	0.025	0.3875	59		
chrX	144337667	144337667	C	A	hom	222	SPANXN1			0.87	0.87	0.87	rs485945 [];										0.375	0.0375	0.5875	45		
chrX	144902644	144902644	-	CACACACACA	hom	214	SLITRK2			0	0	0								389			0.2125	0.0125	0.775	24		
chrX	144904882	144904882	T	C	hom	222	SLITRK2	synonymous SNV	SLITRK2:NM_001144006:exon3:c.T939C:p.P313P,SLITRK2:NM_001144003:exon5:c.T939C:p.P313P,SLITRK2:NM_001144008:exon3:c.T939C:p.P313P,SLITRK2:NM_032539:exon5:c.T939C:p.P313P,SLITRK2:NM_001144009:exon2:c.T939C:p.P313P,SLITRK2:NM_001144004:exon5:c.T939C:p.P313P,SLITRK2:NM_001144010:exon3:c.T939C:p.P313P,SLITRK2:NM_001144005:exon5:c.T939C:p.P313P,	0.94	0.94	0.94	rs2748588 [];					0.8644					0.7625	0.0375	0.2	127		
chrX	144906710	144906713	CTTT	-	het	37.8	SLITRK2			0	0	0								231			0.025	0.0125	0.9625	3		
chrX	144910142	144910142	G	A	hom	222	TMEM257			0.53	0.53	0.53	rs5919909 [];										0.5125	0.0625	0.425	58		
chrX	144910936	144910936	C	T	hom	222	TMEM257			0.93	0.93	0.93	rs2474402 [];										0.775	0.0375	0.1875	80		
chrX	144911518	144911518	-	AATG	hom	214	TMEM257			0	0	0	rs33973705 [];										0.2875	0.0375	0.675	36		
chrX	147003564	147003564	T	C	hom	222	FMR1-AS1			1	1	1	rs1270092 [];								309550 [FMR1 gene - Fragile X syndrome, 300624 (3); Fragile X tremor/ataxia syndrome,300623 (3)];		0.4375	0	0.5625	87		
chrX	147026331	147026331	C	-	hom	108	FMR1			0.97	0.97	0.97	rs11293471 [];								309550 [FMR1 gene - Fragile X syndrome, 300624 (3); Fragile X tremor/ataxia syndrome,300623 (3)];		0.425	0	0.575	45		
chrX	147088249	147088249	C	T	hom	222	FMR1NB	nonsynonymous SNV	FMR1NB:NM_152578:exon3:c.C425T:p.A142V,	0.45	0.45	0.45	rs764631 [];	-0.4520	0.0002	1.0000	0.0010	0.3676					0.3875	0.0625	0.55	71		
chrX	147106677	147106677	C	A	hom	198	FMR1NB			1	1	1	rs215110 [];										0.4375	0	0.5625	46		
chrX	147108312	147108312	A	G	hom	222	FMR1NB			0.98	0.98	0.98	rs215112 [];										0.3875	0.025	0.5875	43		
chrX	147134441	147134441	-	C	hom	77.5	FMR1NB;AFF2		FMR1NB:dist=26254;AFF2:dist=447698	0	0	0	rs56076756 [];										0.7125	0.025	0.2625	68		
chrX	147891558	147891558	T	C	hom	203	AFF2			0.95	0.95	0.95	rs11117555 [];								300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.425	0	0.575	44		
chrX	147967552	147967552	G	T	hom	222	AFF2			0.03	0.03	0.03	rs41299108 [];					0.0614			300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.0375	0	0.9625	6		
chrX	148035345	148035346	AC	-	het	27.5	AFF2			0	0	0	rs10608807 [];							309	300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0	0.1125	0.8875	10		
chrX	148037055	148037055	G	C	hom	192	AFF2			0.75	0.75	0.75	rs16994868 [];								300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.4125	0.0125	0.575	44		
chrX	148055144	148055144	A	G	hom	222	AFF2			0.96	0.96	0.96	rs5980615 [];					0.9993			300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.9625	0	0.0375	210		
chrX	148062377	148062377	G	A	hom	222	AFF2			0.63	0.63	0.63	rs12688573 [];					0.7206			300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.2875	0.0375	0.675	56		
chrX	148079639	148079639	A	C	hom	222	AFF2			0.87	0.87	0.87	rs16994920 [];								300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.925	0.0125	0.0625	150		
chrX	148079740	148079740	A	C	hom	222	AFF2			0.86	0.86	0.86	rs58901446 [];								300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.9375	0	0.0625	149		
chrX	148079877	148079877	T	C	hom	222	AFF2			0.83	0.83	0.83	rs16994922 [];								300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.9375	0	0.0625	150		
chrX	148081110	148081111	GT	-	het	17.5	AFF2			0	0	0								222	300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0	0.7375	0.2625	110		
chrX	148081140	148081140	A	G	hom	222	AFF2			0.91	0.91	0.91	rs184050542 [];							222	300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.9375	0	0.0625	153		
chrX	148081451	148081451	A	G	hom	222	AFF2			1	1	1	rs141776682 [];								300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.9875	0	0.0125	156		
chrX	148614478	148614478	C	T	hom	119	LOC100131434			0.8	0.8	0.8	rs2272561 [];								300823 [Iduronate 2-sulfatase (Hunter syndrome) - Mucopolysaccharidosis II, 309900 (3)];		0.8375	0.0125	0.15	81		
chrX	148614589	148614589	G	A	hom	185	LOC100131434			0.79	0.79	0.79	rs145413300 [];								300823 [Iduronate 2-sulfatase (Hunter syndrome) - Mucopolysaccharidosis II, 309900 (3)];		0.85	0	0.15	82		
chrX	148621334	148621334	G	C	hom	222	LOC100131434			0.84	0.84	0.84	rs12116320 [];										0.3625	0.05	0.5875	43		
chrX	148622385	148622385	G	C	hom	222	CXorf40A			1	1	1	rs113049484 [];										0.4375	0	0.5625	46		
chrX	148622398	148622398	C	G	hom	222	CXorf40A			0.96	0.96	0.96	rs112658167 [];										0.4375	0	0.5625	46		
chrX	148622508	148622508	A	C	hom	222	CXorf40A			0.99	0.99	0.99	rs111314546 [];										0.4375	0	0.5625	46		
chrX	148622539	148622539	C	T	hom	222	CXorf40A			0.11	0.11	0.11	rs41302150 [];										0.2	0.0125	0.7875	21		
chrX	148622730	148622730	G	A	hom	222	CXorf40A			0.84	0.84	0.84	rs3747443 [];										0.85	0.05	0.1	90		
chrX	148622745	148622745	T	A	hom	222	CXorf40A			0.84	0.84	0.84	rs3747442 [];										0.85	0.05	0.1	90		
chrX	148627384	148627384	A	G	hom	193	CXorf40A	nonsynonymous SNV	CXorf40A:NM_001171909:exon3:c.A208G:p.T70A,CXorf40A:NM_001171908:exon4:c.A208G:p.T70A,CXorf40A:NM_178124:exon4:c.A208G:p.T70A,CXorf40A:NM_001171907:exon4:c.A208G:p.T70A,	0.91	0.91	0.91	rs145921071 [];	-0.0490	0.0000	0.6800	0.0000						0.9375	0	0.0625	139		
chrX	148627504	148627504	C	G	hom	152	CXorf40A			0	0	0	rs200394392 [];										0.0875	0	0.9125	10		
chrX	148628490	148628490	A	T	hom	192	CXorf40A	synonymous SNV	CXorf40A:NM_001171908:exon5:c.A459T:p.P153P,CXorf40A:NM_178124:exon5:c.A459T:p.P153P,CXorf40A:NM_001171907:exon5:c.A459T:p.P153P,	0	0	0	rs12116111 [];										0.9875	0	0.0125	167		
chrX	148851538	148851538	A	G	het	67	MAGEA11;HSFX1		MAGEA11:dist=52610;HSFX1:dist=4188	0.81	0.81	0.81	rs148144905 [];										0.075	0.0375	0.8875	10		
chrX	148853820	148853820	-	CCC	hom	26.5	MAGEA11;HSFX1		MAGEA11:dist=54892;HSFX1:dist=1906	0	0	0											0.05	0	0.95	4		
chrX	148853831	148853831	C	T	hom	56.2	MAGEA11;HSFX1		MAGEA11:dist=54903;HSFX1:dist=1895	0	0	0											0.0125	0.0375	0.95	5		
chrX	149013727	149013727	A	G	hom	222	MAGEA8	synonymous SNV	MAGEA8:NM_001166401:exon3:c.A681G:p.A227A,MAGEA8:NM_001166400:exon4:c.A681G:p.A227A,MAGEA8:NM_005364:exon3:c.A681G:p.A227A,	0.87	0.87	0.87	rs5983916 [];					0.7948					0.775	0.025	0.2	127		
chrX	149109123	149109123	C	A	hom	222	LOC100272228			0.99	0.99	0.99	rs28454191 [];										0.4375	0	0.5625	46		
chrX	149391902	149391902	G	A	hom	222	LOC100272228;MIR2114		LOC100272228:dist=206884;MIR2114:dist=4337	0.26	0.26	0.26	rs12399776 [];										0.1125	0.0375	0.85	19		
chrX	149680221	149680221	G	C	hom	222	MAMLD1			0.61	0.61	0.61	rs659188 [];										0.225	0.0625	0.7125	31		
chrX	149680554	149680554	C	T	hom	222	MAMLD1	synonymous SNV	MAMLD1:NM_001177465:exon5:c.C2208T:p.S736S,	0.6	0.6	0.6	rs2070779 [];										0.5	0.0875	0.4125	57		
chrX	149680832	149680832	C	T	hom	222	MAMLD1	nonsynonymous SNV	MAMLD1:NM_001177465:exon5:c.C2486T:p.A829V,	0.01	0.01	0.01	rs186833799 [];	-0.7750	0.0191	0.5500	0.0000						0.0625	0	0.9375	5		
chrX	149681925	149681925	T	C	hom	222	MAMLD1			0.62	0.62	0.62	rs567517 [];										0.6	0.0875	0.3125	67		
chrX	149826503	149826503	G	A	hom	222	MTM1		MTM1:NM_000252:exon11:c.1260+3G>A	0.58	0.58	0.58	rs222410 [];					0.4987			300415 [Myotubularin - Myotubular myopathy, X-linked, 310400 (3)];		0.45	0.075	0.475	129		
chrX	149931106	149931106	C	T	hom	222	MTMR1	synonymous SNV	MTMR1:NM_003828:exon15:c.C1902T:p.G634G,	0.85	0.85	0.85	rs16995747 [];					0.8796					0.825	0.05	0.125	131		
chrX	149933128	149933128	G	-	hom	90.5	MTMR1			0	0	0											0.9	0.025	0.075	90		
chrX	149933415	149933415	-	AAGTA	hom	214	MTMR1			0	0	0											0.05	0.0125	0.9375	6		
chrX	149935100	149935100	T	C	hom	222	CD99L2			0.49	0.49	0.49	rs6877 [];										0.575	0.0625	0.3625	62		
chrX	149936748	149936748	C	G	hom	222	CD99L2			0.27	0.27	0.27	rs5925425 [];										0.3375	0.075	0.5875	36		
chrX	150344067	150344067	T	C	hom	222	GPR50			0.29	0.29	0.29	rs736752 [];										0.475	0.075	0.45	48		
chrX	150344148	150344148	T	C	hom	222	GPR50			0.14	0.14	0.14	rs5969987 [];										0.25	0.1	0.65	31		
chrX	150344434	150344434	A	C	hom	222	GPR50			0.39	0.39	0.39	rs573861 [];										0.325	0.1125	0.5625	39		
chrX	150348228	150348228	C	T	hom	222	GPR50			0.79	0.79	0.79	rs1202874 [];					0.8839					0.3625	0	0.6375	67		
chrX	150349871	150349871	A	G	hom	222	GPR50	nonsynonymous SNV	GPR50:NM_004224:exon2:c.A1816G:p.I606V,	0.31	0.31	0.31	rs13440581 [];	0.4930	0.0239	0.0800	0.0020	0.5834					0.5	0.0625	0.4375	89		
chrX	150789690	150789690	C	T	hom	195	PASD1			0.8	0.8	0.8	rs5924976 [];										0.3875	0	0.6125	41		
chrX	150789767	150789767	C	T	hom	222	PASD1			0.91	0.91	0.91	rs5924653 [];										0.4375	0	0.5625	46		
chrX	150789950	150789950	C	T	hom	222	PASD1		PASD1:NM_173493:exon6:c.308-4C>T	0.8	0.8	0.8	rs945815 [];					0.9237					0.85	0.0125	0.1375	126		
chrX	150868799	150868799	C	G	hom	222	PRRG3			0.3	0.3	0.3	rs4469605 [];										0.1375	0.025	0.8375	15		
chrX	150869267	150869267	A	G	hom	222	PRRG3	nonsynonymous SNV	PRRG3:NM_024082:exon4:c.A458G:p.N153S,	0.93	0.93	0.93	rs4323608 [];	0.4060	0.0000		0.0000	0.9340					0.8625	0	0.1375	127		
chrX	150911500	150911500	-	ACACAC	het	116	CNGA2			0	0	0								831			0	0	1	0		
chrX	150911512	150911512	G	A	het	74	CNGA2			0.91	0.91	0.91	rs5924686 [];							831			0.15	0.2625	0.5875	44		
chrX	150911513	150911513	T	C	het	67	CNGA2			0	0	0	rs5924687 [];							831			0.1375	0.275	0.5875	44		
chrX	151092653	151092653	G	A	hom	222	MAGEA4	nonsynonymous SNV	MAGEA4:NM_001011550:exon3:c.G517A:p.A173T,MAGEA4:NM_002362:exon3:c.G517A:p.A173T,MAGEA4:NM_001011548:exon3:c.G517A:p.A173T,MAGEA4:NM_001011549:exon3:c.G517A:p.A173T,	0.53	0.53	0.53	rs1047251 [];	-0.6600	0.0000		0.0030	0.5430					0.5375	0.0375	0.425	93		
chrX	151123384	151123384	G	A	hom	222	GABRE	nonsynonymous SNV	GABRE:NM_004961:exon9:c.C1310T:p.P437L,	0.03	0.03	0.03	rs45439991 [];	0.4020		0.0500	0.5870	0.0532					0.0375	0	0.9625	7		
chrX	151129822	151129822	G	A	hom	222	GABRE	synonymous SNV	GABRE:NM_004961:exon5:c.C579T:p.A193A,	0.28	0.28	0.28	rs2256882 [];					0.1225					0.1125	0.0625	0.825	24		
chrX	151282592	151282592	T	A	hom	222	MAGEA10-MAGEA5;MAGEA5			0.77	0.77	0.77	rs2471978 [];										0.775	0.025	0.2	78		
chrX	151282610	151282610	G	A	hom	222	MAGEA10-MAGEA5;MAGEA5			0.99	0.99	0.99	rs210571 [];										0.95	0	0.05	91		
chrX	151282657	151282657	G	C	hom	222	MAGEA10-MAGEA5;MAGEA5			0.81	0.81	0.81	rs2452124 [];										0.7625	0.025	0.2125	77		
chrX	151283004	151283004	G	C	hom	222	MAGEA10-MAGEA5;MAGEA5			0.99	0.99	0.99	rs210573 [];										0.9875	0	0.0125	98		
chrX	151283336	151283336	T	C	hom	222	MAGEA10-MAGEA5;MAGEA5			0.78	0.78	0.78	rs3565 [];						COSN414020 [1(urinary_tract)]; 				0.7875	0.025	0.1875	82		
chrX	151283437	151283441	TTATC	-	hom	214	MAGEA10-MAGEA5;MAGEA5			0	0	0	rs67540048 [];										0.8125	0.025	0.1625	84		
chrX	151283567	151283567	A	T	hom	222	MAGEA10-MAGEA5;MAGEA5			0.98	0.98	0.98	rs210575 [];										1	0	0	100		
chrX	151283599	151283599	T	G	hom	222	MAGEA10-MAGEA5;MAGEA5			1	1	1	rs210576 [];					0.9999					1	0	0	126		
chrX	151286320	151286320	A	G	hom	215	MAGEA10-MAGEA5;MAGEA5			0.8	0.8	0.8	rs6627537 [];										0.3375	0.025	0.6375	38		
chrX	151303393	151303393	C	T	hom	222	MAGEA10	nonsynonymous SNV	MAGEA10:NM_001251828:exon5:c.G700A:p.V234I,MAGEA10:NM_021048:exon4:c.G700A:p.V234I,MAGEA10:NM_001011543:exon5:c.G700A:p.V234I,	0.99	0.99	0.99	rs210586 [];	0.2920	0.0000	1.0000	0.0020	0.9997					0.975	0	0.025	144		
chrX	151303596	151303596	C	T	hom	222	MAGEA10	nonsynonymous SNV	MAGEA10:NM_001251828:exon5:c.G497A:p.R166K,MAGEA10:NM_021048:exon4:c.G497A:p.R166K,MAGEA10:NM_001011543:exon5:c.G497A:p.R166K,	0.96	0.96	0.96	rs210585 [];	-1.5200	0.0000	1.0000	0.0060	0.9994					0.9875	0	0.0125	143		
chrX	151560868	151560868	G	A	hom	222	GABRA3			0.41	0.41	0.41	rs5970292 [];										0.1875	0.075	0.7375	28		
chrX	151619708	151619708	T	G	hom	222	GABRA3			0.65	0.65	0.65	rs7391474 [];										0.7625	0.075	0.1625	81		
chrX	151619799	151619800	CT	-	hom	131	GABRA3			0	0	0	rs67603066 [];							417			0.4125	0.2	0.3875	57		
chrX	151817912	151817912	C	G	hom	216	GABRQ			0.09	0.09	0.09	rs4478723 [];										0.0625	0.025	0.9125	9		
chrX	151817969	151817969	G	C	hom	222	GABRQ			0.09	0.09	0.09	rs5924752 [];							322			0.0625	0.025	0.9125	9		
chrX	151818008	151818008	C	T	hom	222	GABRQ			0.44	0.44	0.44	rs5924753 [];							322			0.275	0.025	0.7	31		
chrX	151821277	151821277	T	A	hom	222	GABRQ	nonsynonymous SNV	GABRQ:NM_018558:exon9:c.T1432A:p.F478I,	0.46	0.46	0.46	rs3810651 [];	-4.3390	0.0000	1.0000	0.0000						0.5625	0.05	0.3875	97		
chrX	151869745	151869745	C	T	hom	222	MAGEA6	synonymous SNV	MAGEA6:NM_175868:exon3:c.C435T:p.Y145Y,MAGEA6:NM_005363:exon3:c.C435T:p.Y145Y,	0.14	0.14	0.14	rs7057497 [];					0.1577					0.1125	0.025	0.8625	23		
chrX	151869765	151869765	G	T	hom	222	MAGEA6	nonsynonymous SNV	MAGEA6:NM_175868:exon3:c.G455T:p.S152I,MAGEA6:NM_005363:exon3:c.G455T:p.S152I,	0.11	0.11	0.11	rs7056365 [];	0.5730	0.0190	0.1000	0.2160	0.1589					0.1125	0.025	0.8625	24		
chrX	151870574	151870574	T	C	het	14.2	MAGEA6			0	0	0	rs1047232 [];										0.0625	0.0375	0.9	9		
chrX	151870578	151870578	G	A	het	18.1	MAGEA6			0	0	0	rs1047234 [];										0.075	0.025	0.9	10		
chrX	151884493	151884493	C	T	hom	35	MAGEA2			0	0	0	rs5742344 [];										0.0875	0	0.9125	7		
chrX	151896029	151896029	A	G	hom	222	CSAG4			0.54	0.54	0.54	rs2515827 [];										0.5	0.0625	0.4375	53		
chrX	151899355	151899355	T	C	hom	222	MAGEA12			0.54	0.54	0.54	rs2471773 [];										0.4875	0.0625	0.45	53		
chrX	151899760	151899760	A	G	hom	222	MAGEA12			0.99	0.99	0.99	rs2515830 [];										0.9875	0	0.0125	96		
chrX	151899789	151899789	G	A	hom	222	MAGEA12			0.54	0.54	0.54	rs3005 [];										0.5	0.0625	0.4375	56		
chrX	151899818	151899818	C	T	hom	222	MAGEA12			0.53	0.53	0.53	rs2233056 [];					0.6012					0.4875	0.0625	0.45	67		
chrX	151900967	151900967	G	C	hom	222	CSAG4			0.55	0.55	0.55	rs2471774 [];										0.1875	0.0375	0.775	25		
chrX	151903140	151903140	A	G	hom	222	MAGEA12			0.54	0.54	0.54	rs2515836 [];										0.4875	0.0625	0.45	52		
chrX	151908844	151908844	A	T	hom	222	CSAG1	nonsynonymous SNV	CSAG1:NM_001102576:exon3:c.A83T:p.Y28F,CSAG1:NM_153478:exon4:c.A83T:p.Y28F,	0.09	0.09	0.09	rs1894359 [];	-0.2230	0.0001	0.0800	0.0000	0.1562					0.125	0.025	0.85	26		
chrX	151908845	151908845	C	G	hom	222	CSAG1	stopgain SNV	CSAG1:NM_001102576:exon3:c.C84G:p.Y28X,CSAG1:NM_153478:exon4:c.C84G:p.Y28X,	0.09	0.09	0.09	rs1894360 [];	-0.0970		0.2100		0.1573					0.125	0.025	0.85	26		
chrX	151909156	151909156	A	G	hom	222	CSAG1	nonsynonymous SNV	CSAG1:NM_001102576:exon4:c.A185G:p.K62R,CSAG1:NM_153478:exon5:c.A185G:p.K62R,	0.58	0.58	0.58	rs2515848 [];	-0.0980	0.0000	0.2500	0.0000	0.5847					0.5375	0.075	0.3875	97		
chrX	151909490	151909490	A	G	hom	222	CSAG1			0.57	0.57	0.57	rs2515850 [];										0.5625	0.0875	0.35	62		
chrX	151934751	151934751	A	G	het	20	MAGEA3			0	0	0											0	0.1125	0.8875	11		
chrX	151935150	151935150	G	C	hom	222	MAGEA3			0.14	0.14	0.14	rs3567 [];										0.075	0.025	0.9	11		
chrX	152018832	152018832	T	G	hom	222	NSDHL	synonymous SNV	NSDHL:NM_015922:exon3:c.T132G:p.G44G,NSDHL:NM_001129765:exon4:c.T132G:p.G44G,	0.87	0.87	0.87	rs5969919 [];					0.8639			300275 [NAD(P)H steroid dehydrogenase-like protein - CHILD syndrome, 308050 (3); CK syndrome, 300831 (3)];		0.825	0.025	0.15	186		
chrX	152225379	152225379	C	A	hom	222	PNMA3			0.21	0.21	0.21	rs73244173 [];					0.4362		2170			0.325	0.1	0.575	50		
chrX	152226542	152226542	T	C	hom	222	PNMA3	nonsynonymous SNV	PNMA3:NM_013364:exon2:c.T1130C:p.V377A,	0.91	0.91	0.91	rs6526155 [];	-0.8440	0.0010	1.0000	0.0000	0.8577					0.7625	0.05	0.1875	122		
chrX	152228361	152228361	G	A	hom	222	PNMA3			0.23	0.23	0.23	rs1045069 [];										0.3	0.1	0.6	37		
chrX	152228523	152228523	T	C	hom	222	PNMA3			0.81	0.81	0.81	rs9035 [];							271			0.7	0.05	0.25	76		
chrX	152228778	152228778	T	G	hom	222	PNMA3			0.51	0.51	0.51	rs7122 [];										0.55	0.0625	0.3875	60		
chrX	152610051	152610051	A	T	hom	222	ZNF275			0.71	0.71	0.71	rs1467880 [];					0.5094					0.2125	0.0375	0.75	44		
chrX	152610108	152610108	G	C	hom	222	ZNF275			0.71	0.71	0.71	rs1467881 [];					0.5107					0.4875	0.05	0.4625	82		
chrX	152610225	152610233	GTGACCTCT	-	hom	214	ZNF275			0.71	0.71	0.71	rs35024993 [];					0.4866					0.4875	0.05	0.4625	82		
chrX	152610294	152610294	A	G	hom	222	ZNF275			0.71	0.71	0.71	rs1467882 [];										0.2125	0.0375	0.75	26		
chrX	152610947	152610947	T	C	hom	188	ZNF275			0.71	0.71	0.71	rs3213465 [];					0.5103					0.2125	0.0375	0.75	45		
chrX	152611191	152611229	GGGGTCCCAGCTGAGCTCTTGGAGTTGAGGTTAGGGTTT	-	hom	214	ZNF275			0	0	0											0.1375	0.025	0.8375	15		
chrX	152613112	152613112	C	T	hom	222	ZNF275	synonymous SNV	ZNF275:NM_001080485:exon4:c.C969T:p.C323C,	0.71	0.71	0.71	rs7066295 [];					0.5039					0.4875	0.05	0.4625	76		
chrX	152616741	152616741	A	T	hom	222	ZNF275			0.74	0.74	0.74	rs8781 [];										0.55	0.075	0.375	59		
chrX	152728003	152728003	T	C	hom	222	HAUS7			0.5	0.5	0.5	rs3020967 [];					0.3117					0.1625	0.05	0.7875	31		
chrX	152760871	152760871	G	A	hom	114	BGN			0.93	0.93	0.93	rs2980045 [];							240			0.9375	0	0.0625	87		
chrX	152770402	152770402	A	G	hom	222	BGN			0.86	0.86	0.86	rs2980053 [];										0.375	0.025	0.6	43		
chrX	152771509	152771509	C	T	hom	222	BGN	synonymous SNV	BGN:NM_001711:exon4:c.C540T:p.S180S,	0.37	0.37	0.37	rs1126499 [];					0.4660					0.425	0.05	0.525	67		
chrX	152772758	152772758	T	C	hom	114	BGN			0.73	0.73	0.73	rs2269404 [];										0.2625	0.05	0.6875	31		
chrX	152774423	152774423	C	A	hom	222	BGN			0.23	0.23	0.23	rs11538656 [];										0.3375	0.05	0.6125	38		
chrX	152774520	152774521	TG	-	het	20.5	BGN			0	0	0								405			0	0.05	0.95	5		
chrX	152774745	152774745	A	G	hom	222	BGN			0.98	0.98	0.98	rs2980054 [];										0.95	0	0.05	95		
chrX	152807425	152807425	G	A	hom	222	ATP2B3			0.62	0.62	0.62	rs762733 [];					0.8594					0.2875	0.0375	0.675	56		
chrX	152807505	152807507	CTT	-	hom	113	ATP2B3			0	0	0	rs10531880 [];										0.35	0.05	0.6	39		
chrX	152807627	152807627	C	-	hom	25.5	ATP2B3			0	0	0	rs5904365 [];										0.35	0	0.65	32		
chrX	152807665	152807665	A	G	hom	148	ATP2B3			0.95	0.95	0.95	rs2980012 [];										0.4375	0	0.5625	44		
chrX	152807923	152807923	G	C	hom	222	ATP2B3			0.99	0.99	0.99	rs2980013 [];					0.9999					0.4375	0	0.5625	219		
chrX	152814373	152814373	T	C	hom	222	ATP2B3			0.42	0.42	0.42	rs2285034 [];										0.1875	0.0875	0.725	29		
chrX	152815089	152815089	A	G	hom	222	ATP2B3	synonymous SNV	ATP2B3:NM_001001344:exon9:c.A1473G:p.G491G,ATP2B3:NM_021949:exon9:c.A1473G:p.G491G,	0.99	0.99	0.99	rs3020949 [];					0.9999					0.9625	0	0.0375	289		
chrX	152821887	152821887	C	T	hom	222	ATP2B3			0.96	0.96	0.96	rs3020957 [];					0.9994					0.4375	0	0.5625	239		
chrX	152823836	152823836	G	T	hom	222	ATP2B3			0	0	0											0	0	1	0		
chrX	152825414	152825414	G	T	hom	222	ATP2B3			0.91	0.91	0.91	rs3020959 [];					0.9489					0.4	0.0125	0.5875	212		
chrX	152825433	152825433	A	G	hom	222	ATP2B3			0.99	0.99	0.99	rs2980018 [];					0.9987					0.4375	0	0.5625	74		
chrX	152830322	152830322	A	G	hom	147	ATP2B3			0.94	0.94	0.94	rs4243536 [];										0.4	0.0125	0.5875	42		
chrX	152830684	152830684	C	T	hom	81.5	ATP2B3			0.92	0.92	0.92	rs5987097 [];										0.3	0.0125	0.6875	32		
chrX	152846544	152846544	-	TG	hom	60.5	ATP2B3			0	0	0											0.6625	0.0125	0.325	64		
chrX	152847291	152847291	T	C	hom	222	ATP2B3			0.85	0.85	0.85	rs4898425 [];										0.8125	0.05	0.1375	88		
chrX	152847301	152847301	G	C	hom	222	ATP2B3			0.85	0.85	0.85	rs4898426 [];										0.825	0.05	0.125	89		
chrX	152847488	152847488	T	G	hom	222	ATP2B3			0.85	0.85	0.85	rs5945311 [];										0.825	0.05	0.125	85		
chrX	152848425	152848425	A	C	hom	222	ATP2B3			0.85	0.85	0.85	rs5945312 [];										0.3625	0.05	0.5875	43		
chrX	152848459	152848459	T	G	hom	222	ATP2B3			0.85	0.85	0.85	rs5945313 [];										0.3625	0.05	0.5875	43		
chrX	152864481	152864481	-	C	hom	49.4	FAM58A	unknown	UNKNOWN	0	0	0											0.6375	0	0.3625	120		
chrX	152913814	152913814	C	A	hom	222	DUSP9			0.13	0.13	0.13	rs7882888 [];					0.1739					0.125	0.05	0.825	20		
chrX	152916023	152916023	T	G	hom	222	DUSP9			1	1	1	rs6643635 [];										0.9375	0	0.0625	92		
chrX	152916113	152916113	-	CACAGGG	het	209	DUSP9			0	0	0											0.325	0.05	0.625	34		
chrX	152916126	152916126	-	CCCGCCCCTGTCCCCAAGT	het	218	DUSP9			0	0	0											0.1875	0.025	0.7875	19		
chrX	152916237	152916237	-	G	hom	214	DUSP9			0	0	0	rs11407625 [];										0.95	0	0.05	92		
chrX	152935655	152935655	C	T	hom	145	PNCK			0.75	0.75	0.75	rs12848840 [];										0.325	0.0125	0.6625	34		
chrX	152937546	152937546	C	T	hom	222	PNCK			0.003	0.003	0.003	rs200709145 [];					0.0132					0.025	0	0.975	4		
chrX	152961521	152961523	ATT	-	hom	214	SLC6A8			0.03	0.03	0.03	rs200806041 [];								300036 [Solute carrier family 6 (neurotransmitter transporter, creatine), - Creatine deficiency syndrome, X-linked, 300352 (3)];		0.1	0	0.9	16		
chrX	152989830	152989830	A	C	hom	60	BCAP31			0	0	0	rs5987137 [];										0.7125	0	0.2875	64		
chrX	153008911	153008911	C	T	hom	222	ABCD1			0.58	0.58	0.58	rs4898368 [];					0.6245			300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0.2875	0.025	0.6875	75		
chrX	153009197	153009197	G	C	hom	222	ABCD1			0.7	0.7	0.7	rs2229539 [];					0.6915			300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0.6125	0.025	0.3625	185		
chrX	153009448	153009448	A	G	het	73	ABCD1			0	0	0									300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.6625	0.3375	115		
chrX	153009488	153009488	C	T	het	7.8	ABCD1			0	0	0	rs201959080 [];								300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.175	0.825	53		
chrX	153009665	153009665	A	G	het	70	ABCD1			0	0	0									300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.6125	0.3875	108		
chrX	153009670	153009670	G	T	het	116	ABCD1			0	0	0	rs199942817 [];								300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.775	0.225	127		
chrX	153009719	153009719	G	A	het	225	ABCD1			0	0	0	rs67211405 [];								300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.9375	0.0625	146		
chrX	153009735	153009741	GGGAGAG	-	het	81.5	ABCD1			0	0	0									300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.1625	0.8375	42		
chrX	153009876	153009876	G	C	het	9.52	ABCD1			0	0	0									300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.4375	0.5625	101		
chrX	153010059	153010059	G	T	het	155	ABCD1			0	0	0	rs72616452 [];								300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0.0125	0.9375	0.05	142		
chrX	153010066	153010066	C	T	het	186	ABCD1			0	0	0	rs11803 [];								300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.625	0.375	100		
chrX	153010083	153010083	G	A	het	182	ABCD1			0.17	0.17	0.17	rs1055847 [];								300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.45	0.55	76		
chrX	153010090	153010090	G	A	het	149	ABCD1			0	0	0	rs75637470 [];								300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.95	0.05	137		
chrX	153010092	153010092	G	A	het	134	ABCD1			0	0	0	rs78155328 [];								300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.95	0.05	135		
chrX	153010224	153010224	C	T	hom	222	ABCD1			0.7	0.7	0.7	rs6643782 [];										0.3	0.025	0.675	84		
chrX	153010267	153010267	G	A	het	114	ABCD1			0.61	0.61	0.61	rs6643784 [];										0.1	0.2125	0.6875	31		
chrX	153010314	153010314	G	A	het	4.13	ABCD1			0	0	0											0	0.225	0.775	20		
chrX	153034752	153034752	C	T	hom	208	PLXNB3			0.36	0.36	0.36	rs2266877 [];					0.5243					0.1625	0.0125	0.825	31		
chrX	153038516	153038516	C	G	hom	222	PLXNB3			1	1	1	rs5945161 [];										0.4375	0	0.5625	73		
chrX	153039615	153039615	A	G	hom	222	PLXNB3			1	1	1	rs1543781 [];										0.4375	0	0.5625	69		
chrX	153041132	153041132	C	T	hom	222	PLXNB3			0.18	0.18	0.18	rs5945162 [];					0.2156					0.2125	0.05	0.7375	32		
chrX	153044369	153044369	C	A	hom	222	PLXNB3			0.17	0.17	0.17	rs2071121 [];					0.1902					0.075	0.0625	0.8625	16		
chrX	153044806	153044806	G	A	hom	176	PLXNB3			0.3	0.3	0.3	rs58111377 [];							2277			0.1	0.025	0.875	14		
chrX	153045202	153045202	A	G	hom	222	PLXNB3			0.84	0.84	0.84	rs762650 [];										0.7	0.05	0.25	71		
chrX	153045438	153045438	G	A	hom	222	PLXNB3			0.3	0.3	0.3	rs762651 [];							187			0.1	0.025	0.875	14		
chrX	153045812	153045812	C	T	hom	222	SRPK3			0.3	0.3	0.3	rs762652 [];										0.1375	0	0.8625	15		
chrX	153048403	153048403	T	C	hom	222	SRPK3			0.55	0.55	0.55	rs916001 [];					0.3425					0.2875	0.075	0.6375	58		
chrX	153049389	153049389	A	G	hom	222	SRPK3			0.59	0.59	0.59	rs3969088 [];					0.3379					0.1125	0.0625	0.825	33		
chrX	153049391	153049391	A	G	hom	222	SRPK3			0.39	0.39	0.39	rs7052332 [];					0.1575					0.0375	0.0125	0.95	17		
chrX	153049535	153049535	A	G	hom	222	SRPK3	synonymous SNV	SRPK3:NM_014370:exon10:c.A1014G:p.P338P,SRPK3:NM_001170760:exon10:c.A1011G:p.P337P,	0.54	0.54	0.54	rs4898444 [];					0.3496					0.2875	0.075	0.6375	58		
chrX	153050047	153050047	C	G	hom	156	SRPK3			0.38	0.38	0.38	rs5945164 [];										0.0375	0.0125	0.95	7		
chrX	153050984	153050984	G	A	hom	222	SRPK3			0.38	0.38	0.38	rs1802092 [];					0.1623					0.1	0.025	0.875	23		
chrX	153051907	153051907	G	A	hom	130	IDH3G		IDH3G:NM_174869:exon12:c.925-3C>T,NM_004135:exon12:c.925-3C>T	0.41	0.41	0.41	rs2071122 [];					0.2681					0.175	0.075	0.75	43		
chrX	153052649	153052649	C	A	hom	222	IDH3G			0.41	0.41	0.41	rs2071123 [];					0.2652					0.0625	0.05	0.8875	25		
chrX	153052661	153052661	A	G	hom	222	IDH3G			0.95	0.95	0.95	rs2269482 [];										0.425	0	0.575	45		
chrX	153073319	153073319	G	A	hom	222	PDZD4			0.29	0.29	0.29	rs58306331 [];										0.0375	0.0125	0.95	9		
chrX	153073752	153073752	T	C	hom	222	PDZD4			0.89	0.89	0.89	rs3761532 [];										0.4	0	0.6	43		
chrX	153129556	153129556	G	A	hom	222	L1CAM			0.86	0.86	0.86	rs2071127 [];								308840 [L1 cell adhesion molecule - Hydrocephalus due to aqueductal stenosis, 307000 (3); MASA syndrome,303350 (3); CRASH syndrome, 303350 (3); Hydrocephalus with Hirschsprung disease, 307000 (3); Hydrocephalus with congenital idiopathic intestinalpseudoobstruction, 307000 (3); Corpus callosum, partial agenesis of, 304100 (3)];		0.4125	0	0.5875	44		
chrX	153134521	153134521	G	C	hom	169	L1CAM			1	1	1	rs78371277 [];								308840 [L1 cell adhesion molecule - Hydrocephalus due to aqueductal stenosis, 307000 (3); MASA syndrome,303350 (3); CRASH syndrome, 303350 (3); Hydrocephalus with Hirschsprung disease, 307000 (3); Hydrocephalus with congenital idiopathic intestinalpseudoobstruction, 307000 (3); Corpus callosum, partial agenesis of, 304100 (3)];		0.4375	0	0.5625	45		
chrX	153149709	153149709	-	C	hom	214	L1CAM;AVPR2		L1CAM:dist=8310;AVPR2:dist=20820	0	0	0	rs66466703 [];								308840 [L1 cell adhesion molecule - Hydrocephalus due to aqueductal stenosis, 307000 (3); MASA syndrome,303350 (3); CRASH syndrome, 303350 (3); Hydrocephalus with Hirschsprung disease, 307000 (3); Hydrocephalus with congenital idiopathic intestinalpseudoobstruction, 307000 (3); Corpus callosum, partial agenesis of, 304100 (3)];		0.9375	0	0.0625	136		
chrX	153149715	153149715	C	G	hom	222	L1CAM;AVPR2		L1CAM:dist=8316;AVPR2:dist=20814	0	0	0	rs6643650 [];	-2.6770							308840 [L1 cell adhesion molecule - Hydrocephalus due to aqueductal stenosis, 307000 (3); MASA syndrome,303350 (3); CRASH syndrome, 303350 (3); Hydrocephalus with Hirschsprung disease, 307000 (3); Hydrocephalus with congenital idiopathic intestinalpseudoobstruction, 307000 (3); Corpus callosum, partial agenesis of, 304100 (3)];		0.9375	0	0.0625	135		
chrX	153150929	153150929	G	A	hom	222	L1CAM;AVPR2		L1CAM:dist=9530;AVPR2:dist=19600	0.5	0.5	0.5	rs41311376 [];					0.2120			308840 [L1 cell adhesion molecule - Hydrocephalus due to aqueductal stenosis, 307000 (3); MASA syndrome,303350 (3); CRASH syndrome, 303350 (3); Hydrocephalus with Hirschsprung disease, 307000 (3); Hydrocephalus with congenital idiopathic intestinalpseudoobstruction, 307000 (3); Corpus callosum, partial agenesis of, 304100 (3)];		0.0875	0.0125	0.9	10		
chrX	153168407	153168407	G	A	hom	222	L1CAM;AVPR2		L1CAM:dist=27008;AVPR2:dist=2122	0.5	0.5	0.5	rs3761529 [];								300538 [Arginine vasopressin receptor-2 - Diabetes insipidus, nephrogenic, 304800 (3); Nephrogenic syndromeof inappropriate antidiuresis, 300539 (3)];		0.0875	0.025	0.8875	11		
chrX	153168449	153168449	T	C	hom	178	L1CAM;AVPR2		L1CAM:dist=27050;AVPR2:dist=2080	0.59	0.59	0.59	rs3761528 [];								300538 [Arginine vasopressin receptor-2 - Diabetes insipidus, nephrogenic, 304800 (3); Nephrogenic syndromeof inappropriate antidiuresis, 300539 (3)];		0.0875	0.025	0.8875	11		
chrX	153170448	153170448	-	C	hom	214	AVPR2			0	0	0	rs67971735 [];								300538 [Arginine vasopressin receptor-2 - Diabetes insipidus, nephrogenic, 304800 (3); Nephrogenic syndromeof inappropriate antidiuresis, 300539 (3)];		0.975	0	0.025	95		
chrX	153170980	153170980	T	G	hom	115	AVPR2			1	1	1	rs56689668 [];								300538 [Arginine vasopressin receptor-2 - Diabetes insipidus, nephrogenic, 304800 (3); Nephrogenic syndromeof inappropriate antidiuresis, 300539 (3)];		0.9125	0	0.0875	169		
chrX	153171993	153171993	A	G	hom	222	AVPR2	synonymous SNV	AVPR2:NM_000054:exon3:c.A927G:p.L309L,	0.6	0.6	0.6	rs5201 [];	0.2580	0.2772	0.0200		0.2999			300538 [Arginine vasopressin receptor-2 - Diabetes insipidus, nephrogenic, 304800 (3); Nephrogenic syndromeof inappropriate antidiuresis, 300539 (3)];		0.275	0.0625	0.6625	80		
chrX	153174820	153174820	-	G	hom	96	ARHGAP4			0	0	0	rs33963388 [];										0.4375	0	0.5625	73		
chrX	153174869	153174869	-	G	hom	97	ARHGAP4			0	0	0											0.4375	0	0.5625	73		
chrX	153175054	153175054	-	C	hom	60.4	ARHGAP4			0	0	0	rs56015121 [];							211			0.4	0	0.6	38		
chrX	153178460	153178460	-	C	hom	52.4	ARHGAP4			0	0	0	rs5904376 [];										0.425	0	0.575	90		
chrX	153186413	153186413	-	G	hom	181	ARHGAP4			0	0	0	rs34153599 [];										0.4375	0	0.5625	46		
chrX	153186485	153186485	-	C	hom	30.4	ARHGAP4			0	0	0	rs11428457 [];										0.4375	0	0.5625	73		
chrX	153210196	153210196	-	G	hom	116	RENBP			0	0	0											0.8625	0	0.1375	82		
chrX	153215839	153215839	G	A	hom	222	HCFC1	synonymous SNV	HCFC1:NM_005334:exon24:c.C5859T:p.C1953C,	0.29	0.29	0.29	rs3027875 [];	-1.1950				0.6301					0.575	0.0125	0.4125	131		
chrX	153277889	153277889	C	T	hom	132	IRAK1			0.56	0.56	0.56	rs2239673 [];										0.325	0.025	0.65	38		
chrX	153278307	153278307	G	A	hom	190	IRAK1			0.56	0.56	0.56	rs763737 [];										0.3375	0.025	0.6375	38		
chrX	153278829	153278829	G	A	hom	222	IRAK1	nonsynonymous SNV	IRAK1:NM_001569:exon12:c.C1595T:p.S532L,IRAK1:NM_001025243:exon11:c.C1358T:p.S453L,	0.57	0.57	0.57	rs1059703 [];	-0.3780	0.0001	0.3800	0.0000	0.8528					0.7875	0.0375	0.175	133		
chrX	153279822	153279826	TAAAA	-	het	10.8	IRAK1			0	0	0								189			0	0	1	1		
chrX	153279839	153279844	AAAAAA	-	het	13.7	IRAK1			0	0	0								701			0	0.025	0.975	2		
chrX	153284192	153284192	A	G	hom	222	IRAK1	nonsynonymous SNV	IRAK1:NM_001569:exon5:c.T587C:p.F196S,IRAK1:NM_001025243:exon5:c.T587C:p.F196S,IRAK1:NM_001025242:exon5:c.T587C:p.F196S,	0.68	0.68	0.68	rs1059702 [];	0.2350	0.0004	0.4400	0.0010	0.8595					0.8	0.0375	0.1625	126		
chrX	153284483	153284483	G	A	hom	222	IRAK1	synonymous SNV	IRAK1:NM_001569:exon4:c.C483T:p.V161V [1(stomach)]; IRAK1:NM_001025243:exon4:c.C483T:p.V161V [1(stomach)]; IRAK1:NM_001025242:exon4:c.C483T:p.V161V [1(stomach)]; 	0.48	0.48	0.48	rs1059701 [];					0.8039	150839 [1(stomach)]; 				0.7125	0.0375	0.25	114		
chrX	153292180	153292180	T	C	hom	222	MECP2			0.67	0.67	0.67	rs2734647 [];								300005 [Methyl-CpG-binding protein-2 - Rett syndrome, 312750 (3); Mental retardation, X-linked, syndromic13, 300055 (3); Rett syndrome, preserved speech variant, 312750 (3); Encephalopathy, neonatal severe, 300673 (3); {Autism susceptibility, X-linked3}, 300496 (3); Angelman syndrome, 105830 (3); Mental retardation, X-linked, Lubs type, 300260 (3)];		0.8125	0.0375	0.15	132		
chrX	153294542	153294542	T	C	hom	222	MECP2			0.99	0.99	0.99	rs2853337 [];							200	300005 [Methyl-CpG-binding protein-2 - Rett syndrome, 312750 (3); Mental retardation, X-linked, syndromic13, 300055 (3); Rett syndrome, preserved speech variant, 312750 (3); Encephalopathy, neonatal severe, 300673 (3); {Autism susceptibility, X-linked3}, 300496 (3); Angelman syndrome, 105830 (3); Mental retardation, X-linked, Lubs type, 300260 (3)];		0.9375	0	0.0625	155		
chrX	153416537	153416537	A	C	hom	158	OPN1LW			0	0	0	rs78751796 [];										0.4375	0	0.5625	46		
chrX	153461739	153461739	C	T	het	34	OPN1MW			0	0	0	rs45560249 [];										0	0.0125	0.9875	1		
chrX	153553781	153553781	G	A	hom	222	TKTL1			0.27	0.27	0.27	rs4898475 [];					0.1943					0.075	0.0375	0.8875	26		
chrX	153558418	153558418	A	G	hom	222	TKTL1			0.23	0.23	0.23	rs2872817 [];										0.1625	0.0375	0.8	18		
chrX	153579448	153579448	A	G	hom	222	FLNA			0.4	0.4	0.4	rs2070822 [];					0.2199			300017 [Filamin A, alpha (actin-binding protein-280) - Heterotopia, periventricular, 300049 (3); Otopalatodigital syndrome,type I, 311300 (3); Otopalatodigital syndrome, type II, 304120 (3); Intestinal pseudoobstruction, neuronal, 300048 (3); Melnick-Needles syndrome, 309350 (3);Frontometaphyseal dysplasia, 305620 (3); Heterotopia, periventricular, ED variant, 300537 (3); FG syndrome 2, 300321 (3); Cardiac valvular dysplasia, X-linked, 314400 (3); Terminal osseous dysplasia, 300244 (3)];		0.075	0.025	0.9	27		
chrX	153592315	153592315	C	-	hom	190	FLNA			0.18	0.18	0.18	rs148985076 [];								300017 [Filamin A, alpha (actin-binding protein-280) - Heterotopia, periventricular, 300049 (3); Otopalatodigital syndrome,type I, 311300 (3); Otopalatodigital syndrome, type II, 304120 (3); Intestinal pseudoobstruction, neuronal, 300048 (3); Melnick-Needles syndrome, 309350 (3);Frontometaphyseal dysplasia, 305620 (3); Heterotopia, periventricular, ED variant, 300537 (3); FG syndrome 2, 300321 (3); Cardiac valvular dysplasia, X-linked, 314400 (3); Terminal osseous dysplasia, 300244 (3)];		0.075	0.025	0.9	9		
chrX	153595246	153595246	G	C	hom	222	FLNA			0.19	0.19	0.19	rs4898478 [];					0.1958			300017 [Filamin A, alpha (actin-binding protein-280) - Heterotopia, periventricular, 300049 (3); Otopalatodigital syndrome,type I, 311300 (3); Otopalatodigital syndrome, type II, 304120 (3); Intestinal pseudoobstruction, neuronal, 300048 (3); Melnick-Needles syndrome, 309350 (3);Frontometaphyseal dysplasia, 305620 (3); Heterotopia, periventricular, ED variant, 300537 (3); FG syndrome 2, 300321 (3); Cardiac valvular dysplasia, X-linked, 314400 (3); Terminal osseous dysplasia, 300244 (3)];		0.075	0.025	0.9	25		
chrX	153595259	153595259	G	A	hom	222	FLNA			0.18	0.18	0.18	rs4898479 [];					0.1937			300017 [Filamin A, alpha (actin-binding protein-280) - Heterotopia, periventricular, 300049 (3); Otopalatodigital syndrome,type I, 311300 (3); Otopalatodigital syndrome, type II, 304120 (3); Intestinal pseudoobstruction, neuronal, 300048 (3); Melnick-Needles syndrome, 309350 (3);Frontometaphyseal dysplasia, 305620 (3); Heterotopia, periventricular, ED variant, 300537 (3); FG syndrome 2, 300321 (3); Cardiac valvular dysplasia, X-linked, 314400 (3); Terminal osseous dysplasia, 300244 (3)];		0.075	0.025	0.9	25		
chrX	153609616	153609616	G	C	hom	218	EMD			0.17	0.17	0.17	rs17426 [];								300384 [Emerin - Emery-Dreifuss muscular dystrophy 1, X-linked, 310300 (3)];		0.15	0.0375	0.8125	35		
chrX	153609617	153609617	C	T	hom	216	EMD			0.17	0.17	0.17	rs17427 [];								300384 [Emerin - Emery-Dreifuss muscular dystrophy 1, X-linked, 310300 (3)];		0.15	0.0375	0.8125	34		
chrX	153609963	153609963	C	T	hom	222	EMD			0.23	0.23	0.23	rs17428 [];										0.075	0.025	0.9	9		
chrX	153629155	153629155	A	G	hom	222	RPL10	nonsynonymous SNV	RPL10:NM_006013:exon7:c.A605G:p.N202S,RPL10:NM_001256577:exon6:c.A442G:p.I148V,RPL10:NM_001256580:exon6:c.A497G:p.N166S,	0.71	0.71	0.71	rs12012747 [];	1.5890	0.2894	0.4200	0.0020				312173 [Ribosomal protein L10 - {Autism, susceptibility to, X-linked 5}, 300847 (3)];		0.8	0.025	0.175	179		
chrX	153630255	153630255	G	C	hom	222	DNASE1L1;RPL10			0.71	0.71	0.71	rs12877 [];								312173 [Ribosomal protein L10 - {Autism, susceptibility to, X-linked 5}, 300847 (3)];		0.825	0.025	0.15	136		
chrX	153630293	153630293	C	T	hom	222	DNASE1L1;RPL10			0.71	0.71	0.71	rs12559 [];								312173 [Ribosomal protein L10 - {Autism, susceptibility to, X-linked 5}, 300847 (3)];		0.8	0.025	0.175	133		
chrX	153633359	153633359	G	C	hom	222	DNASE1L1	synonymous SNV	DNASE1L1:NM_001009932:exon5:c.C201G:p.P67P,DNASE1L1:NM_006730:exon3:c.C201G:p.P67P,DNASE1L1:NM_001009934:exon3:c.C201G:p.P67P,DNASE1L1:NM_001009933:exon4:c.C201G:p.P67P,	0.73	0.73	0.73	rs1130929 [];					0.8897					0.8125	0.025	0.1625	133		
chrX	153633533	153633533	G	A	hom	163	DNASE1L1			0.73	0.73	0.73	rs28602900 [];										0.3625	0.0125	0.625	40		
chrX	153633953	153633953	T	C	hom	222	DNASE1L1			0.88	0.88	0.88	rs1050094 [];					0.8921					0.8	0.025	0.175	108		
chrX	153636858	153636858	G	C	hom	222	DNASE1L1			0.73	0.73	0.73	rs4898484 [];										0.3625	0.0125	0.625	40		
chrX	153637305	153637305	T	C	hom	222	DNASE1L1			0.73	0.73	0.73	rs2070807 [];										0.8125	0.025	0.1625	81		
chrX	153640061	153640061	T	-	hom	37.4	TAZ			0.81	0.81	0.81	rs11388353 [];								300394 [Tafazzin - Barth syndrome, 302060 (3);Cardiomyopathy, dilated, 3A, 300069 (3); Left ventricular noncompaction, X-linked, 300183 (3)];		0.5875	0.0125	0.4	66		
chrX	153649813	153649813	G	C	hom	222	TAZ			0.89	0.89	0.89	rs743547 [];								300394 [Tafazzin - Barth syndrome, 302060 (3);Cardiomyopathy, dilated, 3A, 300069 (3); Left ventricular noncompaction, X-linked, 300183 (3)];		0.8125	0.025	0.1625	137		
chrX	153657083	153657083	A	G	hom	152	ATP6AP1	synonymous SNV	ATP6AP1:NM_001183:exon1:c.A45G:p.R15R,	0.91	0.91	0.91	rs28497482 [];					0.9013					0.7875	0.025	0.1875	124		
chrX	153660041	153660041	C	T	hom	222	ATP6AP1			0.83	0.83	0.83	rs11156577 [];										0.3625	0.0125	0.625	39		
chrX	153660070	153660070	T	C	hom	222	ATP6AP1			0.35	0.35	0.35	rs3737557 [];										0.0625	0	0.9375	8		
chrX	153690397	153690397	T	A	hom	128	PLXNA3			0.25	0.25	0.25	rs5986979 [];										0.05	0	0.95	6		
chrX	153690716	153690718	TGG	-	hom	214	PLXNA3			0	0	0											0.05	0	0.95	6		
chrX	153693811	153693811	C	T	hom	222	PLXNA3	synonymous SNV	PLXNA3:NM_017514:exon12:c.C2289T:p.F763F,	0.29	0.29	0.29	rs5945429 [];					0.1324					0.075	0	0.925	21		
chrX	153694334	153694334	C	G	hom	222	PLXNA3	nonsynonymous SNV	PLXNA3:NM_017514:exon14:c.C2589G:p.D863E,	0.29	0.29	0.29	rs5945430 [];	1.0240	0.0000	0.9000	0.0000	0.1330					0.075	0	0.925	19		
chrX	153695908	153695908	G	T	hom	201	PLXNA3	synonymous SNV	PLXNA3:NM_017514:exon20:c.G3462T:p.A1154A,	0.19	0.19	0.19	rs60361517 [];					0.1329					0.075	0	0.925	21		
chrX	153696247	153696247	G	C	hom	222	PLXNA3	synonymous SNV	PLXNA3:NM_017514:exon21:c.G3723C:p.A1241A,	0.29	0.29	0.29	rs5987266 [];					0.1408					0.075	0.0375	0.8875	25		
chrX	153696913	153696913	C	T	hom	222	PLXNA3			0.26	0.26	0.26	rs7886727 [];					0.1313					0.05	0	0.95	14		
chrX	153697347	153697347	C	T	hom	222	PLXNA3			0.26	0.26	0.26	rs5986981 [];					0.1320					0.05	0	0.95	14		
chrX	153697656	153697656	T	A	hom	222	PLXNA3			0.09	0.09	0.09	rs45512498 [];										0.025	0	0.975	4		
chrX	153699364	153699364	G	C	hom	156	PLXNA3			0.29	0.29	0.29	rs5987267 [];										0.0625	0	0.9375	7		
chrX	153701716	153701716	A	G	hom	222	PLXNA3			0.21	0.21	0.21	rs5945431 [];										0.0875	0.0125	0.9	12		
chrX	153706264	153706264	C	G	hom	222	LAGE3			0.19	0.19	0.19	rs6567 [];					0.1104					0.075	0.0125	0.9125	15		
chrX	153712888	153712888	C	T	hom	222	UBL4A			0.26	0.26	0.26	rs1063451 [];										0.075	0.0125	0.9125	11		
chrX	153713167	153713167	G	A	hom	222	UBL4A			0.29	0.29	0.29	rs7051615 [];										0.075	0.0125	0.9125	12		
chrX	153713451	153713451	C	T	hom	222	UBL4A			0.29	0.29	0.29	rs1050047 [];										0.075	0.0125	0.9125	12		
chrX	153713787	153713787	C	T	hom	222	UBL4A			0.29	0.29	0.29	rs7057286 [];	-1.7430	0.0000	0.6600							0.075	0.0125	0.9125	12		
chrX	153714030	153714030	G	T	hom	222	UBL4A			0.29	0.29	0.29	rs5945433 [];					0.1380					0.0625	0	0.9375	15		
chrX	153734787	153734787	T	A	hom	222	FAM3A			0.27	0.27	0.27	rs7611 [];										0.125	0.0125	0.8625	18		
chrX	153759858	153759858	T	C	hom	213	G6PD			0.31	0.31	0.31	rs1050757 [];										0.1125	0.0125	0.875	31		
chrX	153760508	153760508	A	G	hom	222	G6PD			0.31	0.31	0.31	rs2071429 [];					0.1327					0.075	0	0.925	27		
chrX	153760654	153760654	G	A	hom	222	G6PD	synonymous SNV	G6PD:NM_000402:exon11:c.C1401T:p.Y467Y,G6PD:NM_001042351:exon11:c.C1311T:p.Y437Y,	0.14	0.14	0.14	rs2230037 [];					0.1133					0.1125	0	0.8875	38		
chrX	153776155	153776155	C	G	hom	222	IKBKG			0.02	0.02	0.02	rs56262786 [];								300248 [Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase - Incontinentia pigmenti, type II, 308300 (3); Ectodermal dysplasia,hypohidrotic, with immune deficiency, 300291 (3); Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency, 300301 (3); Immunodeficiency,isolated, 300584 (3); {Atypical mycobacteriosis, familial}, 300636 (3); Invasive pneumococcal disease, recurrent isolated, 2, 300640 (3)];		0.05	0.0125	0.9375	15		
chrX	153813743	153813743	-	TTCTG	hom	27.5	CTAG1A;CTAG1B		CTAG1A:NM_139250:exon1:c.269+4->TTCTG;CTAG1B:NM_001327:exon1:c.269+4->TTCTG	0	0	0								225	300248 [Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase - Incontinentia pigmenti, type II, 308300 (3); Ectodermal dysplasia,hypohidrotic, with immune deficiency, 300291 (3); Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency, 300301 (3); Immunodeficiency,isolated, 300584 (3); {Atypical mycobacteriosis, familial}, 300636 (3); Invasive pneumococcal disease, recurrent isolated, 2, 300640 (3)];		0.0875	0	0.9125	17		
chrX	153880181	153880181	G	A	hom	33.3	CTAG2			0.46	0.46	0.46	rs2075897 [];										0.0625	0.0125	0.925	13		
chrX	153880830	153880830	A	C	hom	222	CTAG2	synonymous SNV	CTAG2:NM_172377:exon2:c.T345G:p.P115P,CTAG2:NM_020994:exon2:c.T345G:p.P115P,	0.46	0.46	0.46	rs4326559 [];					0.3799					0.2625	0.05	0.6875	53		
chrX	153881525	153881525	G	C	hom	222	CTAG2	nonsynonymous SNV	CTAG2:NM_172377:exon1:c.C265G:p.Q89E,CTAG2:NM_020994:exon1:c.C265G:p.Q89E,	0.45	0.45	0.45	rs17328091 [];	-3.2440	0.0001	1.0000	0.0160	0.3798					0.2625	0.05	0.6875	53		
chrX	153881773	153881773	T	C	hom	71.1	CTAG2	nonsynonymous SNV	CTAG2:NM_172377:exon1:c.A17G:p.Q6R,CTAG2:NM_020994:exon1:c.A17G:p.Q6R,	0	0	0	rs17855367 [];	-0.2020	0.0000	1.0000	0.1390						0.2125	0.025	0.7625	27		
chrX	153904473	153904473	C	T	hom	222	GAB3			0.46	0.46	0.46	rs4431759 [];										0.275	0.05	0.675	37		
chrX	153994596	153994596	G	T	hom	222	DKC1	synonymous SNV	DKC1:NM_001142463:exon5:c.G369T:p.T123T,DKC1:NM_001363:exon5:c.G369T:p.T123T,	0.99	0.99	0.99	rs2728532 [];	-2.1510				1.0000			300126 [Dyskerin - Dyskeratosis congenita-1, 305000 (3); Hoyeraal-Hreidarsson syndrome,300240 (3)];		0.975	0	0.025	210		
chrX	154009618	154009618	G	-	hom	80.5	MPP1			0	0	0	rs11318110 [];										0.325	0.0375	0.6375	46		
chrX	154013484	154013484	-	C	hom	36.5	MPP1			0	0	0	rs59913063 [];										0.275	0.05	0.675	27		
chrX	154020114	154020114	C	A	hom	222	MPP1	synonymous SNV	MPP1:NM_001166460:exon3:c.G204T:p.T68T,MPP1:NM_001166461:exon3:c.G255T:p.T85T,MPP1:NM_001166462:exon4:c.G165T:p.T55T,MPP1:NM_002436:exon3:c.G255T:p.T85T,	0.62	0.62	0.62	rs1126762 [];					0.7225					0.65	0.0375	0.3125	103		
chrX	154045229	154045229	G	A	hom	222	MPP1;SMIM9		MPP1:dist=11427;SMIM9:dist=6394	1	1	1	rs113790313 [];										0.9625	0	0.0375	89		
chrX	154064580	154064580	T	C	hom	222	F8			1	1	1	rs1396947 [];								300841 [Coagulation factor VIII, procoagulant component - Hemophilia A, 306700 (3)];		0.95	0	0.05	153		
chrX	154158285	154158285	G	C	hom	222	F8	nonsynonymous SNV	F8:NM_000132:exon14:c.C3780G:p.D1260E,	0.25	0.25	0.25	rs1800291 [];	-0.2820	0.0000	1.0000	0.0000	0.1736			300841 [Coagulation factor VIII, procoagulant component - Hemophilia A, 306700 (3)];	RCV000033892.2 [non-pathogenic]; 	0.15	0.0125	0.8375	38		
chrX	154194989	154194989	C	T	hom	187	F8			0.09	0.09	0.09	rs7058826 [];					0.1488			300841 [Coagulation factor VIII, procoagulant component - Hemophilia A, 306700 (3)];		0.05	0.0125	0.9375	14		
chrX	154283899	154283900	AC	-	het	27.5	FUNDC2			0	0	0								237			0	0.0375	0.9625	3		
chrX	154456747	154456747	A	G	hom	222	VBP1	nonsynonymous SNV	VBP1:NM_003372:exon4:c.A367G:p.M123V,	1	1	1	rs572013 [];	1.0640	0.0000	1.0000	0.0000						0.9625	0	0.0375	144		
chrX	154467457	154467457	C	T	hom	222	VBP1			0.43	0.43	0.43	rs11887 [];										0.25	0.05	0.7	34		
chrX	154488432	154488432	G	A	hom	222	RAB39B			0.37	0.37	0.37	rs3105275 [];								300774 [Ras-associated protein RAB39B - Mental retardation, X-linked-72, 300271 (3)];		0.2125	0.05	0.7375	50		
chrX	154507173	154507173	T	G	hom	222	CLIC2			0.33	0.33	0.33	rs559165 [];					0.2359					0.2125	0.05	0.7375	34		